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Thesis Summary 
Lyophilisation or freeze drying is the preferred dehydrating method for pharmaceuticals 
liable to thermal degradation. Most biologics are unstable in aqueous solution and may use 
freeze drying to prolong their shelf life. Lyophilisation is however expensive and has seen 
lots of work aimed at reducing cost. This thesis is motivated by the potential cost savings 
foreseen with the adoption of a cost efficient bulk drying approach for large and small 
molecules. 
Initial studies identified ideal formulations that adapted well to bulk drying and further powder 
handling requirements downstream in production. Low cost techniques were used to disrupt 
large dried cakes into powder while the effects of carrier agent concentration were 
investigated for powder flowability using standard pharmacopoeia methods. This revealed 
superiority of crystalline mannitol over amorphous sucrose matrices and established that the 
cohesive and very poor flow nature of freeze dried powders were potential barriers to 
success. Studies from powder characterisation showed increased powder densification was 
mainly responsible for significant improvements in flow behaviour and an initial bulking agent 
concentration of 10-15 %w/v was recommended. 
Further optimisation studies evaluated the effects of freezing rates and thermal treatment on 
powder flow behaviour. Slow cooling (0.2 °C/min) with a -25°C annealing hold (2hrs) 
provided adequate mechanical strength and densification at 0.5-1 M mannitol 
concentrations. Stable bulk powders require powder transfer into either final vials or 
intermediate storage closures. The targeted dosing of powder formulations using volumetric 
and gravimetric powder dispensing systems where evaluated using Immunoglobulin G (IgG), 
Lactate Dehydrogenase (LDH) and Beta Galactosidase models. Final protein content 
uniformity in dosed vials was assessed using activity and protein recovery assays to draw 
conclusions from deviations and pharmacopeia acceptance values. A correlation between 
very poor flowability (p<0.05), solute concentration, dosing time and accuracy was revealed. 
LDH and IgG lyophilised in 0.5 M and 1 M mannitol passed Pharmacopeia acceptance 
values criteria with 0.1-4 while formulations with micro collapse showed the best dose 
accuracy (0.32-0.4% deviation). Bulk mannitol content above 0.5 M provided no additional 
benefits to dosing accuracy or content uniformity of dosed units. This study identified 
considerations which included the type of protein, annealing, cake disruption process, 
physical form of the phases present, humidity control and recommended gravimetric transfer 
as optimal for dispensing powder. Dosing lyophilised powders from bulk was demonstrated 
as practical, time efficient, economical and met regulatory requirements in cases.  
Finally the use of a new non-destructive technique, X-ray microcomputer tomography 
(MCT), was explored for cake and particle characterisation. Studies demonstrated good 
correlation with traditional gas porosimetry (R2 = 0.93) and morphology studies using 
microscopy. Flow characterisation from sample sizes of less than 1 mL was demonstrated 
using three dimensional X-ray quantitative image analyses. A platinum-mannitol dispersion 
model used revealed a relationship between freezing rate, ice nucleation sites and variations 
in homogeneity within the top to bottom segments of a formulation.  
 
Key words/phrases: Lyophilisation, Bulk drying, Particle characterisation, Flowability, 
Powder technology.  
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1  INTRODUCTION 
1.1 The Pharmaceutical Industry and Freeze drying 
There is continued movement for protein research as potential therapeutics due to progress 
made in understanding their role in the human body and the ease of production in large 
volumes (Sarciaux et al., 1995). Most proteins are unstable in aqueous solution and may 
use freeze drying to prolong their shelf life. Freeze drying or lyophilisation is a drying 
process used for converting solutions of labile materials into dry solids of sufficient stability 
for distribution and storage (Pikal, 2007). By the end of 2003, lyophilised biologicals 
contributed to 46% of all US Food and Drug Administration (FDA) market approvals in the 
biopharmaceuticals category which include vaccines, proteins and peptides (Costantino and 
Pikal, 2004). Proteins and peptides are the most rapidly growing class of drugs and had an 
increased growth rate globally in 2009 of 10.9% (Yang et al., 2009). Formulation strategies 
for current FDA approved vaccines including those adopting freeze drying to overcome the 
cold chain have been reviewed (Kumru et al., 2014). Many studies also continue to focus on 
molecular dynamics in proteins and their freeze drying behaviour in highly concentrated 
formulations (Geidobler et al., 2013, Xu et al., 2014, Hill et al., 2014). 
The demand for freeze drying is not expected to slow over the next decade as many smaller 
freeze drying entities or contract manufacturers continue to invest time into acquiring 
intellectual property along wider business themes. The global market for lyophilisation has 
been forecasted to be worth $3.25bn by 2015 (Visiongain, 2011). 
Freeze drying to date has continued to offer numerous benefits over other drying methods 
which include evapourative and spray drying processes (Walters et al., 2014). Freeze drying 
is a widely accepted method for drying of injectable, offering sterility control from fill to finish; 
it provides the least thermal degradation, controls moisture in the final product as well as 
allowing easier resolution of scale up problems (Pikal, 2007). Freeze drying is however 
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financially expensive (Ratti, 2001, Niazi K. Sarfaraz, 2004) and processes targeted at cost 
reduction are highly welcomed by manufacturers. This has been the motivation of many 
studies in literature and includes this thesis. 
 
1.2  Freeze drying system components  
1.2.1 Origin 
Centuries before the term freeze drying or lyophilisation was coined, the Peruvian Incas 
harnessed the sun's radiative heat energy together with the low pressure afforded at high 
altitudes to dehydrate frozen meat (Rey and May, 1999). The history of freeze drying or 
lyophilisation has been discussed (Rey and May, 1999); with much of the pioneering 
contributions in the early 20th century. The term lyophilisation was coined in 1935 and was 
used for the large scale drying of human plasma during World War 2. Initial reports of 
success for drying vaccines and antibiotics were also mentioned. 
 
1.2.2 Freeze drying process  
The freeze drying process is comprised of three main stages: freezing, primary drying and 
secondary drying. An equilibration step is often included prior to beginning the freezing 
process to assure all liquids are at the same temperature. This involves keeping a 
formulation batch usually at room temperature for a short period before initialising chilling. 
This is to a lesser extent a measure to minimise batch variation although the control of ice 
nucleation (control of ice crystal formation and growth) or annealing (thermal hold treatment) 
in batches will be required to minimise inter and intra batch variation.  
20 
 
The underpinning principle of freeze drying surrounds an understanding of the phase 
diagram of water (Figure 1.1). A liquid formulation solidifies during freezing which must be 
complete before a vacuum is pulled to prevent frothing (Aulton, 2007). 
A frozen product is then supplied with heat energy (latent heat of sublimation) at the primary 
drying stage using a vacuum pressure below the triple point of water. 
 
 
Figure 1.1: Phase diagram of water. Under reduced pressure below 610Pa, liquid frozen (1) to 
solid (ice) can be converted to vapour via sublimation (2) by supplying heat energy (heat of 
sublimation). Image adapted from Aulton (2007).  
 
For sublimation to occur, the heat of sublimation of ice which is 2900 KJkg-1 must be 
supplied (Aulton, 2007). At the end of the sublimation (primary drying stage), all bulk ice is 
removed and any remaining moisture is removed by desorption during the secondary drying 
stage which can require higher elevated temperatures. The economics of the freeze drying 
process are driven largely by the primary drying stage which can be slow and last for long 
periods depending on the chosen freeze drying cycle parameters. 
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Sadikoglu and Liapis (1997) modelled primary and secondary drying stages of a bulk 
solution freeze dried in a tray to describe the transport mechanism of water vapour and inert 
gases through the pores of a bulk dried layer (Figure 1.2). Experimental and mathematical 
model showed the major mechanism of mass transfer were the removal of bound water from 
the solute phase, Knudese diffusion and bulk diffusion.  
 
 
Figure 1.2: Schematic of a solution undergoing bulk freeze drying in a tray. Heat supplied to 
the surface of the dried layer (H1) is by conduction, convection or radiation from the gaseous 
composition in the drying chamber. Thermal transfer from the shelf (H2) is by conduction 
through the bottom of tray subsequently through the frozen matrix towards the sublimation 
front. H3 represents the amount of heat in the vertical sides of the tray or thermal transfer 
between the drying chamber and vertical sides of the tray. Total mass flux is the sum of mass 
transfer of water vapour and inert gas. H3 is relatively negligible and less than H1 or H2. Image 
adapted from Sadikoglu and Liapis (1997). 
 
Lyoprotectant protection of proteins during freeze drying is by either the virtification or water 
replacement hypotheses. But neither mechanism in isolation can fully explain lyoprotection 
(Li et al., 2005). The virtification hypothesis assumes a rigid glass matrix is formed by 
excipients and immobilises the protein mechanically. This results in a restriction of 
translational and relaxation processes capable of protein unfolding and spatial separation 
between protein molecules thus preventing aggregation (Li et al., 2005). The water 
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replacement hypothesis proposes that hydrogen bonds are formed between excipients, 
polar and charged groups on proteins prior to the drying process which replace previous 
bonds with water. Carpenter and Crowe (1989) showed the 1583 cm-1 band of lysozyme 
from fourier transform infrared (FTIR) due to hydrogen bonding of water to the carboxylate 
groups was absent after lyophilisation. Lysozyme however was found to retain the band 
when dried in the presence of sucrose. 
It’s important to stress the importance of the choice of formulation components as it 
influences attributes of the final dried cake because a poor formulation will yield a dried cake 
of questionable quality. 
 
1.3 Fundamentals of the freeze dryer 
Acquisition of freeze drying equipment is a large capital investment. Machine cost together 
with the man hours and long product drying times make the process expensive. Freeze 
dryers consist of a refrigeration unit made up of shelves, a condenser and vacuum pump 
attachment. The drying chamber houses the shelves which hold the products and typically a 
condenser which may be beneath the shelf or externally positioned. 
 
1.3.1 Refrigeration 
Refrigeration is required for cooling the shelf and process condenser using either 
compressed gases (conventional refrigeration) or liquid nitrogen options. A conventional 
refrigeration unit is comprised of a compressor, condenser heat exchanger, capillary or 
expansion valve and evapourative heat exchanger (Wood, 2000). The refrigerant which is 
initially a low pressure vapour is compressed by a reciprocating compressor into a high 
pressure vapour. This is discharged to a condenser heat exchanger where it is condensed 
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into a high pressure warm liquid before being passed on through a capillary or expansion 
valve. The latter is responsible for regulating flow to the evapourator and reduces the 
pressure of the liquid refrigerant. At the evapourative heat exchanger, the now cold low 
pressure liquid received from the expansion valve is evapourated into a gas. The latent heat 
of evapouration required is obtained from the freeze dryer’s circulating silicone oil within the 
evapourator which cools the dryer. The vapour is pumped back into the compressor and the 
refrigeration cycle continues.  
The process condenser typically attains extremely low temperatures in the range of -70°C to 
-75°C before the start of primary drying. The resulting temperature differential between the 
drying chamber and the process condenser is a driver for the collection of sublimed gases 
onto the condenser surface. The other driver is the lower vapour pressure at the condenser 
compared to the product. Condenser capacity is usually specified as the maximum amount 
of water in litres it is capable of holding on its surface, and is referred to as the ice capacity. 
It may be designed as a coil or plate and found either internal or external to the freeze dryer 
chamber. 
 
1.3.2 Pumps and vacuum 
A vacuum pump is required to attain chamber pressures below the triple point of water 
where gas, liquid and solid phases exist in equilibrium. Vacuum pumps vary in their mode of 
operation and can be grouped into two main classes (Umrath, 2007). A class of pumps work 
using compression stage(s) to remove gas molecules from the chamber followed by ejection 
using displacement or pulse transfer into the atmosphere. The other class removes the gas 
molecules by condensation or other means of bonding onto a surface (Umrath, 2007).  
A two stage rotary vane pump which is a form of compression pump was used in these 
studies, capable of pulling vacuums of up to 0.001 mbar. Other types of compression 
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vacuum pumps include root, turbo molecular and vapour pumps (Umrath, 2007) which may 
pull greater vacuums but are of specific use typically for small volume systems.  
Pirani gauge and capacitance manometers are the commonly used pressure measurement 
tools (Patel et al., 2010). Both measure pressure with specific limitations. These limitations 
now form part of a commonly used process analytical tool (PAT) in freeze drying to monitor 
the process.  
 
1.3.3 Types of freeze dryers 
Freeze dryers differ in size, total shelf area, condenser capacity, condenser type (Plate or 
coil), position of the condenser (external or internal) and can be broadly categorised into 
bench top, pilot and production scale dryers (SP Scientific, 2014c). Some bench top dryers 
are often used in research and have condenser ice capacities in the range of 3-9 litres. 
Bench top dryers support vertical and drum manifolds which are useful for drying materials 
on tray racks or in flask attachments. Here the condenser is usually internally positioned. 
Production or commercial scale dryers are considered the largest freeze dryers with 
predominately externally positioned condensers with ice capacities in excess of 40-800 
litres. Pilot dryers are commonly used for production of products during clinical trials and are 
useful for small entities or small contract manufacturers. The design specification for pilot 
scale machines is between the bench and production scale dryers.  
 
1.3.4 Temperature measurement 
The temperature of the product throughout the freeze drying process is an important 
variable. Thermocouples are inserted at the bottom of product vials to inform the product 
temperature during cycles. Thermocouples are made of two different metal alloys connected 
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at a point called a hot junction (Morris and Langari, 2012, Kerlin and Johnson, 2012). This 
junction maintains a voltage difference (emf) which is measured at the open end of the 
thermocouple known as the reference junction (Morris and Langari, 2012, Kerlin and 
Johnson, 2012)  
The American Society for Testing and Materials (ASTM) have standardised letters (J, T, K, 
E, N, C, S, R, and B) assigned to the various types of metal based on their emf-temperature 
behaviour and not the alloy composition (Kerlin and Johnson, 2012). K type thermocouples 
made of nickel and alumel were used in our laboratory together with an eight channel data 
logger for monitoring the complete temperature profile drying cycles. K type thermocouples 
are useful across the temperature range of -200 to +1300°C within an accuracy of ± 0.75°C 
(Morris and Langari, 2012). They are not the most accurate at low temperatures but provide 
the best range for measurement at ambient temperatures and throughout freezing and 
drying.  
Resistive Temperature Detectors (RTDs) and thermistors are resistive temperature 
measurement devices which use a change in electrical resistance to measure temperature. 
RTDs show a linear relation for metals such as platinum, nickel and copper over a limited 
range to produce a measurable change in resistance as a function of temperature (Morris 
and Langari, 2012). Thermistors are made up of a combination of 2-3 metal oxides in a 
ceramic with lead wires connected to a semiconductor chip (Wilson, 2005). 
 
1.4 Efficient Processing of Lyophilised Formulations 
Rational approaches and considerations for cost-efficient, short-cycle development with 
emphasis on bulk freeze drying are next discussed. It must be noted that published work on 
pharmaceutical freeze drying can be drawn from a variety of backgrounds. This may include 
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food, vial or spray systems and we aim to draw information from these studies towards these 
aims. 
Material quality is affected across all stages of lyophilisation and has been reviewed 
extensively; (I) stabilisation (Rathore and Rajan, 2008) (II) freezing (Kasper and Friess, 
2011) (III) primary drying (Franks, 2007a, Mellor, 1978) (IV) secondary drying (Franks, 
2007b, Pikal et al., 1990) (V) back fill and (VI) product sealing (Gassler, 2004, Chang and 
Liu, 2011, Zingle and George, 1997). 
We characterise quality factors as the term given to the individual priorities developers place 
on distinct aspects of a formulation to define its final acceptance. We intend to discuss some 
of the most common quality factors assigned to lyophilized products examining each for its 
implications and limitations. It is never the case that all factors can be maximised, a rational 
selection based on the formulation must be achieved. The economics of freeze drying do not 
allow for both the cost-efficient production and ability to obtain the highest quality score 
across all descriptors, with a mixture of factors being the most common outcome. 
 
1.4.1 Morphology 
Physical appearance is the most common quality factor for any product. However, its priority 
with respect to other descriptors is important. It would be important to describe any particular 
appearance in colour, shape, texture or porosity that is a priority, as during cycle design 
colour may be lost without affecting taste. 
The morphology of a freeze dried cake is often seen to provide reassurance of quality to an 
end user. In particular, physicians are known to reject materials with poor visual appearance. 
It is largely a subjective measure but a cake volume representative of the original frozen 
mass with consistent colouring and minimum surface abnormalities are typically considered 
ideal freeze dried materials. 
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To alter morphology, annealing during the freezing step can be adopted. To anneal a 
formulation it is held frozen at an elevated temperature for an extended period often above 
the glass transition temperature of the maximally frozen concentrate (Tg’) or eutectic 
temperature. The crystal reorganisation of ice and eutectic phases will often reduce product 
resistance during sublimation with a resultant decrease in primary drying time (Chang and 
Patro, 2004). 
Processing of freeze dried materials as dried products demands free flowing powders and is 
found in both food (Mumenthaler and Leuenberger, 1991, Quispe-Condori et al., 2011) and 
pharmaceutical industries (Garmise et al., 2006, Maa et al., 2003); careful characterization 
of the morphology is needed to allow processing or packing. Primary drying temperatures 
above glass transition or collapse are known to significantly affect morphology producing 
shapes pyramidal in structure or high moisture content film residues. To maintain flow 
properties a consistent morphology must be demanded (Howard, 2007). 
  
Figure 1.3: Three-dimensional cross-sectional X-ray MCT into packed powders. Left: Freeze-
dried mannitol powder. Right: Fluid bed dried mannitol powder. Scale bar: 1.25 mm 
 
X-ray micro-computed tomography (X-ray MCT) is allowing the investigation of the micro-
structure of lyophilized powders (Figure 1.3) providing data on surface area, particle 
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orientation and particle size distribution of the freeze dried powders. Parker et al. (2010) 
quantitatively studied the micro-collapse of Bovine Serum Albumin lyophilized cakes, 
correlating porosity and connectivity with electron microscopy images in freeze dried cakes. 
It is suggested that the non-destructive analysis of powders with this technique may expand 
to allow characterization of characteristics as diverse as flow and dissolution through surface 
area and geometric modelling. Unlike scanning electron microscopy (SEM) it has the ability 
to examine the internals of a sample without disruption of the original sample-defining 
morphology within the highly heterogeneous freeze dried cakes. X-ray MCT is described in 
more detail in section 3.4.12 and employed in studies later in chapter 6. 
 
1.4.2 Activity 
Intrinsic activity of an Active Pharmaceutical Ingredient (API) will affect the priority of any 
activity quality factor during cycle design. Although bulk freeze drying is commonly used for 
small molecules (Baheti, 2010) such as antibacterials (e.g., Azithromycin (Pfizer, 2011), 
Clarithromycin and anticancer agents e.g. Doxorubicin, Cisplatin (Asociation of British 
Pharmaceutical Industry (ABPI), 2008) there have been clear trends to explore larger 
sensitive bio-molecules. 
Small drug molecules are intrinsically robust through primary and secondary drying. 
Extensive reviews of small molecules (Baheti, 2010), biopharmaceuticals (Costantino, 2004) 
and their excipients approved over the decades by the Food and Drug Administration (FDA) 
have been made. Common concerns for small molecules during lyophilisation include 
avoidance of melt back as a result of change from solid to a liquid state during primary 
drying (Niazi K. Sarfaraz, 2004). 
Protein API’s have particular stability issues and require careful control of sublimation below 
critical processing temperatures (Tc or Tg’) to avoid activity loss (Wang, 2000). The three-
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dimensional structure of proteins make them particularly sensitive to over drying or under 
drying, requiring carefully titrated levels of moisture within the powdered state (Pikal et al., 
1990). 
 
Obtaining a frozen matrix of a solution can often determine final activity. During the freezing 
step high degrees of super cooling affect activity recovery for enzymes with an inverse 
relationship between the level of super cooling and activity (Cochran and Nail, 2009). The 
higher interfacial areas between ice and concentrated solute enhance adsorption and have 
been linked to reduced activity caused by aggregation and protein unfolding (Cochran and 
Nail, 2009, Strambini and Gabellieri, 1996, Chang et al., 1996, Sarciaux et al., 1999, Webb 
et al., 2002); however, for other typically smaller API’s the interfacial area is of less 
significance. Adopting a reproducible ice nucleation process is desirable. Simple and more 
advanced ice nucleation techniques have been studied using; nucleating agents (Cochran 
and Nail, 2009, Searles et al., 2001a, Searles et al., 2001b), ultrasound (Kasper and Friess, 
2011, Passot et al., 2009), ice fog (Rambhatla et al., 2004, Padilla et al., 2011) and electric 
filed (Petersen et al., 2006) which are discussed by Bursac et. al. (2009). A more recent 
approach involves pressurisation of the product chamber with argon gas to 26-28 psig, 
cooling to a desired nucleation temperature and de pressurising the chamber to 1 psig 
triggering a precise nucleation point (Konstantinidis et al., 2011). The aim of all nucleation 
methodologies is to avoid high degrees of super cooling and induce controlled nucleation at 
high temperatures for production of large ice crystals with minimal batch variation (Searles et 
al., 2001b). The large ice crystals formed minimise the ice water interface preventing protein 
adsorption and the consequential denaturation while maximizing recovery (Cochran and 
Nail, 2009, Passot et al., 2009, Bursac et al., 2009). 
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1.4.3 Dissolution 
High dissolution rates for freeze dried materials are common. However, where further 
enhancement is required, choice of excipients and cycle design may affect a product 
significantly. Non-reducing sugars are commonly used excipients and the use or 
optimisation of the differing physical states of a formulation can affect the dissolution as 
defined in the Noye’s Whitney equation (Noyes and Whitney, 1897) as adapted: 
 (
  
  
)  (
 
 
) (      )  (1.1) 
Equation 1.1: Where ‘D’ is the diffusion coefficient (of the active molecule), h is 
the thickness of the diffusion layer surrounding a surface (A). Cs is the saturation 
solubility of the drug in the diffusion layer. Ct is the concentration of the drug in 
the reconstitution medium at time t. dm is the mass change in solution over a 
period of time (dt). 
Formulations with a high level of nucleation sites produce small ice crystals with a resultant 
large surface area and porosity. This change in surface area (A) provides a higher 
dissolution rate (dm/dt) for a short reconstitution time. In contrast, annealing produces large 
ice crystals with small surface area in the associated phase (A) this increases reconstitution 
time (dm/dt). This effect was seen as an 18-fold decrease in dissolution rate for recombinant 
human interferon-γ cakes (Webb et al., 2003). 
Solutions with high masses of dissolved solute are seen to reduce the level of crystallinity 
(D) during freezing often forming amorphous disorganised states. Freeze-dried pegylated or 
high-level sucrose (>50 mg/mL) systems have often been shown to have shortened 
reconstitution times (Mosharraf et al., 2007). Other approaches have included altering the 
reconstitution medium (Cs) or resorts to modify the actual API (D) (Costantino, 2004). 
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1.4.4 Long-term Storage 
Storage can be considered effective in even poor freeze drying processes; this is due to 
degradation rates in powders often being in orders of magnitude less than those of the 
solution. For bulk freeze dried materials a long-term storage of two years would be a 
common expectation. 
The degradative processes common to lyophilisation are predominated by hydrolysis (Wang, 
2000). Careful optimisation of the secondary drying phase (Pikal et al., 1990) can minimise 
the final water content while avoiding over drying or scorching of a powder. 
Selection and control of excipients can extend the shelf life of products. Fully crystallised 
mannitol was shown to prevent escalation of moisture levels in Bacillus Calmette-Guérin 
(BCG) vaccine on long-term storage (Jin et al., 2011). Conversely, many proteins have been 
reviewed to show damage when exposed to crystallisation during storage (Wang, 2000). It is 
of particular note that unstable excipients may release moisture to a system or change on 
extended storage. An unstable mannitol hydrate required extension of the secondary drying 
period by 13 hours to transform the powder state for long-term storage (Johnson et al., 
2002). In these cases, it is important to have a clear understanding of the degradative 
stresses for the individual API and control crystallisation through annealing and the 
regulation of moisture levels. 
Exclusion of reducing agents is common; these slow reduction reactions are able to damage 
API’s over extended periods of storage. The Maillard reaction describes when reducing 
sugars are oxidised by amino acids producing a browning of a formulation over long periods, 
moisture levels can retard or accelerate such a reaction (Wang, 2000, Kadoya et al., 2010). 
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1.4.5 Cost 
Although not a direct factor for a formulation, the economics (Franks, 2007c) of a freeze 
drying process may override all other quality factors. This is particularly the case for low-
value solutions; but may be particularly of concern for re-optimisation of an existing freeze 
drying cycle or development of a generic pharmaceutical copy. The cost of freeze drying 
cycles is often dictated by how well optimisation was performed to allow scale up. Scale up 
of freeze drying cycles has been discussed in depth (Trappler, 2007), with particular 
importance placed on the monitoring and feedback of this information to the stages of 
drying. Limitations of the final production machine should be considered, as fast cycles often 
include high rates of drying requiring equally high condensation rates not available on all 
systems. 
The cost of maintaining high vacuums and providing both low temperatures for condensation 
and high temperatures for sublimation drives the economic cycle around the batch 
production of freeze dried items. Labour provides additional expense when a cycle is unable 
to complete on a convenient daily cycle resulting in driers being active but not productive. 
Any process that can be adapted to reduce these running times or minimise staff will benefit 
the associated costs. Bhambhani and Medi (2010) discussed primary packing in detail, while 
it was clear bulk drying provided the most basic of container system its use can be 
economical. Bulk freeze drying maximizes shelf area minimizing costs of thermal transfer. 
Avoiding fill depths in excess of 2 cm is common to prevent product resistance to vapour 
flow limiting the maximum primary drying rate (Tang and Pikal, 2004). However, products of 
high solute content may require special attention to prevent significant extension of the 
primary and secondary drying periods (Tang and Pikal, 2004). High super-cooling rates are 
to be avoided as production of large numbers of small ice crystals increases final product 
surface area increasing product resistance to vapour flow during sublimation and increase 
total running time (Pikal, 2007, Passot et al., 2009). Nucleation at higher temperatures is of 
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particular use in the production of large contiguous ice crystals suitable for higher 
sublimation rates (Searles et al., 2001b, Bursac et al., 2009). 
The role of controlled ice nucleation on the total length of some newly developed cycles may 
be self-limiting since any resulting decrease in sublimation time may be offset by an increase 
in desorption time (Passot et al., 2009). However, practically it appears that controlled 
nucleation does provide benefit, cycle lengths reducing by between 14-41% (Passot et al., 
2009, Konstantinidis et al., 2011, Searles et al., 2001b). 
Membrane trays of polypropylene and polytetrafluoroethylene laminate have been proposed 
which are able to minimises product loss or blow out from trays (Patel and Pikal, 2011) 
during or at the conclusion of drying (Gassler, 2004). Gassler and Rey attributed the 
superior heat transfer observed in membrane trays to low thermal inertia. Membranes were 
associated with a 20-30% reduction in freezing time and have been linked with 20-30% 
reductions in drying time when compared with stainless tray systems. However, the 
advantages of stainless steel trays are lost and product transfer may become restricted with 
less protection from rupture of the container. It is also clear that membrane sealed trays may 
demand a lowering of the sublimation rate requiring increased cycle lengths due to container 
resistance (Mayeresse Y. et al., 2009). 
The rule of thumb that a 1°C rise in product temperature will decrease primary drying time 
by about 13% is commonly quoted (Tang and Pikal, 2004) and governed by the sublimation 
rate defined by (Chang and Patro, 2004): 
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)  (   ) 
Where ‘dm/dt’ is the sublimation rate or mass transfer for water vapour (kg/s), ‘P0’ is vapour 
pressure of ice at the product temperature (Pa), ‘Pc’ is chamber pressure (Pa), Rp is product 
resistance (Pa.s/kg) and ‘Rs’ is stopper resistance (Pa.s/kg). During sublimation an 
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increasing thickness of dried layer forms. This layer resists the flow of water vapour through 
the solidifying cake with no direct proportionality to mass flow. It is unaffected below collapse 
temperatures but may show dependence to any resistance within the container used. 
Defining critical formulation temperatures is key for cost reduction over the long term. By 
using temperatures close to those for formulation collapse or glass state transition energy 
transfer is maximized, maintaining the highest sublimation rates possible. These 
temperatures can be exploited in the process of micro-collapse when the lower resistance of 
the dry layer between Tg’ and Tc allows enhanced rates of sublimation to be achieved. 
High protein or solute concentration may contribute to alterations in the Tg’ or collapse of a 
formulation. Increased Bovine serum albumin (BSA) concentration has been found to 
increase Tg’ and Tc allowing aggressive drying temperatures (Parker et al., 2010). Despite a 
low -32°C Tg’ for sucrose, 5 mg/L and 50 mg/L BSA can be successfully dried with a 25°C 
shelf temperature in the presence of sucrose with cakes finally exhibiting 2 year stability 
profiles in line with those freeze dried at -25°C (Parker et al., 2010). 
Crystallising agents may provide scaffolds to allow micro-collapse while maintaining macro 
structure by taking advantage of the high eutectic temperatures of sugars or salts. Mannitol 
sucrose mixtures have been dried at -10°C while avoiding visual signs of macro-collapse, 
exploiting the high eutectic temperature of mannitol -1.5°C (Pikal, 2007). Care, however, 
must be taken to consider the consequences of incomplete crystallisation for long-term 
behaviour. 
Pharmaceutical scientists who bulk freeze dry need to foremost identify what quality factors 
are of a priority during cycle development since the economics of freeze drying do not allow 
for both the cost-efficient production and the ability to obtain the highest quality score across 
all quality factors. Consider; morphology, activity, dissolution, long-term storage, packaging 
and cost. 
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1.5 Current state of the art in freeze drying from the patent landscape 
It is often the case for advances in research to be protected by initial intellectual property; 
usually patented before disclosure in general literature. The 18 months lag between filling of 
patents and publication means most novelty is hidden or unknown for years. This makes the 
patent literature a useful source for industrial trends. The patent literature has been 
examined (unpublished data) for expiring patents and current (2010 – 2013) trends in freeze 
drying. The patents of relevance are discussed in the context of this thesis to highlight 
trends. 
 
1.5.1 Container systems 
As a batch process freeze drying for parenteral applications has typically focused on a 
container or vessel within which the material is freeze dried. GE Healthcare UK Limited 
(2013) recently disclosed a series of container systems (Figure 1.4) suitable for small 
volume drying which suggested a focus on diagnostic uses. Proposing an application for 
polymerase chain reaction (PCR) reagents, the plastic containers made of polycarbonate, 
polypropylene or polystyrene form bottle necks or ‘collars’ (Figure 1.4A). The collar 
separates the container into upper and lower sections retaining powdered material by 
locking it into a fixed position. The presence of angular prongs with textured surfaces (Figure 
1.4B) increase adhesion of the dried cake to the container. Individual containers can be 
arranged in a plastic tray with a sealing membrane of flexible foil or poly laminate covering 
analogous to the well-known lyoguard trays by Gore (Gassler and Rey, 2004). The 
combination appears well suited to address the concerns of friable powder volumes if there 
is sufficient mass to be fixed by the prongs.  
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Figure 1.4: Schematic of container systems disclosed by GE Healthcare (GE Healthcare UK 
Limited, 2013). (A) Vial or 96 well plate system to incorporate a collar to prevent movement of 
the powdered cake on completion of freeze drying. (B) Larger cakes can be held by angular 
prongs that hold the powder in position and prevent it from movement if upturned. (C) Small 
volume system for diagnostic reagent (or similar) that considers the small surface contact 
area of dried powder for easing reconstitution. 
 
Regulatory considerations for complete vial closure under grade A would have been a clear 
focus of the Datwyler container closure for vials (Figure 1.5A) (Datwyler Pharma Packaging 
International, 2013b). It provides for the sealing and crimping of vials within the grade A (EU 
GMP) inside the freeze drier (Datwyler Pharma Packaging International, 2013a). While this 
appears useful, the industry priority for ease of reconstitution by medics or professionals with 
a reduced skill set has seen the disclosure of a variety of syringe freeze drying combinations 
which will compete with such technology. Eulysis UK Limited (2013) disclosed a single 
component vial system where the freeze dried powder is encased within the cap or closure 
of the vial (Figure 1.5 B). Drying of the API is done in the cap with compression of cap 
breaking the base of the cap and releasing the API for reconstitution. Glucago and Lyogo 
LLC disclosed the inner workings of a series of syringes for reconstitution of freeze dried 
formulations (Bartlett. et al., 2013). In a peculiar version, the seal separating the 
reconstitution and diluent chambers within the syringe is fused with a thread/wire made of an 
inert material which runs axially though the attached needle of the device (Figure 1.5 C).   
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Figure 1.5: Schematic of container closures and reconstitution syringe. (A) Container closure 
for vials with the potential for grade A crimping (Datwyler Pharma Packaging International, 
2013b). The crimp is shown held in place during drying and with pressure applied from above 
the outer casing is able to provide a crimp seal to the stopper. (B) Provides for a material 
freeze dried into an initial stopper to be pressed and break at the point marked; releasing 
powder into a reconstitution chamber (Eulysis UK Limited, 2013). (C) Two compartment 
syringe with a separation membrane that can be broken by pulling the plunger with an 
attached thread. Breaking this separation releases the reconstitution fluid in this case from the 
upper chamber (Bartlett. et al., 2013).  
 
The radiative properties of a material can be represented by the emissivity coefficient; glass, 
stainless steel and PTFE have relative emissivity’s of 0.22 0.92 and 0.78 respectively 
(Middlebeek et al., 2009). Middlebeek et al. (2009) reported the use of a black carbon filled 
polyethylene terephtalate to maximise the emissivity of a plastic for freeze drying heat 
radiation.  
Container patents that have entered an expiry period include the Cryopharm collapsible 
blood bag (Figure 1.6 A-B). Designed as flexible, polyvinylchloride film plasticised with 
diethyl hexyly phthalate is reinforced through the insertion of rods to maintain the structure of 
side walls during freeze drying (Cho et al., 1992). The bag system also provides for 
disruption of the freeze dried material prior to reconstitution while sealed. This appears 
intended to provide reduction in shipping or storage volume of the dried material and also 
direct infusion from bag when hanged. 
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Boehringer Mannheim GmbH (1994) disclosed a similar bag or tube composed of 0.5-1 mm 
impermeable resin base with a hermetically sealed membrane (Figure 1.6 B). Sealed with a 
0.2 µm semi permeable membrane of cellulose derivatives and polytetrafluoroethylene it 
appears to provide the same minimal mass flow resistance of current tray systems 
(Lyoguard™). 
The laminated blister packs of Scherer preventing the warping of thin sheets of freeze drying 
blister trays through incorporation of a 45 µm aluminium sheet within a polyvinylchloride, 
polyproplylene or polyamide combination to provide a similar overall co-efficient of thermal 
expansion (Scherer Ltd, 1994). These appear to remain significant for continued or future 
use and indeed relate well into the diagnostic areas of freeze drying previously identified. 
Figure 1.6: Schematic of bulk drying containers. (A-B) A collapsible blood bag for 
lyophilisation (Cho et al., 1992) capable of been re-enforced with rods. The large circular area 
is an exit for sublimed materials with a described aseptic consideration. (C) Sealed tray 
system with semi permeable membrane of practical use in aseptic conditions (Boehringer 
Mannheim GmbH, 1994). (D) Composite materials described to prevent a tray system warping 
during freeze drying e.g. Oral dispersible tablets or for very thin bulk drying trays (Scherer Ltd, 
1994).  
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1.5.2 Continuous flow and traditional tray freeze drying 
Emerging semi continuous and continuous freeze drying systems are allowing a shift from 
batch systems to draw on the cost benefits. Traditional tray drying or use of bulk containers 
are still in use in combination with novel approaches for producing particles for freeze drying.  
A recent patent disclosed by Takano and Gayama used stainless steel tray drying for 
processing dry yeast high in s-adenosyl-L-methionine for its potential use within 
nutriceuticals (Kentarou Takano and Shinyo Gayama, 2013). 
Sanofi has recently reported processing lines capable of semi continuous or continuous 
freeze drying for terminal powder dispensing (Sanofi Pasteur Sa, 2013b). An atomizing 
chamber freezes calibrated droplets (200-500 µm range) for aseptic transfer into a rotating 
drum freeze dryer housed in a vacuum controlled chamber (Sanofi Pasteur Sa, 2013c). 
Temperature controlled inner walls allow heat transfer for sublimation while an absence of 
stopper resistance and increased exposed surface area suggests potential decrease in 
drying times. There are clear concerns for drying homogeneity and powder scorching within 
rotating drums. Replacing heated walls with a radiation emitter may resolve drawbacks 
caused by moisture and electrostatics (Sanofi Pasteur Sa, 2013a). Inventors describe a 50% 
reduction in drying time when using an active radiation emitter.  
Middlebeek et al. (2009) disclosed a method for freeze drying a frozen bed of particles using 
a container which is heated beneath by conduction and the top powder surface by radiation 
from above using two heating plates preferably warmed to the same temperatures. Final 
product moisture content of less than 1.5% is claimed. 
 An interesting patent disclosed by Qiagen is built on the disposition for one of two 
immiscible phases to inherently form a spherical shape when combined (Wende and 
Jesziorski, 2011). The immiscible phases are either hydrophobic or hydrophilic and either 
can serve as a solvent for dissolving the API of interest prior to incorporating a second liquid 
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phase. A continuous application of the invention is also disclosed as a set up with a 
continuous circular flow of a hydrophobic media. The hydrophilic phase containing the API is 
injected to form spherical entities.  
Lamprecht (2013) reported the spray freeze drying of lysozyme, insulin and Immunoglobulin 
G (IgG). The patent focused on flowability by engineering spherical mono dispersed particles 
aimed for different administration routes including oral, buccal and sublingual routes. The 
invention required a mix of at least a cryoprotectant and a stabilizer with the API to yield 
porous mono dispersed particles in the 1 µm-1 mm size range. 90% activity was retained 
after drying 1 %w/v lysozyme, 5 %w/v mannitol with BSA, dextran or PVP at 0.1-10 %w/v. 
After 6 months, stability of the 10 %w/v solid content was statistically unchanged. 
 
It is envisaged that bulk drying using these combinations of semi continuous and tray drying 
or continuous flow drying approaches will be best for process economics if final containers 
are dosed from bulk freeze dried solids. Perhaps the use of tray drying solely could suffice 
and thus avoid the huge capital investment for new equipment requirements or retrofitting of 
existing dryers. Dosing from bulk is however hypothesised to be heavily challenged by 
flowability of the final porous amorphous freeze dried powders. 
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1.6 Characterising freeze dried powders  
As previously mentioned, knowledge of the critical temperatures of a formulation is required 
for a successful drying process. These refer to glass transition temperature of the maximally 
freeze-concentrated phase (Tg’), eutectic temperature (Teu) and collapse temperature (Tc) 
(Pyne et al., 2002, Hawe and Friess, 2006b). Thermal analysis techniques such as DSC 
(differential scanning calorimetry) are available for measuring Tg’. Freeze drying microscopy 
can also be used to determine collapse temperatures of formulations prior to drying. During 
the freezing step, if the solute crystallises it forms a eutectic with ice and the eutectic 
temperature becomes important (Pyne et al., 2002). Primary drying above the Tc and Teu of a 
material will lead to cake collapse and melt back respectively.  
 
1.6.1 Flow properties of bulk solids 
Flowability of powders is influenced by many properties such as size distribution, moisture, 
static electricity and density (Lavoie et al., 2002, Jiang et al., 2009, Staniforth and Aulton, 
2007, Schneider et al., 2007). History of powder handling could also induce variation in 
measurements for the same powder. For instance, the number of -30°C to 30°C freeze-thaw 
cycles used in preparing microcrystalline cellulose-starch composites increased the angle of 
repose and Carr’s index (Builders et al., 2010).  
  
42 
 
A B C 
 
 
 
D E F 
 
  
 Avalanche Methods  
 G H 
  
Jenike shear cell
ⱡ
 Rotational shear cells
ⱡ
 
I J K 
 
 
 
Aeration
#
 Permeability 
ⱡⱡ
 Bed expansion ratio 
‡‡
 
Figure 1.7: Schematic of the types of available flow characterisation methods. Images adapted 
or drawn from : * British Pharmacopoeia Commission (2013a) ; ** Ruppel et al. (2009); ⱡ 
Schwedes (2003); ‡ Faqih et al. (2006); # Freeman (2007); ‡‡ M. Krantz et al. (2009) and ⱡⱡ Fu et 
al. (2012). GDR = Gravitational displacement rheometer. N = Normal force 
Anvil
Cam
Graduated cylinder
Cylinder support
Balance
Stopper
Stirrer
Funnel
Camera
base
Ring
Lid
N
Shear force
N N
Air
N
Compressed 
Dry Air
Fluidised powder
Porous Distributer
Angle of repose Tapped density* Modified outflow funnel** 
GDR 
‡ 
43 
 
Various methods have been reported for characterising these flow attributes and the main 
available techniques and some variations of interest are herein introduced (Figure 1.7). 
Angle of repose, tapped density (Carr’s index) and shear cell methods were used in chapter 
4 for studies which characterise bulk lyophilised powders.  
Methods for characterising the flow of pharmaceutical powders can be categorised into 
direct and indirect methods (Staniforth and Aulton, 2007, British Pharmacopoeia 
Commission, 2013c). Indirect methods include angle of repose, bulk density measurements, 
Hausner’s ratio and Carr’s index. Direct methods include hopper flow rate and recording flow 
meter. Tests can alternatively be grouped into static and dynamic tests with the later 
believed to be most ideal as it mimics the actual intended process.  
When a powder is allowed to flow onto a surface, it may form a heap and the angle (θ) which 
the free surface forms to the horizontal plane (Figure 1.7 A) is referred to as the angle of 
repose (Howard, 2007). Poured and drained angle of repose methods are the two main 
types of angle of repose available. The former is the angle measured when a powder pile is 
poured freely onto a flat surface while the latter is measured on the conical surface of a 
powder when it is discharged through an orifice onto the bass of a flat bottomed vessel 
(Howard, 2007). More than one angle of repose may be formed by a powder bed making 
this rather low cost and simple test error prone. Lavoie et al. (2002) were challenged with 
multiple angles for cohesive lactose, malto-dextrin and microcrystalline cellulose. This 
technique has been described as “crude” or “rough” but useful in early drug development 
and quality control where new chemical entities are usually available only in small quantities 
(Staniforth and Aulton, 2007, Howard, 2007).  
Shah and Misra (2004) used angle of spatula method to evaluate the flow of lyophilised 
liposomes of Amikacin dry powder. It involved estimating the angle formed by a heap of 
powder at the end of a spatula held horizontally. 
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 Vibrating spatula is another modification of the angle of spatula method and deemed as a 
dynamic method for accessing powder flow (Louey et. al., 2004). The apparatus measures 
the mass of powder falling from a vibrating spatula as a function of time.  
Different powders will be consolidated to various extents when compressed and the poorer 
the flow properties of powder, the more compact it becomes. This powder characteristic is a 
measure of inter particulate forces (Carr, 1965). Carr’s compressibility index and Hausner’s 
ratios are similar methods of accessing flowability based on tapped density and bulk density 
measurements. Using a graduated cylinder, bulk and tap densities of a powder can be 
determined (Figure 1.7 B). Hausner’s ratio is expressed as a ratio of bulk to tapped density 
or a ratio of bulk volume to tapped volume (British Pharmacopoeia Commission, 2013a, 
Howard, 2007). Powders with low inter particulate friction are free flowing and have ratios of 
approximately 1.2 (Carr, 1965). Both tests require the measurement of bulk density using 
graduated cylinders and the precise method adopted in pouring the powder into a container 
has a more profound effect on particle packing variation than on the container sizes used 
(Brown and Richards, 1970). 
A modification of the standard flow through an orifice test method which determines the flow 
rate of a powder through an orifice (British Pharmacopoeia Commission, 2013c) was 
reported by Ruppel et al. (2009). The “modified outflow funnel” apparatus measures powder 
flow based on other parameters such as powder arch destruction time and descriptors 
calculated from the torque used by the stirrer (Figure 1.7 C).  
The use of static flow predictions has often being criticised as not informing the complete 
flow behaviour of a material. Lavoie et al. (2002) criticised the flowability predictions made 
on static beds as unable to inform on the complete flow behaviour of a material and 
recommended the use of methods of assessment under a dynamic condition of avalanche 
which was more representative of powder working conditions. These avalanche techniques 
45 
 
use a rotating drum or cylinder in combination with either a light source and detector (Figure 
1.7 D) or a camera (Figure 1.7 E) or load cell (Figure 1.7F). 
The time between avalanches can be used to characterise the avalanche behaviour which is 
captured by signals recorded by photocells as powders avalanche (Hancock et al., 2004, 
Lindberg et al., 2004). Good flowing powders show short reproducible avalanches but 
powders which adhere to surfaces can interfere with signals meant for the photoelectric 
detector (Thalberg et al., 2004). Cohesive powders may form aggregates and be 
erroneously characterised as good flowing if they display short intervals between 
avalanches. This makes this technique poor in discriminating between more cohesive 
powders (Thalberg et al., 2004).This setup was commercially available as Aeroflow™ and 
was discontinued in 2006 (TSI, 2014) perhaps due to lack of patronage or competition from 
newer techniques on the market. 
A camera can be used to monitor the maximum angle formed by a powder before it 
avalanches (Krantz et al., 2009) which in effect is a dynamic angle of repose. The camera 
system can be employed to also monitor the avalanche and the signals Fourier transformed 
to inform flow (unpublished powder flow cascade by J Davies and A. Ingham). A 
gravitational displacement rheometer (GDR) is a variation of the previously described 
avalanche apparatus (Figure 1.7 F). It utilises a load cell to investigate the size of 
avalanches using the change in the centre of a powder’s mass (Faqih et al., 2006, Vasilenko 
et al., 2011).  
Different rank order of flowability can be generated by different measurement techniques 
and emphasises is often made to utilise techniques that is representative of the process 
(Schneider et al., 2007).  
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Shear cell testers are particularly useful in measuring cohesion, ranking flowability using flow 
function and invaluable tools for hopper design since the first introduction of the Jenike 
Shear cell tester. The various types such as the Jenike or translational (Figure 1.7 G), 
uniaxial, biaxial and rotational or ring shear cells (Figure 1.7 H) have been comprehensively 
reviewed (Schwedes, 2003). The main differences surround the application of the normal 
force (N) in relation to the measured shear force (S) and type of powder receptacle in use. 
Powder behaviour under a series of different normal stresses and the corresponding shear 
forces are studied using Mohr circles to rank powders. The underpinning operation principles 
are the same for all types of shear cells. The background of a ring shear and the application 
of Mohr circles to characterise flow of lyophilised powders is described in more detail in 
section 3.4.10.3 on page 70. 
A powder rheometer reported by Freeman (2007) is a peculiar apparatus with a stirring rod 
which can be interchanged from a blade into a flat surfaced piston or shear cell lid making it 
a versatile powder characterisation tool. A similar apparatus using a helical blade has also 
been reported (Shah et al., 2008). Freeman’s blade performs aeration test (Figure 1.7 I) 
which measures cohesive strength as “flow energy” as it ploughs through a powder bed. 
Pistons can be used to measure compressibility or used in combination with supply of air 
through the powder bed for permeation test (Figure 1.7 J) which informs resistance between 
powder particles as a function a change in pressure. A similar set up reported as a bed 
expansion ratio apparatus (Figure 1.7 K) characterises powders based on the ratio of 
fluidised powder height to settled powder height (Krantz, 2009). 
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1.7 Powder dispensers 
The use of powder dispensers is common in solid dose form manufacture such as capsule 
filling (Jones, 2001, Nalluri et al., 2013). Powder dispensers can be grouped based on their 
main method of operation into pneumatic, volumetric, gravimetric, screws or augers, 
electrostatic and vibratory methods (Yang and Evans, 2007). Pneumatic dispensers are a 
form of volumetric method that dispense power volumes using a dosing die or aspirating 
tube. A negative and positive pressure is used to pick and dispense powders. Gravimetric 
methods rely on the use of a load cell in combination with a suitable powder feed from 
usually a hopper. A commercially available pneumatic powder dispenser and two different 
types of gravimetric dispensers are used in studies investigating compatibility with freeze 
dried powders in chapter 5 on page 123. 
 
1.8 Material visualisation through tomography  
Tomography is a non-invasive and quantitative description of a section or slice of matter 
from within a bulky object or material (Baruchel et al., 2000). It has found uses in traditional 
medical imaging and with the equipment now downsized; found use for analysis in food 
(Mousavi et al., 2005), tissue engineering (Lin et al., 2013), pharmaceutics (Monkare et al., 
2012) and the wider material science industry (Fu et al., 2005). X-ray and gamma ray 
tomography are the most widely used in industry. Its simplest form, transmission 
tomography, provides a map of linear attenuation co-efficient (a measure of X-ray absorbed 
or scattered) of the object under investigation as a function of its density and atomic number. 
For a clear separation between density and atomic number, scattered photon tomography is 
able to relate the ratio of Compton and Rayleigh scattered photons to atomic number with no 
influence from density while emission tomography is used in the detection of photons 
emitted by an object which is itself under investigation (Baruchel et al., 2000). 
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Transmission tomography is based on Beer-Lambert’s Law or attenuation law (Equation 
below): 
         [ ∫ (   )  ]  (1.2) 
 A reconstruction of the linear attenuation map of a sample can be obtained from several 
measurements through the same sample slice. This is correlated from the energy of the 
photon, density and atomic number of the material. N0 and N1 are the number of photons 
emitted and transmitted through a single line across a sample and µ(x, y) is the linear 
attenuation co-efficient at point (x, y) within the sample (See Figure 1.8).  
 
Figure 1.8: Representation of transmission tomography within a single slice. The number of 
photons emitted from the source (N0) and transmitted (N1) though a single line across sample 
is used to obtain the integral of the attenuation co-efficient (µ) along the path of the X-ray 
photon. µ(x, y) represents linear attenuation co-efficient at point (x, y). Redrawn from  
Baruchel et al. (2000). 
 
Transmission X-ray tomography which uses a cone beam and computer algorithm for image 
reconstruction was used to study freeze dried powders in chapter 6. 
Y=Y1 N0 N1
Y
X
µ(x, y)
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2 THESIS AIMS AND OBJECTIVES 
Freeze drying is currently an expensive batch process and faces competition from cheaper 
drying alternatives. There is regulatory pressure to stop the use of batch processing to 
reduce variability. While there have been attempts to convert it into a continuous process, 
these are yet to be successful. 
Leading pharmaceutical companies including Sanofi and Bayer have disclosed a series of 
patents in this area (Sanofi Pasteur Sa, 2013a, Sanofi Pasteur Sa, 2013c, Sanofi Pasteur 
Sa, 2013b, Gehrmann et al., 2010). All strategies for either semi continuous or continuous 
drying systems require processing of the final bulk lyophilised powders. 
The freeze drying tray has been used for bulk purposes mostly for food in the past. 
Emerging drying and powder transfer technologies provide the opportunity for large bulk tray 
lyophilisers and accurate (less than 3% RSD) powder dispensers to be combined to reduce 
the overall mass processed. Harnessing these technologies for high throughput commercial 
production could have significant economic benefits. However a published knowledge gap 
exits around bulk formulation requirements that would allow formulations to meet regulatory 
approval and be designed to maximise the efficiency of such a paradigm shift from 
traditional vial fill to finish drying. 
This thesis is motivated by the potential cost savings associated with bulk drying of small 
and large molecule pharmaceuticals. It is anticipated that findings would not be limited to 
bulk tray freeze drying but would also benefit semi-continuous and continuous bulk drying 
provisions in areas where they too may require handling of final product material outside the 
freeze dryer. 
Tray drying is revisited in the quest for findings expected to be useful for scientists 
considering manipulation of freeze dried powder using conventional bulk tray drying for 
parenteral use, direct powder compression or production of process intermediates. 
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The primary objectives of this thesis are set out here as studied in chapters 4 to 6.  
Chapter 4: Assessment of the flow behaviour of bulk lyophilates. 
The aim was to fully characterise bulk freeze dried powders (lyophilisates) for flow 
behaviour. Flow properties of potential bulking agents were evaluated to identify 
relationships with variations in solute concentration. An objective was to understand the role 
of cooling rate and thermal holds during bulk freezing on final cake morphology and powder 
flow. Identification of a suitable, industrially acceptable and consistent method for disrupting 
large bulk cakes into loose powder systems for handling was a further objective. 
 
Chapter 5: Investigations into the compatibility of bulk lyophilised powder for vial or ampoule 
enclosure. 
Studies aimed at investigating volumetric and gravimetric methods of freeze dried powder 
transfer into container closures using both small and large scale commercial dispensers. 
The objective was to identify the problems associated with dispensing a final patient suitable 
dose in a market suitable packaging. Evaluation of the regulatory concerns for dose 
uniformity and identifying the implications of powder flowability to maximise both precise and 
accurate doses were prioritised objectives due to an absence in literature. Identification and 
optimisation of formulation properties of significance to allow a standard for successful 
powder transfer was to be defined. 
 
Chapter 6: X-ray Microcomputer tomography studies for the determination of powder flow 
characteristics and dose uniformity of freeze dried active pharmaceuticals. 
The aim was to explore this new non-destructive technique to identify correlations with 
traditional methods used for characterising powders for porosity, size and shape. An 
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objective was to establish the use of small powder volumes for full and reliable freeze dried 
powder flow characterisation while avoiding incompatibilities associated with freeze dried 
powders such as its hygroscopic nature. A further objective was to provide a quantitative 
evaluation of active pharmaceutical ingredient (API) uniformity throughout freeze dried cakes 
and provide an understanding into the effects of freezing rate on dose uniformity.  
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3 MATERIALS AND METHODS 
3.1 Preparation of active pharmaceutical ingredient 
Immunoglobulin G (IgG) was obtained from caprylic acid precipitation of ovine sera and was 
received as a gift from MicroPharm UK (Polyclonal, Wales, Sheep no. 1363 16/02/94). A 
detailed description of materials and methodology is outlined in appendix I on page 238. 
 
3.2 Pre-formulation characterisation 
3.2.1 Collapse point and eutectic melt determination  
3.2.1.1 Background 
A freeze drying microscope (Lyostat3, Biopharma UK) allows the qualitative identification of 
collapse and eutectic temperatures of formulations prior to freeze drying (Figure 3.1). Its 
cryogenic stage is equipped with an imaging station and a silver heating block. The 
temperature control system utilises a heating element and liquid nitrogen supply to meet 
temperature in the working range of -196°C to +125°C. A Pt100 temperature probe 
connected to the stage logs product temperature during drying. The cryogenic stage is also 
fitted to a vacuum pump which is regulated through pirani gauge feedback. The imaging 
station is comprised of a camera and lens objective which is capable of real time image 
capture using Linksys 32 software. 
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Figure 3.1: Schematic representation of a freeze drying microscope stage showing sample and 
stage assembly for identification of collapse temperatures. Redrawn from Ward (2010).  
 
3.2.1.2 Procedure 
The microscope was validated using known collapse temperatures of sucrose at -32°C and 
eutectic melt of sodium chloride at -21.5°C. The lid and stage were unscrewed and opened 
to allow access to the silver sample block and the fitting of a sample holder. The sample 
holder ring was fitted onto the sample block and secured. A drop of silicon oil was introduced 
onto the block within the confines of the sample holder ring and covered with a 16 mm 
quartz glass with the aid of a vacuum pen. A 70 µm semi-circular metallic spacer or shim 
was introduced onto the sample block with forceps. A sample solution of 1.5 µL was 
introduced onto the stage and covered with a 13 mm glass slide using a vacuum pen. For 
easy identification and tracking of the drying front or sublimation interface, the edge of the 
solution was moved to around the edge of the light source on the stage by adjusting the 
sample holder ring. The lid was screwed back into place and a nitrogen curtain introduced to 
prevent condensation during analysis. Sample was frozen and sublimation commenced by 
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pulling a vacuum. The sublimation interface and samples were observed through the course 
of drying within temperatures of interest to identify critical temperatures. 
A sample of 1-2 µL was frozen using a ramp rate of 20 °C/min to -40°C and held isothermal 
until an amorphous and or crystalline material was completely formed. Vacuum was pulled 
to 0.369 mbar (36.9 Pa) to commence the sublimation process. Image capture was initially 
set at a delay of 60 seconds during freezing and initial sublimation. This was reduced to a 5 
seconds delay further into sublimation. Onset of collapse was initially identified using a 1 
°C/min temperature ramp and the sample observed for changes in the sublimation interface. 
Upon initial identification of the collapse temperature, heat-cool cycles were repeated at a 
slower ramp rate of 0.5 °C/min to confirm the collapse or eutectic temperature. 
 
3.2.2 Differential scanning calorimetry 
3.2.2.1 Background 
Differential scanning calorimetry (DSC) is a form of thermal analysis useful in characterising 
the thermal properties of solutions or the final dried product. It measures the heat flow 
changes within a sample in comparison to a reference. Heat flux and power compensation 
DSC are the two available types (Ford and Timmins, 1989). A heat flux DSC measures the 
temperature difference between a sample in a DSC pan and a reference (empty pan). The 
latter measures the heat flow required to maintain the sample and the reference at the same 
temperature. 
A Q200 series MDSC (TA Instruments, USA) with a refrigerated cooling system (RCS 40) 
capable of -40°C to 400°C cooling and heating was used to study phase transitions of 
formulation solution to be freeze dried. Purge nitrogen gas (BOC, UK) supply of 50 mL/min 
was used at all times. 
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3.2.2.2 Procedure 
3.2.2.2.1 Calibration  
The DSC was initially calibrated before sample analysis using the inbuilt calibration wizard. 
Tzero aluminium pan, standard and hermetic lids were purchased from Walters UK.  
 
3.2.2.2.1.1 Tzero calibration or baseline calibration  
Runs were performed to generate cell resistance and capacitance. The cells of the DSC 
were run empty from -40°C to 200°C at a ramp rate of 20 °C/min. A clear (sample) and red 
sapphire (reference) disc (TA Instruments, USA, Lot 970345.901) both weighing 108.5 mg 
were placed directly on the cell and the thermal program was initiated. A ΔT and Δ Tzero 
versus time plots showing no transitions and low noise to signal ratio in both empty and 
sapphire runs was accepted as ideal. The resulting cell resistance and capacitance was then 
plotted and saved. Increasing capacitance and a decrease in resistance with temperature 
was accepted as ideal. 
 
3.2.2.2.1.2 Cell constant and Temperature 
Pre melted indium of 9.8 mg (TA Instruments, P-E P/N 0319-0033) was run from 100°C to 
180°C at 10 °C/min to calibrate for cell constant and temperature. A melting point observed 
at 156.6°C and enthalpy of fusion of 28.457 J/g was deemed acceptable. The cell constant 
was calculated and logged to file. 
 
3.2.2.2.1.3 Heat capacity (Cp) constant calculation 
Existing values for reversing and total heat cp constants were reset to a value of 1. Sapphire 
was run from -40 to 200°C at 5 °C/min amplitude of ± 0.1°C using nitrogen gas at 50 mL/min 
purge and desired period. Values resulting from Cp, reversing Cp and temperature plot were 
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exported into Microsoft Excel and the Cp calibration constants were calculated from an 
average of 3 ratios of theoretical to measured Cp values. 
 
3.2.2.2.2 Sample analysis 
Samples were weighed by difference in a Tzero aluminium pan. A standard lid was used for 
solid samples while solutions were hermetically sealed using an encapsulating press (TA 
Instruments, USA). An empty pan was weighed and used as reference. Sample and 
reference pans were placed in the DSC cell and covered with the cell lid. The thermal 
program specifying equilibration and temperature range, heating rate, amplitude and period 
was initiated. Thermographs were analysed for phase transitions and labelled using TA 
instrument universal analysis 2000 4.5A software. 
 
3.3 Lyophilisation process design  
Freeze drying was performed in a Virtis Advantage bench freeze dryer (Figure 3.2) using 
cycles specified in individual thesis chapters. A stainless steel tray and a custom made three 
compartment tray (Dense grade polystyrene model foam frame (Trylon, UK) and 
polyethylene base (Tesco, UK) were used as bulk container systems (Figure 3.3). 
Conventional vial freeze drying was performed in 10 mL type 1 glass freeze drying vials 
(Adelphi Healthcare Packaging, UK). K type thermocouples (RS Components, UK) were 
used to monitor product temperature during the drying process.   
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Figure 3.2: Laboratory scale Virtis Advantage freeze dryer 
 
 
 
 
Figure 3.3: Schematic representation of bulk drying tray containers used in lyophilisation 
process. Left: Stainless steel tray. Right: Custom made 3 compartment dense grade 
polystyrene model foam tray system with a polyethylene base. 
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3.4 Post freeze drying characterisation 
3.4.1 Dried sample transfer and moisture control through isolation 
Sample trays were transferred from the freeze dryer at the end of drying cycles into a flexible 
polyurethane isolator (Soloflex, UK) purged with oxygen free dry nitrogen (BOC, UK) to 10-
20% relative humidity. Isolator was fastened onto the Virtis advantage freeze dryer using 
polyurethane (PU) skirt and an O-ring (Figure 3.4). 
 
 
Figure 3.4: Schematic of custom designed 2 gloves polyurethane flexible isolator supported 
on an aluminium frame for dried bulk tray transfer from freeze dryer. Image from Soloflex UK 
design proposal (Ingham group 2012). 
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3.4.2 Karl Fischer coulometric analysis 
3.4.2.1 Background 
The coulometric method of moisture analysis by Karl Fisher is preferred in freeze drying for 
its lower working range of 0.0001% to 5% of sample. Karl Fischer used equation (3.1) which 
requires sulphur dioxide in the presence of iodine in a non-aqueous medium to quantify 
water content (Mettler Toledo, 2009).  
 I2 + SO2 + 2 H2O → 2HI + H2SO4 (3.1) 
Acidic by-products previously eliminated with pyridine were replaced with imidazole 
(CH3H4N2) which is a less toxic base. The use of methanol as solvent results in a 1:1 water 
to iodine consumption. The standard reaction equation for Karl Fischer moisture 
determination (Scholz, 1981) is : 
 ROH + SO2 + 3RN + I2 + H2O → (RNH)•SO4R + 2(RNH)I  (3.2) 
The titration cell of a coulometric Karl Fischer houses the anode and cathode electrodes.  
The anode or generating electrode electrochemically yields iodine by oxidation according to 
the half equation: 
 2I
-
 → I2 + 2e (3.3) 
The 2 electrons liberated at the anode reduce positive hydrogen ions to hydrogen at the 
cathode. Electrons can be related to current and time using to quantify water content using 
Faraday’s constant (96485 coloubs/mol). From the relation between the molecular mass of 
water and total current required for anodic iodine production, 1 mg of water requires 10.712 
coulomb of electric current. The end point of moisture content titration is determined by 
biopotentiometric indication which requires the application of a known polarization electric 
current to the cathode platinum pins and a high voltage to maintain such polarization current 
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(Mettler Toledo, 2009). At the end point of titration, free iodine will be present in the titration 
cell and will react with the platinum pins to reduce the voltage required to keep the 
polarization current constant. The end point is reached when a defined voltage is exceeded 
and terminates the titration. 
 
3.4.2.2 Procedure 
Residual moisture content determinations were performed using a coulometric C20 Karl 
Fischer titrator (Mettler Toledo, Switzerland). 100 mL of CombiCoulomat fritless (Apura®) 
Karl Fischer reagent (VWR, UK, Product No: 1.09257.0500) was poured into the titration cell 
and titrated to dryness. Using a 12 cm hypodermic needle (Sterican, VWR, UK, Product No. 
612-0161) and 10 mL syringe, 1 mL of dry reagent was drawn from the titration cell into 
aluminium crimped sample vials. Sample vials were bath sonicated for 10 minutes to 
facilitate moisture extraction. An aliquot (1 mL) of sample and anolyte was injected into the 
cell and titrated to the endpoint. Three replicates were measured per sample and recorded 
as the total water content (C). Total moisture content in a freeze dried sample was 
calculated using the equation: 
     (
          
    
)  (
    
    
) (3.4) 
Equation 3.4: Where R is water content in the sample; C is the measured total 
water content; Msol is the amount of solvent (g); Mext is the amount of sample (g) 
extracted with the solvent. 
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3.4.3 Helium pycnometry 
3.4.3.1 Background 
Porosity was calculated from pycnometry determinations of true and bulk density of 
materials. The principle of gas pycnometry is drawn from Archimedes principle of fluid 
displacement. The small atomic dimensions of helium which is 0.90 ± 0.06 angstrom 
(Youxue and Zhengjiu, 1995) makes it an ideal inert displacement gas for exploring inter and 
intra particulate pores. Using helium as fluid, the particle or true density of samples can be 
calculated from the resulting pressure difference when helium flows from a known reference 
cell volume into a sample cell (Figure 3.5).  
 
 
Figure 3.5: Schematic representation of a gas multipycnometer (Quantachrome Instruments, 
2009). 
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3.4.3.2 Procedure 
A Multipycnometer (Model MUP- 6DCE Quantachrome Instruments, USA) was purged with 
10 cycles of helium gas (BOC, UK) and validated using a 2.145 cm3 micro calibration sphere 
standard. Powder samples were mechanically agitated through a 1 mm aperture sieve to 
remove any agglomerates formed on storage. Bulk density was calculated as a ratio of mass 
to volume obtained from a 10 mL measuring cylinder and an analytical balance. Sample was 
loaded into a 12.03 cm3 micro sample cell volume (Vc) and the 6.397 cm3 reference cell 
volume (Vr) was used. True powder volume (Vp) and porosity were calculated using the 
equation: 
          ((
                                  
                             
)   )  (3.5) 
Porosity was calculated from the equation (3.6) for an average of three measurements and 
its standard deviation was reported (Kumar et al., 2001). 
              
            
                    
  (3.6) 
A detailed standard operating procedure is available in appendix II on page 244 . 
 
3.4.4 Light microscopy 
Morphology studies were conducted with a light microscope (Carl Zeiss, Scope.A1 
Germany) equipped with a polariser, camera system (Axiocam MRM) and imaging software 
(Axiovision version 4.8). Bottle of stock powder was homogenously mixed by 30 seconds of 
hand shaking. A small powder sample heap was collected with a metallic spatula onto a 
glass microscope slide (VWR, UK). Sample was spread uniformly on the slide by gentle 
tapping on the sides to remove excess powder and was covered with an 18x18 mm glass 
cover slip (Menzel Glaser, DE). Samples were viewed at magnifications of x10 eyepiece and 
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x10 or x40 objective lens. Three sets of camera images were taken per sample and focal 
stacked to create one image where applicable. 
 
3.4.5  Mechanical sieving and laser light diffraction 
3.4.5.1 Mechanical sieving  
The size distribution of powders were measured using a mechanical sieve shaker (Retsch, 
AS 200 basic, Germany) with a 16 set 38 mm diameter brass sieve stack (Endecotts, UK) 
with aperture sizes ranging from 1000-63 μm. The mass of test sample used per 
assessment and maximum allowed residual masses after test was adapted from a published 
standard which is based on 200 mm diameter sieve area (International Organization for 
Standardization, 1988). Test samples were shaken at an amplitude of 80 mm at 5 minute 
intervals. The endpoint of the sieving process was reached when the mass of none of the 
test sieves was unchanged by more than 5% or 0.1 g of its previous mass (British 
Pharmacopoeia Commission, 2013d). 
 
Figure 3.6: Particle size analysis by mechanical sieving. 
Mechanical Shaker 
Sieve stack 
Custom made 38mm sieve 
adapter 
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3.4.5.2 Laser light diffraction 
3.4.5.2.1 Background 
Diffraction patterns resulting from directing a laser beam at a particle can be used to obtain 
its particle size distribution. The laser light diffraction particle sizer utilises light-particle 
interactions to generate cumulative size distributions from an optics set up of Fourier lens, 
multi element photo detector and mathematical models. The intensity distribution with angles 
of diffraction are transferred onto a detector ring of known radius and transformed using 
Fraunhofer or Mie algorithms (Sympatec, 2013) to produce a size distribution. 
 
3.4.5.2.2 Procedure 
Particle sizing of a sample was measured with the laser light diffractor, Sympatec Helos/BF 
(Sympatec, DE), with windows 5.4.0 control software. A senor range of 0.25/0.45-87.5 µm 
was selected for use with a clean 50 mL optical glass cuvette and magnetic stirrer. Cuvette 
was filled with 40 mL of ultra-pure water and a reference diffraction measurement was 
determined at a stirring speed of 200 rpm. A sample volume of 2 mL was transferred with a 
pipette into the cuvette and a diffraction measurement was made at a particle dispersion 
speed of 200 rpm. Cumulative size distributions with standard deviation were recorded for 3 
replicates per sample.  
 
3.4.6 X-ray powder diffraction 
3.4.6.1 Background  
X-ray powder diffraction is used to characterise the physical form of a material. It provides 
information directly related to the molecular packing within the solid state peak positions and 
intensities, amorphous and crystalline forms of a material can be differentiated and verified 
against reference diffraction patterns (Newman, 2011, Raj Suryanarayanan, 1995).  
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3.4.6.2 Procedure  
Samples were analysed with an X-ray powder diffraction (Bruker D2 Phaser, UK) using 30 
kV 10 mA 300 W X-ray source. 
 
3.4.7 Bicinchoninic acid assay (BCA) 
3.4.7.1 Background 
Quantification of total protein content using BCA is based on the colorimetric detection of 
cuprous ions at 526 nm (Smith et al., 1985). It is based on the biuret reaction which involves 
the reduction of cupric to cuprous ions by the presence of proteins. Cuprous ions are 
chelated by two molecules of BCA to form a purple coloured complex caused by the 
presence of amino acids, peptide bonds and the protein macro structure (Wiechelman et al., 
1988). 
 
3.4.7.2 Procedure 
Total protein content was determined using a bicinchoninic acid (BCA) assay kit (Thermo 
scientific, UK) in combination with a Multiskan spectrum plate reader (Thermo scientific). Six 
standard solutions were prepared with distilled water to prepare a calibration curve. Known 
standards were either BSA (Bovine serum albumin) or immunoglobulin depending on the 
type of unknown to be quantified. BCA working reagent was prepared from a 50:1 ratio of 
reagent A (sodium carbonate, sodium bicarbonate, bicinchoninic acid and sodium tartrate in 
0.1 M sodium hydroxide) and reagent B (4% cupric sulphate). A standard of 25 µL was 
transferred into 96 clear flat bottom micro well plates (Greiner Bio-one, UK). Working 
reagent (200 µL) was added to each well with 3 pipette mixing manipulations. Plates were 
incubated in a plate reader at 37°C for 30 minutes and absorbance was measured at 562 
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nm. A standard calibration curve from an average of three readings for each standard 
concentration was drawn for use in the determination of unknowns (Figure 3.7). 
 
 
 
 
 
 
 
Figure 3.7: Typical calibration plot for bovine serum albumin standard solutions analysed by 
BCA assay. 
 
3.4.8 Lactate dehydrogenase activity assay 
3.4.8.1 Background 
LDH activity was determined using a kinetic UV spectroscopy assay conducted at 340 nm 
on the Multiskan spectrum plate reader (Thermo scientific, USA). 
In the presence of NADH (Reduced Nicotinamide Adenine Dinucleotide) and LDH, Pyruvate 
is converted to lactic acid. Measurement of the absorbance at 340 nm is related to the 
amount of NADH consumed and is used to quantify the amount of LDH present (Krieg et al., 
1967, Grant, 2010). 
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3.4.8.2 Procedure 
A detailed standard operating procedure is available in Appendix III on page 248. 
 
3.4.9 Fluorescence quenching assay  
3.4.9.1 Background 
A fluorescence quenching assay is a simple analytical method for quantifying proteins. 
When attached to a protein, fluorescein will fluoresce if exposed to an excitation wave length 
of 491 nm and subsequently emit at 520 nm. Immunoglobulin G raised against fluorescein 
isothiocynate (Anti-FITC IgG) will bind to fluorescein in solution and quench the fluorescence 
intensity of any fluorescein present.  
 
3.4.9.2 Procedure 
The assay was initially optimised for excitation and emission wave lengths of Anti-FITC IgG. 
The optimised process is available in appendix IV on page 252. The fluorescence quenching 
assay was performed according to standard operation procedure found in Appendix V on 
page 256. 
 
3.4.10 Flowability characterisation 
3.4.10.1  Compressibility index 
3.4.10.1.1 Background 
The extent of compaction exhibited by a powder when compressed provides a measure of 
its flowability. Good flowing powders are less compressible, have lower compressibility 
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indices and show low particulate friction (Carr, 1965). The index is calculated from either of 
the below equations: 
                            
(                          )
              
  (3.7) 
                        
(                         )
           
  (3.8) 
Hausner’s ratio is a variation to compressibility index expressed as a ratio of bulk to tapped 
density or a ratio of bulk volume to tapped volume (British Pharmacopoeia Commission, 
2013c, Howard, 2007). Powders with low inter particulate friction are free flowing with ratios 
of 1.12-1.18 (Carr, 1965). 
 
3.4.10.1.2  Procedure 
Compressibility index was determined using a tap density apparatus (Sotax FD2, USA). The 
measurement of bulk density was adapted from the British Pharmacopoeia Commission 
(British Pharmacopoeia Commission, 2013a) using a 10 mL or 100 mL cylinder dependent 
on the amount of bulk powder available. Samples were passed through a sieve with 1 mm 
aperture to remove any agglomerates formed on storage. Using a 200 mL funnel, samples 
were poured gently into a dry cylinder and the unsettled apparent volume or bulk volume 
was measured and bulk density was calculated as a ratio of sample weight to bulk volume. 
The cylinder was transferred to the United States Pharmacopoeia I (USP I) holder to 
conduct the tap density measurement. The endpoint of the tapped sample was reached 
when there was no more than a 2 mL change in sample volume. Tapped density was 
calculated as a ratio of sample weight to tapped volume. Compressibility index was 
calculated as a percentage of the difference between tapped and bulk density divided by its 
tapped density. An average of three measurements and its standard deviation was recorded. 
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3.4.10.2 Angle of repose 
3.4.10.2.1 Background 
Powders allowed to flow onto a surface may form a heap or a stock pile and the three 
dimensional angle (θ) that its surface forms to the horizontal plane is referred to as the angle 
of repose (Howard, 2007, British Pharmacopoeia Commission, 2013c). It provides an 
indirect measure of inter particulate resistance or friction to movement within a powdered 
mass. Carr (1965) classifies powders with values between 31-35  as “good” and above 66  
as “Very very poor”. 
 
3.4.10.2.2  Procedure 
Measurements were made using the experimental set up (Figure 3.8) of a 100 mL funnel 
and retort stand above a flat base. Samples were poured through the funnel and allowed to 
form a heap with height (h) and radius (r). The tip of the powder heap was at least 2 cm from 
the funnel. Angle of repose was calculated as the inverse function of the ratio of height to 
radius and reported as an average of three replicates with a standard deviation. 
 
Figure 3.8 : Schematic of an angle of repose experimental set up. The angle of repose is 
expressed as       
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3.4.10.3 Shear Cell 
3.4.10.3.1  Background 
Shear cell testers provide more precise powder flowability assessments and inform the 
basics for hopper design from both derived and raw determinants such as yield loci, angle of 
internal friction, unconfined yield strength and tensile strength of a material (BP 2013).  
The Brookfield powder flow tester (Figure 3.8) is a shear cell capable of wall friction, bulk 
density, standard and time consolidated flow function tests.  
Applying a shear stress causes a powder to flow and its magnitude is dependent on the bulk 
density of material which relates to the compacting and normal stresses (Williams, 1990). At 
different compacting stresses, the vane lid traps powder particles in compartments and are 
sheared against particles in the sample trough. Different shear stress and normal stresses 
can be studied to obtain the relationship called the yield locus. In combination with 
tangentially drawn Mohr circles to the yield locus, the angle of internal friction, unconfined 
yield strength and principal compacting stress tensile strength of a material can be derived 
(Schwedes, 2003).  
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Figure 3.9: Left: Exploded schematic view of shear cell arrangement of a Brookfield powder 
flow tester (PFT). Image adapted from operation manual (Brookfield Engineering Laboratories 
Inc.) Right: Picture of PFT used in research laboratory. 
 
3.4.10.3.2  Procedure 
Shear cell measurements were obtained using a Brookfield powder flow tester (Brookfield, 
USA) with Powder Flow Pro V1.2 Build 20 software. Test samples were passed through a 1 
mm test sieve to break any agglomerates that may have formed on storage. 
Sample was filled into a 6 inch small trough using a powder scoop and sample weight was 
obtained by difference. Outer and inner catch trays were attached to trap powder overflows 
during powder levelling and analysis. Powder was levelled by clockwise rotation of the 
shaping blade in the plough position. The flat shaping blade position was used for powder 
levelling during wall friction tests in conjunction with a wall friction lid. Type of test, number of 
consolidation stresses and number of stresses were specified according to 1 of 4 desired 
assessments as previously described (section 3.4.10.3.1). A refresh sample was used to 
determine 3 replicates where possible and results recorded. 
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3.4.11 Lyophilised powder dispensing 
3.4.11.1 Gravimetric and Volumetric dispensing of non-annealed freeze dried powders 
Non annealed freeze dried powders were gravimetric and volumetric dispensed using either 
a Quantos mass dispenser (Mettler Toledo, UK) or Accofil volume dispensing system 
(Biopharma, UK) shown in figures below.  
 
 
Figure 3.10: Experimental set up of Quantos gravimetric dosing system. Left: Schematic and 
Right: Picture Insert: Magnification of dosing head. The dosing head of the Quantos system 
has a stirrer, dosing pin and a radio frequency identification (RFID) chip for storage of unique 
sample data.  
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Figure 3.11: Schematic representation of experimental set up using the Accofil volumetric 
dispensing system. Insert: Picture of the dosing head or die with die volume adjusting screw 
top. 
 
3.4.11.2 Gravimetric dispensing of annealed freeze dried powders 
Prior to dosing, samples were passed through a 1 mm aperture sieve to break up 
aggregates formed on storage before dispensing using a commercial Fill2Weight powder 
dispensing system by 3P Innovation, UK (Figure 3.11). Powders were conditioned by 
aeration before dosing. Dosing was performed in a fixed relative humidity (12.8%-14.5%) at 
a 20°C temperature. 
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Figure 3.12: Experimental set up of Fill2weight™ gravimetric dosing system Left: Schematic 
and Right: Picture Insert: Magnification of dosing head. A powder dosing valve is opened and 
closed in response to weight feedback from a calibrated weighing cell.  
 
3.4.12 Micro Computer Tomography 
3.4.12.1 Back ground 
X-ray beams are absorbed or scattered when directed through an object. A detector can 
capture these attenuated X-rays into corresponding shadow images. X-ray attenuation is 
influenced by density, atomic number and X-ray energy (Baruchel et al., 2000). Using the 
Feldkamp cone beam algorithm these shadow images are can be converted into computer 
tomographic (CT) images which are 2 dimensional slice by slice cross section image 
representations (Feldkamp et al., 1984). By stacking a series of 2D images, a 3D 
reconstructed volume can be produced to inform the internal geometry of the object. X-ray 
microcomputer tomography (Micro CT) analyses were performed using a SkyScan 1172 
Micro CT scanner (Bruker, Belgium) equipped with a 20-1000 kV/10 W X-ray source and 11 
mega pixel cooled 12 bit charge coupled device (CCD) camera. Analysis chamber housed a 
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standard object or sample stage capable of angular rotation on its axis. An object with a 
maximum of 50 mm diameter and 70 mm length could be scanned. 
 
3.4.12.2 Procedure 
Samples were securely mounted upright on the object stage with multipurpose tac or dental 
beading wax in the analysis chamber. Micro CT analyses were with a 36-60 kV X-ray source 
with current and power settings which were study dependent. Samples were imaged with 
0.2-0.7° object stage rotations. Camera resolution was 3-6 microns with 2-10 images 
averaged. Samples were confirmed to be upright, remained in the field of view of camera 
through the entire scan and scan initiated using the Skyscan 1172 control software. Fresh 
samples were used for replicates were applicable. Resulting X-ray projection images were 
reconstructed into 2 or 3 dimensional cross sectional images using the Nrecon (local version 
1.6.6) software and volume rendered with CTvox (version 2.2). Reconstructed images were 
analysed to provide information on the structural attributes using CT Analyser (Version 1.12) 
software. 
 
3.4.13 Statistical analysis 
One way analysis of variance (ANOVA) statistical analysis was performed using Graph pad 
Prism 6 analysis software. A probability value (P) of less than 0.05 within 95% confidence 
limits was defined as statistically significant. 
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4 INVESTIGATING THE FLOW BEHAVIOUR OF BULK 
LYOPHILATES 
4.1 Introduction 
The need to characterise pharmaceutical materials for their powder flow properties is 
commonplace in pre-formulation studies for tableting and quality control (QC). The powder 
handling industries characterise powder flow patterns as it influences flow from storage 
vessels and prior to packaging at processing lines and also informs hopper design. 
While many pharmaceuticals powders have been thoroughly characterised for flow, only 
brief fragments of such studies of freeze dried powders are available in literature. Arguably 
this area has not caught the attention of freeze drying scientists because the status quo is to 
dry sterile small molecules and biopharmaceuticals in glass vials. Bulk freeze drying 
applications which require powder flow characterisation do however exist predominantly in 
the food industry where sterility is not a concern. Powder characterisation in industry often 
involves the use of a cost effective and simple aerated methods such as angle of repose, 
flow through an orifice, tapped density or the non-aerated shear cell method (Guerin et al., 
1999, British Pharmacopoeia Commission, 2013c). 
The number of times flow properties of lyophilised pharmaceuticals have been reported is 
very few. Garmise et al. (2006) characterised the morphology of lyophilised inactive 
influenza viruses in lactose and trehalose. Samples were however vial dried and flow 
properties were measured for milled powders in the 45-125 micron particle size range only. 
Schiffter et al. (2010) measured tap density of spray freeze dried nano suspensions of 
insulin in trehalose, mannitol and dextran. Sample volumes were limited and a modified 
pharmacopoeia method using a 5 mL volumetric vessel was used. Generally lessons for 
flowability of bulk lyophilised formulations cannot be ideally drawn. Kaialy and Nokhodchi 
(2013) investigated 5 %w/v freeze dried mannitol (63-90 µm) in comparison with commercial 
77 
 
and spray died mannitol for its superior pulmonary delivery. The attention given to flow 
though minimum was the highest fill volume reported in literature that had been dried and 
investigated for flow properties. Interestingly, a 100 mL initial solution was freeze dried in a 
250 mL round bottom volumetric flask at -110°C. The choice of drying container and cycle 
temperatures are not desirable and atypical for an optimal bulk freeze drying process.  
There is no literature fully characterising flow behaviour of bulk freeze dried powders which 
can serve as the bench mark for work in this area to harness the cost benefits of bulk tray 
drying. Such bench mark study will also require a reproducible powder breaking or disruption 
technique for bulk tray dried cakes into powder capable of further processing. 
 A hexagonal arrangement of vials on freeze dryer shelves is adopted in industry to 
maximise the use of shelf space (Figure 4.1).  
 
Figure 4.1: Section of the hexagonal packing of vials on a typical freeze dryer shelf showing 
dead space (grey area) not in use. From shelf and vial dimensions including wall thickness, 
the volume not being used can be calculated using trigonometry. 
 
However comparing vials to bulk drying in a tray held on the same shelf dimensions, 23% to 
34.4% of the shelf volume is wasted when a comparison is made. A shelf to be loaded with 
vials and a fixed volume will require either an increase in fill depth of vials or additional vials 
a
b
c
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(bigger shelf) to make up the total liquid volume to be dried (See Table 4.1). Any increase in 
fill depths exceeding 2 cm is not considered ideal due to an expected increase in resistance 
to mass transfer and a resultant increase in primary drying times. 
Table 4.1: Calculation of the volume of dryer shelf not used when filled using the hexagonal 
arrangement of vials on different freeze dryer (A-F) shelves. Calculations were based on vial 
and tray wall thicknesses of 1.5 mm, fill height of 10 mm and an outer vial diameter of 29 mm 
or 50 mm. Waste is expressed as a percentage volume not used. Alternatives to meeting the 
short fall is expressed as additional process vials or suggested increase in fill depth. 
Type of freeze dryer and geometry 
Freeze dryer A B* C D** E F G H* E F** 
Shelf width (m) 0.3 0.654 1 1.524 5 10 0.3 0.654 1 1.524 
Shelf length (m) 0.6 0.711 3 1.829 7 10 0.6 0.711 3 1.829 
Area (m
2
) 0.18 0.46 3 2.79 35 100 0.18 0.46 3 2.79 
Drying process 
Vials diameter (mm) 29 29 29 29 29 29 50 50 50 50 
Shelf not used (%) 19.6 14.5 13 12.1 10.3 10.2 21.5 15.5 13.2 14.8 
Shelf holds (vials) 219 602 3953 3708 47506 136026 72 200 1326 1210 
Fill height (mm) 10 10 10 10 10 10 10 10 10 10 
Volume not used (%) 34.4 30.7 29.8 29.1 27.9 27.7 29.5 24.7 23 24.4 
Increase fill by (mm) 4.22 3.55 3.41 3.30 3.10 3.09 3.71 2.9 2.64 2.85 
Process additional (vials) 115 266 1675 1523 18348 52210 30 66 396 391 
* Virtis AdVantage 2.0 bench top freeze dryer. Dryer dimension taken from SP Scientific 
(2014a). ** Hull production freeze dryer model 450FxS800. Dryer dimension taken from SP 
Scientific (2014b). 
The adoption of bulk tray drying is challenged by the difficulty to maintain sterility, sample 
losses or “blow out” and wapping of stainless trays on the long term (Patel and Pikal, 2011). 
Commercially available lyoguard trays by Gore (Gassler and Rey, 2004) and a patent 
disclosed by Bergmann and Brustmann (1994) addressed sample losses using semi 
permeable membrane tray covers with minimal resistance to vapour flow. Cho et al. (1992) 
also disclosed collapsible blood bags for bulk lyophilisation. Some materials by nature will 
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only benefit from bulk drying and examples include lyophilised medical wound dressings and 
lyophilised cidofovir sheets which require moulding (Piette et al., 2013).  
Recent advances in technology is allowing aseptic bulk tray drying. An isolated aseptic 
commercial scale GMP freeze dryer with automated loading and unloading for bulk stainless 
steel trays has been reported in detail for drying polypeptides from fill to finish (Telstar, 
2010). The technology has since being integrated for production lines used in bulk drying of 
sterile antibiotics in industry (Telstar, 2012). 
There is the need to bulk dry either at early stage drug development which requires large 
amounts of lyophilised API or production of process intermediates for storage in intermediate 
bulk containers. Bulk drying can also be a final requirement in spray freeze drying 
approaches. Spray freeze drying techniques continue to utilise bulk drying vessels after 
atomization, freezing and collection of droplets into final stainless steel tray, bowl (Schiffter 
et al., 2010) or glass dishes (Costantino et al., 2000) for drying on a standard freeze dryer 
shelf.  
 Mannitol was chosen for flowability studies in this chapter because of its common 
use as bulking agent in freeze drying, diluent in oral disintegration tablets and carrier in dry 
powder inhalers. Most importantly it can fully crystallise when freeze dried which is desired 
for final stability. Mannitol has been well studied in literature for its final freeze dried 
attributes. Freeze dried mannitol provides structural support to produce cakes with an 
elegant appearance (Pyne et al., 2002). It also provides structural support in the presence of 
a collapsed amorphous phase; a phenomenon referred to as micro collapse (Johnson et al., 
2002). Its high eutectic temperature of -1.5oC allows the use of both conventional and 
aggressive high temperature drying (Kim et al., 1998, Hawe and Friess, 2006b, Cao et al., 
2006). Mannitol is known for its vial breaking tendency when in the crystalline state can exist 
as a mixture of both amorphous and crystalline forms as well as a hydrate (Yu et al., 1999, 
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Cao et al., 2006). Its stabilising effect however deteriorates with increasing crystallinity 
(Izutsu et al., 1994). The various polymorphs of mannitol and their preparation have also 
been thoroughly reported (Burger et al., 2000, Yu et al., 1999) and its behaviour in the 
presence of other co solutes is well known (Torrado, 2002, Hawe and Friess, 2006b). 
 We hypothesise crystalline components in a freeze dried powder system will be 
responsible for good flowability rather than amorphous components if present. Poly 
dispersed powder particles from disrupted bulk freeze dried powders may be produced and 
will influence flow. 
 
4.2 Aim and Objectives 
It is the aim of this chapter to investigate the flow properties of bulk lyophilised mannitol and 
sucrose as carriers for small molecules and biopharmaceuticals. The effect of total solute 
content on particle morphology which influence flow properties were investigated using 
standard pharmacopoeia methods. A further objective was to investigate the role of thermal 
treatment during the freezing stage of the lyophilisation process on these flow properties. 
The chapter is concluded with considerations to inform aspects for further processing of bulk 
lyophilised biopharmaceuticals or small molecules downstream in a production line. It must 
be emphasised that maintaining aseptic conditions during drying and powder manipulation 
are not within the scope of this chapter. 
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4.3 EFFECT OF SOLUTE CONCENTRATION ON FLOWABILITY OF BULK 
FREEZE DRIED POWDERS 
4.3.1 Materials and Methods 
Fluid bed dried D-mannitol Ph. Eur. was purchased from Fagron, UK. Fluid bed dried 
sucrose BP was obtained from Fischer Scientific, UK. CombiCoulomat fritless Karl Fischer 
reagent was purchased from VWR, UK.  
 
4.3.1.1 Freeze drying  
4.3.1.1.1 Pre-formulation characterisation 
Eutectic melt temperature (Teu) for mannitol and glass transition temperature of the 
maximally frozen solution (Tg’) for sucrose where investigated using MDSC as previously 
described (Section 3.2.2.2). About 20mg of sample was equilibrated at -40°C with ± 0.5°C or 
1°C modulation every 50 or 100 seconds. A ramp rate of 1°C/min to 20°C was used. 
 
4.3.1.1.2 Drying cycle 
Mannitol and sucrose (300 mL, 1-15 %w/v) solutions were freeze dried in a stainless tray 
(Figure 3.3 page 57) in a Virtis advantage freeze dryer. Samples were shelf loaded and 
cooled from room temperature to -55°C with 6 hours hold. Primary drying was performed at -
30°C for 32 hours with secondary drying at an elevated temperature of 20°C for 4 hours. 
Condenser was at a constant -75°C with pressure at 200 µbar. Product temperature was 
monitored using K type thermocouples placed at the centre and edge of trays to monitor 
product temperature during the freeze drying cycle. Trays containing bulk dried cakes where 
transferred through a funnel into sealed bottles for storage in a desiccator over moisture 
indicating dried silica gel. 
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4.3.1.2 Cake disruption technique (I) 
Bulk freeze dried cakes were broken down into powder with a British pharmacopeal tablet 
friabilator (Sotax USP F2, Switzerland) using a fixed 1000 revolutions in simulation of typical 
handling. 
 
4.3.1.3 Karl Fischer moisture content determination 
Residual moisture content determinations were performed using a coulometric C20 Karl 
Fischer titrator, Mettler Toledo, Switzerland as previously described in the materials and 
methods section 3.4.2.2 on page 60. 
 
4.3.1.4 Compressibility index  
Compressibility index was calculated from bulk and tapped densities measured using a 100 
mL measuring cylinder as described in material and methods chapter section 3.4.10.1 on 
page 67. 
 
4.3.1.5 Angle of repose 
Angle of repose was measured by passing samples through a funnel from the calculated 
tangential inverse function of the ratio of powder height to radius as previously described in 
material and methods section 3.4.10.2.2 page 69.  
 
4.3.1.6 Light microscopy 
Morphology studies were conducted with a light microscope (Carl Zeiss, Scope.A1 
Germany) equipped with a camera system (Axiocam MRM) and imaging software 
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(Axiovision version 4.8). Magnifications of x10 eyepiece and x10 or x40 objectives were 
used. 
 
4.3.1.7 Particle sizing by mechanical sieving 
Particle sizing method (British Pharmacopoeia Commission, 2013d) was performed using a 
mechanical sieve shaker (Retsch, AS 200 basic, Germany) and 200 mm test sieves with an 
aperture size range of 1000-75 μm. An amplitude of 60 mm for 5 minutes per run was used 
until the endpoint of the sieving process was reached as defined by the BP and described in 
materials and methods section 3.4.5.1 on page 63. 
 
4.3.1.8 Porosity studies  
Porosity measurements were made using a helium gas multipycnometer (Quantachrome, 
MUP-6DCE, USA). Standard operating procedure for this analysis is available in the 
appendix II on page 244. 
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4.3.2 Results 
4.3.2.1 Freeze drying 
Pre-formulation characterisation results showed a eutectic melt of -1.44°C ± 0.01 for 
mannitol and a Tg’ of -31.58°C ± 0.43 on the reverse heat flow curve for 15 %w/v sucrose 
(Appendix VIII). These were in agreement with the published eutectic melt of mannitol of -
1.4°C (Kim et al., 1998). Pikal (2007), Chang and Randall (1992) reported Tg’ of -35°C and -
32°C for sucrose. 
  
Mannitol and sucrose from 1-15 %w/v solution were freeze dried producing elegant looking 
bulk dried cakes without product collapse or melt back. Minor cracks were observed in 
products with lower solute content (1-5 %w/v). Average thermocouple readings indicated 
that primary drying was completed in all cases, elevated thermocouple reading indicative of 
reduced sublimation cooling was seen for all dried materials. During primary drying, product 
temperatures were maintained below the measured eutectic melt of mannitol and the Tg’ of 
sucrose. A typical cycle thermograph is available in appendix VI Figure A 10.  
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4.3.2.2 Flow characterisation 
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Figure 4.2: Compressibility index and porosity of freeze dried mannitol and sucrose from 1-15 
%w/v solutions. Fluid bed dried = BP grade crystalline powdered mannitol and sucrose 
(Fagron UK and Fisher UK respectively). ** Represents significance at P≤0.01 (n = 3) ANOVA 
between mannitol and sucrose porosity. *** Represents significance of 10 %w/v at p<0.001 
from 15 %w/v in mannitol and sucrose porosity. 
 
Compressibility index and Hausner ratios were calculated. To avoid duplication in discussion 
of the interrelated indices, only the compressibility index is discussed.  
Freeze drying mannitol and sucrose from a 1-15 %w/v solution produced dried cakes which 
when broken into powder using technique (I) (Fixed revolutions in a friabilator) produced 
powders with significantly (p≤0.01) higher compressibility indices (Figure 4.2). A high 
compressibility index (Carr’s index) value meant powders were very compressible, more 
cohesive and exhibited poor flow (Carr, 1965). Fluid bed dried sucrose powder had excellent 
flow, classified as 4.59 ± 4.58 %, in contrast lyophilised sucrose was classified as ‘very very 
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poor’ (74.31 ± 3.21 %) when lyophilised from an initial solution concentration of 1 %w/v. The 
same comparison could be made for mannitol. An increase in the total solid content of both 
mannitol and sucrose solutions was found to influence compressibility indices of the final 
lyophilised powder. Increasing solute concentration correlated with a decrease in 
compressibility index and an improvement in the assigned flow character within freeze dried 
batches. Above 5 %w/v, there was no significant decrease (P>0.05) in compressibility and 
no significant improvement in flowability of mannitol in its lyophilised forms.  
 
4.3.2.3 Angle of repose 
The angle of repose assessment based on the recommended British pharmacopoeia 
method was not possible in cases. Lyophilised powders did not flow and required forcing 
through funnels using a micro spatula, thus invalidating the measurement. Fluid bed dried 
samples however required no modification to their assessment method. 
The angle of repose for fluid bed dried mannitol and sucrose was 27.77 ± 0.52° and 13.13 ± 
0.63° respectively which conferred a flowability attribute of “Excellent” (Carr, 1965). 
Determination of angle of repose for lyophilised mannitol and sucrose were recorded as 
invalid due to bridging or arching that blocked the funnel.  
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4.3.2.4 Moisture content determination 
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Figure 4.3: Moisture content (n = 3) of bulk freeze dried mannitol and sucrose powders from 1-
15 %w/v solutions. Fluid bed dried = BP grade crystalline powder mannitol and sucrose 
purchased from Fagron UK and Fisher UK respectively. * represents significance at p<0.05 
from mannitol lyophilised from 5 %w/v solution. # represents significance at p<0.05 from 
mannitol lyophilised from 1% and 3 %w/v solution. 
 
Moisture content (Figure 4.3) for both bulk dried mannitol and sucrose from 1-15 %w/v 
solutions were below 2.6 %w/w. Higher moisture content which average 0.4 %w/w was 
present in corresponding powders of the same solute content.  
Moisture content for freeze dried mannitol ranged between 1.8-2.5 %w/w and sucrose 
ranged between 2.2 %w/w-2.6 %w/w. 
There were no significant differences in moisture content within the lyophilised sucrose 
formulation batch. The same was true within the lyophilised mannitol batch except for 
powders dried from 5 and 10 %w/v solutions (p<0.05). Other statistical significance at 
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p<0.05 (n = 3 one way ANOVA) observed between some mannitol and sucrose batches 
were due to very minute differences in residual moisture of less than 1 %w/w in all cases 
(Figure 4.3).  
Fluid bed dried sucrose recorded the least moisture content of 0.94 %w/w and higher 
residual moisture of 1.64 %w/w in fluid bed dried mannitol. 
 
4.3.2.5 Porosity studies 
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Figure 4.4: Bulk density (n = 3) of bulk freeze dried mannitol and sucrose powders from 1-15 
%w/v solutions. Fluid bed dried = BP grade crystalline powder mannitol and sucrose (Fagron 
UK and Fisher UK respectively). * = P<0.05, ** = P<0.01, **** = P<0.0001 from all formulations (n 
= 3 one way ANOVA) 
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Table 4.2: Mannitol and Sucrose powders densities. Bulk and true densities (Mean ± SD, n = 3) 
with literature comparison. Values are rounded to two decimal places where appropriate.  
Fluid bed dried Sample Density (g/cm3) Literature 
Mannitol (Ph. Eur.) (Fagron, 
UK)  
Bulk density 
True density 
0.45 ± 0.02 
1.73 ± 0.02 
0.43 g/cm
3
 (Powdered) * 
1.514 g/cm
3 
* 
Sucrose BP (Fischer Scientific 
, UK) 
Bulk density 
True density 
0.93 ± 0.02 
1.62 ± 0.002 
0.93 g/cm
3
 (crystalline)   
1.6 g/cm
3 
  , 1.586 g/cm
3
 
¤
 
* (Armstrong, 2009a)   (Armstrong, 2009b) ¤ (Imamura et al., 2008) 
 
Bulk and true density measurements used for calculation of porosity were in agreement with 
literature values as shown in Table 4.2.  
Powders from freeze dried mannitol and sucrose from 1-15 %w/v solution were very porous 
in nature (Figure 4.2) and calculated from true and bulk densities (Figure 4.4). 
Porosity-concentration dependent variation was evident for freeze dried carriers and was 
skewed towards the production of less porous samples as total solid content increases per 
formulation. On the average, freeze dried mannitol had a porosity of 98.57% compared to 
73.85% observed for its fluid bed dried form. A similar trend is observed in freeze dried 
sucrose with porosity averaging 97.83% within the batch compared to its fluid bed dried 
form, 42.58%. This represented a magnitude change of about 2 in total porosity (p<0.001 n 
= 3 ANOVA). 
Powders from freeze dried mannitol and sucrose from 1-15 %w/v solution were very porous 
in nature (Figure 1) and porosities were calculated from true and bulk densities (Figure 2). 
Porosity-concentration dependent variation is evident for freeze dried carriers and is skewed 
towards the production of less porous samples as total solid content increase per 
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formulation. On the average, freeze dried mannitol had a porosity of 98.57% compared to 
the 73.85% observed for its fluid bed dried form. A similar trend is observed in freeze dried 
sucrose with porosity averaging 97.83% within the batch compared to its fluid bed dried 
form, 42.58%. This represented a magnitude change of about 2 in total porosity (p<0.001 n 
= 3 ANOVA). 
Low total solid contents were observed not to significantly yield different final powder 
porosity in either mannitol or sucrose and the least porous samples resulted from the highest 
15 %w/v solute concentrations. No significant differences (P>0.05) in porosity was observed 
either within lyophilised mannitol powder batch formulated from 1-5 %w/v solutions or 
sucrose powders originating from an initial solute concentrations of 1-10 %w/v. 
 
4.3.2.6 Particle sizing analysis 
P a r t ic le  S iz e (m )
C
u
m
m
u
la
t
iv
e
 o
v
e
r
s
iz
e
 (
%
)
0 1 0 0 2 0 0 3 0 0 4 0 0 5 0 0 6 0 0 7 0 0 8 0 0 9 0 0 1 0 0 0
0
2 5
7 5
1 0 0
M A N  1 0  % w /v
M A N  1 5  % w /v
M A N  5  % w /v
M A N N IT O L
M A N  3  % w /v
S U C R O S E
1 0
5 0
9 0
S U C  1 5  % w /v
S U C  1 0  % w /v
Figure 4.5: Cumulative particle oversize distribution (n = 1) of freeze dried mannitol from 
solutions of 3-15 %w/v and freeze dried sucrose from 10 %w/v and 15 %w/v solutions. Fluid 
bed dried = BP grade crystalline powder mannitol and sucrose (Fagron UK and Fisher UK 
respectively). Size distributions collected into a sieving pan were below 75 microns.   
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There was not enough statistical evidence to suggest a correlation between final particle 
size distribution and initial concentration of freeze dried solution feed. The median particle 
size for disrupted freeze dried mannitol (1-15 %w/v) was between 100-280 microns and 120-
200 microns in sucrose (10 and 15 %w/v only). 
Particle size analysis for 1-5 %w/v freeze dried sucrose was not possible due to the high 
hydroscopic nature of the powder and moisture uptake during the powder assessment 
period at room temperature and pressure. 
4.3.2.7 Morphology studies by light microscopy 
  
  
Figure 4.6: Light microscope images of freeze dried particles from 1 %w/v mannitol solution 
using x100 magnification (top row) and x 400 magnification (bottom row). 
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Figure 4.7: Light microscope images of freeze dried particles from 5 %w/v mannitol solution 
using x100 magnification (top row, Focal plane stacked) and x400 magnification (bottom row). 
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Figure 4.8: Light microscope images of freeze dried mannitol from 15 %w/v mannitol solution 
at magnifications Top: x400 and Bottom: x100. 
 
Freeze dried mannitol (lyophilised from 1 %w/v and 15 %w/v solution) had irregular shapes 
with rough surfaces (Figure 4.6 to Figure 4.8). Platy and acicular or flaky particulate 
morphologies were also observed (Figure 4.6). Fluid bed dried sucrose particles were 
observed as crystalline blocks or masses (Figure 4.8) consistent with the description by 
Armstrong (2009b). They appeared more prismatic compared to fluid bed dried mannitol. 
Fluid bed dried mannitol were described by Armstrong (2009) as orthorhombic. In 
agreement, this study observed various sizes and shapes with some needle like 
appearance. 
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Figure 4.9: Focal plane stacked light microscope images of fluid bed dried mannitol (x400 
magnification, left column) and fluid bed dried sucrose (x100 magnification, right column). 
 
A correlation was identified between measured compressibility indices and some flow 
properties investigated (Figure 4.10). A strong relationship between porosity and bulk 
density of lyophilised mannitol and sucrose formulations exist. The least porous formulations 
(high bulk densities) showed better compressibility indices across formulations. The same 
was true in fluid bed dried forms serving as controls in this study. 
95 
 
1 .5 2 .0 2 .5 3 .0
0
2 0
4 0
6 0
8 0
1 0 0
M o is tu r e  c o n te n t  (% w /w )
C
o
m
p
r
e
s
ib
il
it
y
 I
n
d
e
x
 (
%
)
B u lk  L y o p h ilis e d  M a n n ito l B u lk  L y o p h ilis e d  S u c ro s e
2 0 4 0 6 0 8 0
0
2 0
4 0
6 0
8 0
1 0 0
9 0 9 2 9 4 9 6 9 8 1 0 0
P o r o s ity  (% )
C
o
m
p
r
e
s
ib
il
it
y
 I
n
d
e
x
 (
%
)
B u lk  L y o p h ilis e d  M a n n ito l
B u lk  L y o p h ilis e d  S u c ro s e
F lu id  b e d  d r ie d  S u c ro s e
F L u id  b e d  d rie d  M a n n ito l
F lu id  b e d  d r ie d B u lk  L y o p h i l is e d
0 2 0 0 4 0 0 6 0 0
0
2 0
4 0
6 0
8 0
M e d ia n  p a r t ic le  s iz e  ( m )
C
o
m
p
r
e
s
ib
il
it
y
 I
n
d
e
x
 (
%
)
B u lk  L y o p h ilis e d  M a n n ito l
B u lk  L y o p h ilis e d  S u c ro s e
F lu id  b e d  d r ie d  S u c ro s e
F L u id  b e d  d rie d  M a n n ito l
0 .0 0 0 .0 5 0 .1 0 0 .1 5 0 .2 0
0
2 0
4 0
6 0
8 0
1 0 0
0 .4 0 .6 0 .8 1 .0
B u lk  d e n s ity  (g /c m
3
)
C
o
m
p
r
e
s
ib
il
it
y
 I
n
d
e
x
 (
%
)
B u lk  L y o p h ilis e d  M a n n ito l
B u lk  L y o p h ilis e d  S u c ro s e
F lu id  b e d  d r ie d  S u c ro s e
F L u id  b e d  d rie d  M a n n ito l
F lu id  b e d  d r ie dB u lk  L y o p h i l is e d
Figure 4.10: Correlation between compressibility index (CI) of powders and Top: moisture 
content and Porosity. Bottom: Median particle size and Bulk density. CI (Mean ± Standard 
deviation) is plotted against the mean (n = 3) of moisture and porosity. Median particle size 
was determined from total sample lyophilised. Particle size of sucrose lyophilised from 1-5 
%w/v sucrose solution and mannitol lyophilised from 1 %w/v solution are not documented.  
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4.3.3 Discussion 
4.3.3.1 Flowability 
Compressibility had a strong relationship with; the type of excipients lyophilised and the 
initial solute content of formulations. Bulk lyophilised mannitol batches were found to exhibit 
better flow characteristics when compared with sucrose formulations. The high 
compressibility indices observed in freeze dried sucrose implied it was more compressible 
than mannitol. For example sucrose freeze dried from 5 %w/v solution was significantly 
different in flow when compared with a dried mannitol powder from same solute 
concentration.  
The compressibility index value for fluid bed dried sucrose corresponds to an excellent flow 
character which is in agreement with literature (Armstrong 2009). 
Our initial postulation that increasing the solute concentration of a bulk carrier agent would 
increase the flowability of powders was confirmed true. Increased solute concentration from 
1-15 %w/v decreased compressibility indices and improved flow behaviour. 
Increasing the solid content of the initial freeze dried solution resulted in powders with a 
higher bulk density and explains the trend seen with decreasing compressibility indices 
(Figure 4.10). The extent to which the bulk density can be increased in formulations is 
however limited by solubility of its excipients. For example the solubility of mannitol and 
sucrose at 20°C are 1 in 0.5 and 1 in 5.5. Heating on a stirring plate may be required in 
cases where solubility at room temperature has been exceeded. This would not be ideal for 
heat labile APIs. A significant second factor is the need to avoid drying of an extra mass 
which may be unnecessary within the formulation, as this would negatively drive the 
economics of the lyophilisation process towards longer cycle lengths. Within this study, 
drying a mass of mannitol or sucrose above any solute concentration not associated with 
improvement in flowability will be wasteful. The presence of higher solute content results in 
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higher mass transfer resistance during the sublimation period and primary drying time is 
prolonged.  
High solute content has been seen to provide similar benefits in literature (Maa et al., 2004, 
Lamprecht, 2013). A high solid content of 20-30% for spray freeze dried influenza vaccine 
yielded powdered particulates with high “tap densities” was reported by Maa et al. (2004). 
The highest tap density reported was from a mixture of dextran, trehalose and mannitol at 
0.79 g/mL; however these were not obtained with standard pharmacopeia methodology. The 
author’s methodology involved the use of samples in glass vials which were tapped on the 
bench 20 times and compared to an equivalent volume of water. 
Lamprecht (2013) documented that by increasing the concentration of either BSA, dextran or 
PVP from 0.1 to 1 or 10% in spray freeze dried lysozyme they were able to produce a 
smooth and uniform lyophilised particle with fewer cracks and increase in mechanical 
strength from SEM.  
  
4.3.3.2 Moisture and morphology 
 No one property can predict the flowability (British Pharmacopoeia Commission, 2013c) but 
it is controlled by a multitude of flow properties including; moisture, porosity, density, size 
and morphology. 
 At the end of primary drying, samples still contain about 5-20% residual moisture 
dependent on the formulation (Tang and Pikal, 2004). This is due to the presence of 
unfrozen water in its solute phase and requires elevated drying temperatures during 
secondary drying for removal by desorption. The typical objective of secondary drying would 
be to reduce moisture content to a level deemed optimal for the stability of a given 
formulation which is usually a level of less than 1 %w/w (Tang and Pikal, 2004). 
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The extent to which flowability of porous cohesive materials are affected by moisture was 
limited because residual moisture penetrates the core of particulates instead of forming 
liquid bridges (Howard, 2007). Formation of liquid bridges would negatively affect flow 
behaviour. Amorphous or crystalline mannitol can be produced depending on the freeze 
drying process and may exist in one of its polymorphic forms (Yu et al., 1999). In its 
crystalline form, surface adsorption is the most common route of moisture uptake where 
water molecules interact at the vapour interface through weak interactive forces and form 
water mono layers on the crystal surface (Hancock and Shamblin, 1998). This observation is 
analogous to the behaviour of water insoluble powders which form water vapour or liquid 
bridges at high humidity (Coelho and Harnby, 1978). In this case it is the relative humidity 
and not the moisture content that determines whether any moisture present remains in the 
form of liquid bridges or is adsorbed as water vapour (Coelho and Harnby, 1978). While at 
low relative humidity (RH) moisture is adsorbed as vapour, formation of liquid bridges are 
favoured as RH increases after condensation at the particle contact points. It must be noted 
however that crystalline sucrose can absorb up to 1% moisture and is hygroscopic when 
finely divided (Armstrong, 2009b). 
In this chapter, while tap density measurements were made at RTP, storage and measuring 
cylinder required for determinations were sealed from ingress of moisture. The effect of any 
absorbed moisture impacting on the compressibility of hygroscopic freeze dried sucrose 
(Armstrong, 2009b) can be assumed to have been negligible. Conversely, freeze dried 
mannitol is non hygroscopic after lyophilisation and has been demonstrated from moisture 
sorption studies in literature. Fakes et al, (2000) disclosed lyophilised mannitol remained 
unchanged even at a high relative humidity of 60%. The authors found lyophilised sucrose 
absorbed up to 4% more moisture at 50% RH and desorbed at 55% RH Amorphous sucrose 
can absorb moisture and crystallise if poorly stored. Hancock and Dalton (1999) reported the 
crystallisation of amorphous sucrose after 3 months of storage at 30°C was above 40% RH.  
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 Despite the absence of enough statistics to establish a relationship between size 
distribution and solid content, the effect of particulate size on lyophilised powder flowability 
was apparent. 
Fluid bed dried mannitol and lyophilised mannitol from 5-10 %w/v solutions had particle 
fractions below 90 microns collected into the sieving pan. In the absence of the availability of 
other suitable characterisation methods, it could be assumed these micronised fractions may 
contain particles below 10 microns which are known to have bulk behaviour when in contact. 
Powders exhibiting bulk behaviour are cohesive due to the presence of surface energy 
forces which are strong enough to cause plastic deformation on the surface of particles at 
the points of contact (Walton et al., 2007). Another difficulty working with very fine particles 
is the fact that they can become fluidized and may cause flooding (Carr, 1965) which can 
affect downstream processes or equipment not designed to handle a sudden influx of 
powder in larger quantities. 
 
Particles above 250 microns are free flowing whiles below 100 microns flow problems are 
eminent due to increasing cohesiveness (Staniforth and Aulton 2007). Coarser particles are 
influenced more by gravitational forces than cohesive forces which negate good flow 
behaviour. For example freeze dried mannitol from 10% and 15 %w/v solutions, 
compressibility results show increasing flow behaviour which may be linked to the fact that 
15 %w/v contained 38.16% oversize of 250 micron particles compared to 9.13% over size of 
250 micron in the former. Freeze dried sucrose which showed excellent flow properties had 
the largest cumulative oversize distribution with 50% of particles above 540 µm. Notably, 
91.97% of particles were sized above 250 microns (Figure 4.5).  
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Fluid bed dried mannitol was composed of more fines compared to fluid bed dried sucrose 
although both crystalline in nature. Only 60% of the former was above 80 microns (40% 
below 80micons) compared to the 90% found greater than 280 microns in the later. 
 Flaky particles have a high surface to volume ratio and result in poorer flow 
behaviour (Staniforth and Aulton, 2007). This supports why the poorest flow behaviour was 
shown by powders with the least solute content, 1 %w/v. The more irregular the shapes of 
the particles, the poorer its flowability (Howard, 2007). 
Similar benefits of both increasing solute concentration, shape and density was reported by 
Schiffter et al., (2013) who used trehalose, mannitol and dextran with a total solid content of 
35 %w/w to yield high density and robust spray freeze dried particles with irregular shape 
and wrinkled or rough surface morphology. The observed morphology was attributed to 
collapse of the amorphous phase and concluded to be beneficial for needle free ballistic 
insulin powder injection. These benefited from increased density and mechanical strength. 
Whilst a direct comparison cannot be made due to the 5 mL volumetric flask used in the 
determination of tap density by Schiffter and co-workers, reported Hausners indicate a range 
of spray freeze dried with fair to poor flowing powders. 
 The final physical form of a bulking agent or stabiliser is important for final storage. 
Clearly the use of mannitol in formulations over sucrose is warranted on the basis of its 
superior flowability over sucrose (Figure 4.1). Mannitol is however not ideal for lyoprotection. 
Other motivations for the use of mannitol in freeze dried formulations have been the elegant 
cakes that result and also for being a good bulking agent that will fully crystallise during 
drying. This prevents the release of moisture on storage that can affect stability of 
pharmaceuticals (Izutsu et al., 1994). Sucrose is a better lyoprotectant than mannitol and as 
such the use of mannitol-sucrose mixtures have been investigated in literature (Johnson et 
al., 2002). It is anticipated that such binary mixtures will be investigated further in this thesis 
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to identify considerations for bulk drying of pharmaceuticals where powder flowability is of 
immense importance. 
 
4.3.4 Conclusion 
Dryer shelf volume of 23%-34.4% was wasted when the hexagonal vial arrangement was 
compared to bulk drying in trays. 
Both methods of accessing flow reinforced each other to emphasise the negative impact of 
freeze drying on powder flow behaviour. Fluid bed dried mannitol and sucrose showed better 
flow properties than all bulk lyophilised batches. A positive correlation between particle size, 
bulk density, porosity and freeze dried powder flowability has been found to exist. Increased 
solute content increases density and improves flow of freeze dried powders up to 15 %w/v. 
Mannitol as a flow enhancing bulking agent must be used at a concentration not less than 5 
%w/v. 
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4.4 EFFECT OF FREEZING RATE AND THERMAL TREATMENT ON 
FLOWABILITY OF BULK FREEZE DRIED POWDERS. 
4.4.1 Background 
From the concentration-flowability studies in section 4.3 of this chapter, it was established 
that increasing the solute content of initial solution feed of freeze dried powders benefited its 
flow behaviour after breaking the cake into powder. The freezing step in lyophilisation is the 
most critical stage when the ice crystal morphology is formed depending on the freezing 
conditions. The use of a slow freezing rate no higher than 0.5 °C/min is often recommended 
in industry for the formation of large ice crystals to benefit from shorter primary drying times. 
Annealing formulations also induce homogeneity in ice morphology and reduce drying times 
(Searles et al., 2001a). However, higher freezing rates for example when formulations are 
loaded onto precooled shelves and quench or rapid cooling in liquid nitrogen are 
occasionally adopted. These higher freezing rates produce smaller ice crystals and are 
associated with longer drying times. Unlike bulk tray drying, conventional drying in vials 
using these different freezing rates do not require any further cake processing and as such 
the flow properties that may be induced is unknown and not of concern. 
In the following section of this chapter, the effect of different freezing rates and thermal 
treatment (Annealing) that could be adopted in bulk tray freeze drying is investigated to 
identify freezing step considerations for maximum benefits to final bulk dried powder 
flowability. 
 
4.4.2 Materials and Methods 
Fluid bed dried D-mannitol Ph. Eur. was purchased from Fagron, UK. Fluid bed dried 
sucrose BP was obtained from Fischer Scientific, UK. CombiCoulomat fritless Karl Fischer 
reagent was purchased from VWR, UK.  
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4.4.2.1 Freeze drying 
Mannitol solutions (100 mL, 0.056 M-1 M) were freeze dried in a Virtis advantage freeze 
dryer using a custom made three compartment tray (Dense grade polystyrene model foam 
frame (Trylon, UK) and polyethylene base (Tesco, UK)) (figure 3.3 in Chapter 3).  
Different freezing rates of 0.2 °C/min, 1 °C/min and 5 °C/min were used. Samples chilled at 
0.2 °C/min and 1 °C/min were equilibrated on a 25°C shelf for 30 minutes, shelf temperature 
was ramped to -55°C and held frozen for 6 hours. Samples which required annealing were 
equilibrated on a 25°C shelf for 30 minutes and chilled to -55°C (0.2 °C/min) with an 
additional temperature hold at -20°C for 2 hours. Samples which required freezing at 5°C 
/min were loaded directly onto a -70°C precooled shelf. Primary drying used a -10°C shelf 
temperature. 
 A constant -80°C condenser and vacuum of 200 µbar was used. Shelf was subsequently 
elevated to 20°C for secondary drying over 6 hours. K type thermocouples were placed at 
the centre and edge of trays to monitor product temperature during the entire freeze drying 
cycle. Tray containing bulk dried cakes where transferred into polyethylene bags and into a 
nitrogen purged isolator (Soloflex, UK). Cakes were passed through a funnel into sealed 
bottles for storage in desiccators over moisture indication dried silica gel. 
 
4.4.2.2 Cake disruption technique (II) 
Freeze dried cakes were broken into powder through mechanical sieving at a vibration 
amplitude of 80 mm through a 200 mm diameter sieve nest with aperture size range 710-75 
µm fixed onto a mechanical sieve shaker (Retsch, AS 200 basic, Germany). Endpoint of the 
powder breaking process was reached when the mass on any of the test sieves were 
unchanged by more than 5% or 0.1g of its previous mass (British Pharmacopoeia 
Commission, 2013d). 
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4.4.2.3 Karl Fischer moisture content determination 
Residual moisture content determinations were performed using a coulometric C20 Karl 
Fischer titrator, Mettler Toledo, Switzerland as previously described (Section 3.4.2.2). 
 
4.4.2.4 Light microscopy 
Morphology studies was conducted with a light microscope (Carl Zeiss, Scope.A1 Germany) 
equipped with a camera system (Axiocam MRM) and an imaging software (Axiovision 
version 4.8). Magnifications of x10 eyepiece and x10 or x40 objectives were used to capture 
3 sets of images per powder sample.  
 
4.4.2.5 Particle sizing by mechanical sieving 
Method for particle sizing (British Pharmacopoeia Commission, 2013d) was performed using 
a mechanical sieve shaker (Retsch, AS 200 basic, Germany). Ten test sieves with an 
aperture size range of 1000- 53 μm and base pan were used at an amplitude of 80 mm for 5 
minutes per run. Endpoint of the sieving process was reached as previously described.  
 
4.4.2.6 Porosity studies  
Porosity measurements were made using a helium gas multipycnometer (Quantachrome, 
MUP-6DCE, USA). Standard operating procedure for this analysis can be found in Appendix 
II. 
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4.4.2.7 Compressibility index  
Compressibility index was calculated from bulk and tapped densities measured as described 
in material and methods chapter using a 50 mL measuring cylinder which was sealed with 
parafilm . 
 
4.4.2.8 Angle of Repose 
Angle of repose was measured by passing samples along the side of a funnel in small 
quantities to form a heap of powder. The tangential inverse function of the ratio of powder 
height to radius calculated as previously described in material and methods section 
3.4.10.2.2. 
 
4.4.2.9 Shear cell 
Flow function test was measured using a Brookfield powder flow shear cell tester 
(Brookfield, USA) as previously described (Section 3.4.10.3.2). A geometric spacing with 4 
consolidation levels and 3 stresses up to a maximum of 6.26 kPa was used. The shear 
tester was set to an axial speed of 1 mm/sec and torsional speed of 1 rev/hr. Sample trough 
and vane lids of 5 inches in diameter were used. All measurements were performed at room 
temperature and pressure. 
 
4.4.3 Results 
4.4.3.1 Freeze drying 
Formulations were successfully freeze dried and typical freeze drying cycle plots are 
available in appendix VI (Figure A11-A14, page 261). Thermograms for mannitol freeze 
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dried confirmed product temperature remained below the eutectic melt of mannitol of -1.5°C 
(Kim et al., 1998). Vacuum and condenser temperature remained constant with evidence of 
sublimation cooling during the primary drying phase. A subsequent elevation in product 
temperature during primary drying depict the removal of bulk ice and the cycle allowed 
enough soaking period to guarantee uniformly dried middle and edges of the bulk cake. 
Freeze dried cakes were elegant in appearance with no visual observation of melt back. 
 
4.4.3.2 Moisture content determination 
 
Figure 4.11: Moisture content (n = 3) for bulk freeze dried mannitol from 0.056-1 M solutions. 
Slow = 0.2 °C/min. Mid = freezing rate of 1 °C/min. Fast = freezing rate of 5 °C/min. 
All freeze dried samples recorded residual moisture content of less than 0.6 %w/w without 
significant difference at p>0.05 (Figure 4.11). 
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4.4.3.3 Compressibility Index 
 
Figure 4.12: Effect of freezing rate and thermal treatment on compressibility index (n = 3) of 
bulk freeze dried mannitol from 0.056-1 M solution. Slow = 0.2 °C/min. Mid = freezing rate of 1 
°C/min. Fast = freezing rate of 5 °C/min. * = p< 0.05, *** = p<0.001 and # = p< 0.05 from power 
lyophilised from 1 M mannitol solution.  
 
The effect of freezing rate and thermal treatment of mannitol lyophilised from 0.056 M-1 M 
solution revealed some apparent concentration-flowability relationships with statistical 
evidence in cases. Increasing compressibility values corresponded to a decline in powder 
flowability. Except for mannitol lyophilised from 1 M solution which was frozen at 0.2 °C/min, 
freezing solutions at rates of 0.2-5 °C/min or annealing produced powders with no 
improvement in compressibility index and were classed as "Very very poor" in flowability. 
Based on same compressibility criteria, the former was classed as very poor. Fluid bed dried 
mannitol and sucrose however were poor (p<0.05) and excellent (p<0.00001) in flowability 
respectively. 
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Total solid content-compressibility index relationship is apparent in powders lyophilised from 
solutions chilled at 0.2 °C/min and at 5 °C/min (p>0.05). Increasing solute concentration 
from 0.25 M to 1 M resulted in a marginal improvement in compressibility index with 
significance p<0.05 (one way ANOVA). A similar trend was observed when 0.056 M to 1 M 
mannitol solutions were lyophilised from an initial chilling at 0.2 °C/min without significance 
(P>0.05). 
Freezing samples faster on precooled freeze drying shelves at 5 °C/min yielded no benefit 
neither did annealing samples at a -20°C (2hours hold) provide benefits from compressibility 
indices. Majority of the evidence from compressibility indices suggests the use of higher 
solid content of 0.25 M to 1 M cooled at either 0.2 °C/min or 1 °C/min was beneficial. 
 
4.4.3.4 Angle of Repose 
Angle of repose measurements detected no significant differences between bulk lyophilised 
powders regardless of their handling history (Figure 4.13). Fluid bed dried mannitol and 
sucrose were however significantly different from all lyophilised powders with significance at 
p<0.05 and p<0.0001 respectively. 
The angle of repose for lyophilised powders ranged from 47.41 -51.07  which corresponded 
to poor on Carr's flowability scale and therefore classed as materials which require agitation 
or vibration (Carr, 1965). Fluid bed dried mannitol was measured at 40.18  and classed with 
a flow property between fair and passable while fluid bed dried sucrose measured at 22.21  
was classed as excellent.  
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Figure 4.13 Effect of cooling rate and thermal treatment on angle of repose (n = 3) of bulk 
freeze dried mannitol from 0.056-1 M solution. Slow = 0.2 °C/min. Mid = 1 °C/min. Fast = 
freezing rate of 5 °C/min. 
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4.4.3.5 Porosity studies 
 
Figure 4.14: Effect of cooling rate and thermal treatment on bulk density (n = 3) of bulk freeze 
dried mannitol from 0.056-1 M solution. Slow = 0.2 °C/min. Mid = 1 °C/min. Fast = freezing rate 
of 5 °C/min.  
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Figure 4.15: Effect of freezing rate and thermal treatment on porosity (n = 3) of bulk freeze 
dried mannitol from 0.056-1 M solution. Slow = 0.2 °C/min. Mid = 1 °C/min. Fast = freezing rate 
of 5 °C/min. 
Bulk density (Figure 4.14) and porosity (Figure 4.15) showed densification of powders were 
achieved from increased solid concentration and appeared not to be generally influenced by 
freezing rate or thermal treatment during lyophilisation.  
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4.4.3.6 Particle size analysis 
 
Figure 4.16: Particle sizing analysis of bulk freeze dried mannitol from 0.056 M (n = 2), 0.25-1 M 
(n = 3) solutions with varied thermal treatment and powder breaking. Slow = 0.2 °C/min. Mid = 
1 °C/min. Fast = 5 °C/min. 0.056 M Fast formed agglomerates on sieving and were invalid. 
 
Median cumulative particle size ranges were below 250 µm in all samples (Figure 4.16). 
These were 100-210 µm, 100-240 µm, 60-100 µm and 90-190 µm in slow (2 °C/min), 
medium (1 °C/min), fast (5 °C/min) and annealed (0.2 °C/min held at -20°C) powders 
respectively (Figure 4.17). In powders obtained from initial 1 M solute contents, increasing 
the freezing rate of solutions resulted in a decline in median cumulative particle size from 
210 µm to 60 µm. The observed trend in particle size is discussed in relation to the 
disruption or breaking step (Figure 4.18) later in this chapter. 
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Figure 4.17: Median particle sizes of bulk freeze dried mannitol from 0.056 M (n = 2), 0.25-1 M 
(n = 3) solutions with varied thermal treatment and powder breaking. Slow = 0.2 °C/min. Mid = 
1 °C/min. Fast = 5 °C/min. 0.056 M Fast formed agglomerates on sieving and were invalid. 
 
Figure 4.18: Schematic of disruption process of sections of bulk freeze dried mannitol cake 
dried from solution with varied cooling rates and thermal treatment. Different cooling rates 
produce cakes of different pore sizes (Order of increasing pore size: Fast, Mid, Slow and 
Annealed). Dotted lines represent points of fracture within cakes from mechanical agitation of 
sieves (710-75 µm). Slow = 0.2 °C/min. Mid = 1 °C/min. Fast = 5 °C/min. Annealed = 0.2 °C/min 
Slow Mid
Annealed Fast
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with -20°C thermal hold (2 hours). 0.056 M Fast formed agglomerates on sieving and were 
invalid. 
4.4.3.7 Morphology studies-light microscopy 
  
  
Figure 4.19: Light microscope images at x100 magnification for powders freeze dried from 
mannitol solutions of Top Left: 1 M (cooled at 1 °C/min, Mid), Top Right: 0.5 M (cooled at 1 
°C/min, Mid), Bottom Left: 1 M (cooled at 5 °C/min, Fast) and Bottom Right: 0.5 M (cooled at 5 
°C/min, Fast). Scale bar = 20 µm 
Optical microscopy revealed irregular, plate like (flaky), angular and needle like 
morphologies in all powders regardless of cooling rate and thermal treatment (Figure 4.19). 
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4.4.3.8 Shear Cell 
 
 
Figure 4.20: Typical stress data for bulk lyophilised mannitol from 1 M solution at a slow 
cooling rate of 0.2 °C/min showing effect of consolidation level on 4 yield loci drawn 
tangentially to each pair of Mohr circles (Small and large). 1 & 1’, 2 & 2’, 3 & 3’ and 4 & 4’ form 
individual pairs of small and large Mohr circles. Flow function curve was derived from a 
separate plot of major principal consolidation stress (  ) and unconfined yield strength ( c) for 
each yield locus. 4th yield locus showed (σ1) = 15.986 kPa, (σc) = 4.997 kPa strength and 
consolidation endpoint (σE) = 6.630 kPa. 
 
Stress data (Figure 4.20) plotted as a function of shear stress to normal stress for samples 
produced flow function curves (Figure 4.21) which were obtained from resulting yield locus 
and Mohr circles drawn from stress data.  
Lyophilised powders from 0.5 M and 1 M mannitol solutions were cohesive in nature (Figure 
4.21). Flowability of bulk solids categorised by a flow function curve worsens in an anti-
clockwise order from ‘free flowing’ to ‘very cohesive’. Powders from 1 M mannitol solution 
frozen at 5 °C/min 1 M Man (Fast) was very cohesive at lower consolidation stress of less 
than 2 kPa and become cohesive at higher consolidation stresses (Figure 4.21). Its 
flowability was worse from 2 kPa up to about 10 kPa consolidation stresses. Freeze dried 
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2’ 
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mannitol from 0.5 M mannitol frozen at 5 °C/min was visually observed as the most cohesive 
and was adhered the most to the shearing lid vanes of the annular shear tester (Figure 
4.22). Fluid bed dried mannitol and sucrose were easy flowing and free flowing respectively.  
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Figure 4.21: Flow function curve of bulk lyophilised powders (n = 3) from 1 M mannitol 
solution at different cooling rates compared to fluid bed dried mannitol and sucrose. Slow = 
0.2 °C/min. Mid = 1 °C/min. Fast = 5 °C/min.  
 
Flow index is the slope of the line drawn through the origin of a flow function curve to a yield 
loci at a given consolidation stress and higher values correspond to poor flowability. The flow 
index of lyophilised powders from 0.5 M solutions ranged from 0.29 to 0.39 and showed no 
significant difference in cohesive behaviour (Table 4.3).  
All powders from 0.5 M solute content except annealed samples failed to withstand the 
same level of continuous shear as higher 1 M content powders (See footnote of Table 4.3). 
Annealed powders from 0.5 M solution and all powders dried from 1 M mannitol solution 
withstood shear stresses above 6.626 kPa while the former lost strength during the 
determination of the 3rd yield loci.  
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Table 4.3: Flow index determined from shear cell measurements of powders bulk lyophilised 
from 0.5 M mannitol (Man) solution. 
Bulk lyophilised Powder (Cooling rate, °C/min) Flow index (°) n = 3 mean (SD) 
0.5 M Man (Slow, 0.2 °C/min) * 0.39 (0.04) 
0.5 M Man (Mid, 1 °C/min) * 0.29 (0.06) 
0.5 M Man (Fast, 5 °C/min) * 0.26 (0.02) 
 0.5 M Man (Annealed, 0.2 °C/min) 0.29 (0.00) 
* Powder lost strength during determination of 3rd yield locus at stresses above 6.626 kPa. 
  
A 
 
B 
 
Figure 4.22: Freeze dried mannitol powder adhered to shear cell. A: Shear cell lid with vanes 
covered with mannitol powder freeze dried from 0.5 M Mannitol at a shelf cooling rate of 5 
°C/min. B: sample trough of shear cell expected to hold all powder under analysis. 
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4.4.4 Discussion 
A powder breaking step would be required to disrupt or break large bulk dried cake into 
loose powder. A different powder breaking step which involved mechanical shaking at an 
amplitude over time using a standard nest of analytical sieves was used in this chapter. The 
chapter’s previous approach involved the use of a standard tablet friability tester with a 
rotating drum. Both techniques simulate powder handling through comb or sieve disruption 
at a commercial level. The rotating drum was operated for a specified number of revolutions 
with cakes being broken into powder under conditions of avalanche. Sieve disruption was 
performed to British Pharmacopoeia criteria for completion with all fractions recombined and 
used. 
It was proposed that the use this method of standard stainless steel sieving would be 
appropriate, easily reproducible and of a low cost. The use of a standard tablet friability 
tester needed to be resistant to the build-up of static as the freeze dried powders were seen 
to easily acquire electrostatic charges when in contact with the plastic surfaces. Either 
particle-particle or particle-wall collusions and particle fragmentation could have led to 
charging of the powders (Amidon, 1995). The potential regulatory hurdle envisaged for the 
use of a sieve system for processing parenterals would be to guarantee absence of metal 
particulates which may be shed during the mechanical shaking of stainless steel sieves. This 
is foreseen as a lesser problem for bulk powders intended for oral drug delivery.  
 
4.4.4.1 Effect of cooling rate and annealing 
Both the cooling rate and freezing rate were found to be similar (Figure A11-A14 in appendix 
VI on page 261). The freezing rate is the rate of ice growth within a formulation after 
nucleation and is dictated by the extent of supercooling (Liu, 2006). The number of ice 
nuclei, rate of ice crystal growth and size of ice crystals are dependent on the degree of 
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supercooling observed during the cooling stage in freeze drying (Rambhatla et al., 2004, 
Searles et al., 2001b). The nucleation events during freezing determine the morphology of 
the final dried cake. At high degrees of supercooling, the nucleation rate is high and freezing 
rate is faster. The fast freezing rate causes the formation of many small ice crystals with a 
high surface area while a lower degree of supercooling yields fewer large ice crystals with 
lower surface area. The ice crystals formed from freezing sublime during primary drying to 
leave behind pores. The pore size distribution and hence the final porosity within the bulk 
dried cake are therefore a result of the freezing process. 
The use of the annealing step provided additional mechanical strength to freeze dried 
powders. Formulations dried from a lower concentration of 0.5 M mannitol solution lost 
mechanical strength at stresses above 6.626 Kpa, while this was not observed in the 
annealed formulation (Table 4.3). The observation can be attributed to the freezing events 
during the thermal hold where ice crystal morphology was modified by the annealing 
treatment. Ice crystals grow during annealing in a phenomenon referred to as Ostwald 
ripening (Searles et al., 2001a). Annealing also benefits formulations by ensuring the 
complete crystallisation of mannitol, reducing the propensity for release of moisture during 
storage. This chapter revealed mannitol had superior flow behaviour over sucrose but also 
recognises its poorer activity stabilising effect. An annealed formulation’s mechanical 
strength is proposed to improve handling due to a reduction in friability and assisting 
downstream processing. 
 
4.4.4.2 Flow properties 
The final residual moisture content in the freeze dried samples were below 0.6 %w/w and all 
negligible (Figure 4.11) in their respective effect on flow as previously discussed (section 
4.3.3.2 page 97). Moisture on this scale would penetrate the central core rather than form 
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liquid bridges which affect flowability (Howard, 2007). Nonetheless moisture levels are an 
important determinant of final product stability. Acting as a plasticiser, water promotes 
chemical degradation by depressing the glass transition and induces changes from an initial 
glassy physical state to a more mobile and less viscous rubbery state (Li et al. 2005). Very 
low moisture levels however do not always favour protein stability and many examples have 
been cited by Wang (2000). For example bovine serum albumin was found to be more 
stable at 10 %w/w moisture content than at levels less than 1 %w/w. Stability of the final 
powered state from a bulk freeze dried cake is identifiable as a formulation specific 
parameter not within the scope this thesis.  
 
Particle size distribution results from mechanical sieving suggested the involvement of three 
main properties in the observed sizes of final disrupted powder (Figure 4.16). These were 
the concentration of solute content present, tendency to agglomerate (cohesiveness) and 
the initial pore size of the cake from which the powder was formed. 
We suggest solute content and initial cake pore size influenced the powder breaking or 
attrition processing. Different cooling rates would produce different amounts and sizes of ice 
crystals which result in pores of varied sizes after sublimation (Figure 4.18). Pores were 
therefore expected to be few and large in size for formulations slow cooled at 0.2°C/min. 
Thermal treatment (annealing) during a slow cooling step would be expected to grow the few 
but large ice crystals causing them to increase in size. As the cooling and freezing rate 
increases, the number of pores increases while pore size decreases (Figure 4.18).  
Comparing the same area of dried cake in all formulations, the size and number of pores 
present would influence the cake fracturing process and therefore the final particle size of 
disrupted powder. For example, in the presence of many small pores in fast cooled (5°C) 
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cakes when fractured (dotted line on Figure 4.18) across pores would produce the smallest 
particle sizes (Figure 4.17).  
However the initial pore size of the cake was not the only determining factor for powder size 
distribution because the increased median particle size observed should have followed the 
increasing order of initial cake pore size (from fast, mid, slow to annealed) across all solute 
concentrations. This was not the case from solute concentrations of below 0.5 M mannitol 
content (Figure 4.17). The largest particle sizes would have been produced in the annealed 
formulations due to the presence of fewest and largest pores (Figure 4.18 and 4.17). The 
limitation of analytical sieving and particle morphology could explain the higher median size 
recorded for powders cooled at 0.2°C (Slow) over annealed. Rod like shaped particles could 
be erroneously sized as they could pass through sieves if vertically oriented. 
Below 0.5 M mannitol solute content, increasing cohesive forces increased the tendency for 
powders to agglomerate and they produced high median particle sizes. This was supported 
by the visually observed agglomeration of 0.056 M samples cooled at 5°C which was invalid 
(Figure 4.16). However, at higher mannitol solute concentrations of above 0.5 M increasing 
mechanical strength afforded especially to the annealed would be expected to make 
powders less friable and would influence production of larger sized powders during the 
fracturing process.  
The relationship between these observed particle sizes and the cohesive nature of powders 
observed were related (Figure 4.21). Bulk solids experience inter particulate forces of which 
a greater proportion are usually Vander Waals forces compared to other forces such as 
gravitational forces (Visser, 1989). At smaller particle sizes flowability would be expected to 
decline as particles experience larger magnitudes of Vander walls forces (Visser, 1989). 
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Size and moisture play synergistic roles in making bulk solids cohesive. Forsyth et al., 
(2002) found that the critical value of humidity for glass spheres to become cohesive 
increased with increasing particle size and the cohesive inter particulate forces increased 
with increasing relative humidity. Larger particles have a greater mass and inertia which 
require larger forces to impede free flow (Forsyth et al., 2002). A reduced particle size 
corresponds to an increase in surface area per unit mass which therefore allows cohesive 
forces to interact with the greater surface area (Fitzpatrick et al., 2004). 
 
4.4.5 Conclusion 
The use of a standard nest of 200 mm sieves (710-75 µm) produces reproducible powder 
systems from bulk lyophilised cakes. This was the most appropriate, reproducible and low 
cost approach for disruption into powder (Section 4.4.4) 
 
Powders with highest flow behaviour correlate with solute concentrations of between 0.25 M 
and 1 M (Section 4.4.3.3). Mannitol content of formulations optimised for flow should be at a 
concentration of 0.5 M-1 M.  
Bulk formulations intended for further processing should be cooled at rates between 0.2°C to 
1 °C/min and cooling rates of 5 °C/min or greater avoided. The latter cooling rate (5 °C/min) 
yields the most cohesive powders at the least consolidation stresses of 2 kPa from shear 
cell data and would be most problematic for processing (Section 4.4.3.8). Overall, while 
annealing showed no benefits for improving powder flowability (From compressibility index 
and shear cell) when 0.2°C and 1 °C/min cooling rates were compared, the benefits 
accorded by an added mechanical strength in low solute content formulations would be 
beneficial for successful adoption of powders for further processing.  
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5 DISPENSING OF BULK LYOPHILATES FOR VIAL OR AMPOULE 
ENCLOSURE 
5.1 Introduction 
Lyophilisation or freeze drying is most common in the food and pharmaceutical industry. In 
many cases it is the ideal drying process technology for materials liable to thermal 
degradation. This preference is however, largely due to but not limited to maximised activity 
recovery, optimum reconstitution times and an ability to confer significant shelf-life on the 
final powdered state. The trend within the pharmaceutical industry towards large molecule 
biologic drug substances is well documented. These compounds tend to require injection as 
the delivery route into the body, and they are not shelf stable in aqueous solution. To avoid 
the expense (and often impracticality) of cold chain supply, this has led to significant growth 
in dual chamber reconstitution devices whereby the drug substance is stored as a powder 
and mixed with the diluent just prior to use. The incumbent system lyophilises the drug 
substance into a powder cake within a dual chamber device. This process is recognised as 
being slow and expensive, and limits formulation flexibility.  
Few cost analyses of the lyophilisation process have been recorded but drying is known to 
be financially expensive in comparison with fluid bed or simpler forms of dehydration (Ratti, 
2001). Process analytical technology tools (PAT) and quality by design (QbD) provide 
strategies for shortening cycle times and reducing financial costs while increasing quality 
and reproducibility. Strategies involving the freezing step include annealing, controlled 
nucleation and use of aggressive primary drying temperatures have previously been 
reviewed in relation to final product acceptance and product quality factors (Ekenlebie and 
Ingham, 2011).  
Here we propose a paradigm shift away from conventional drying within the primary 
container (vial or a dual chamber cartridge) towards bulk or continuous freeze drying to 
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benefit from the potential cost savings. A potential barrier to adoption of a bulk process will 
be a requirement for final powder dispensing into a product container.  
Bulk drying coupled with a commercially viable dosing system may afford cost savings in the 
region of 30% (Ekenlebie and Ingham, 2013). These proposed savings were derived from 
the typical wasted shelf area and hence the volume not used. Wasted volume calculations 
also considered wall thickness of all glass vials arranged in a hexagonal packing order in 
comparison to a bulk product in a single tray.  
This study investigates the use of commercially available gravimetric and volumetric 
(pneumatic) dispensing system using freeze dried powders from lyophilised bulk cake. There 
is limited literature disclosure of dispensing technologies for such powders. Lyophilised 
bovine vaccine pellets have been recently dosed using a screw conveyor and a vibration 
chute systems but the specifics of final recovery and important physical attributes of the final 
dosed units remain ambiguous (Gehrmann et al., 2010). Sanofi disclosed advantages of tray 
freeze dried vaccine micro pellets for end stage container filling using a commercial dosing 
technology but falls short of reporting which dosing mechanism is ideal and the physical 
effects on the dried particulates (Chouvenc and Françon, 2009). The same is true for other 
published patents where frozen droplets were engineered for subsequent sublimation in 
lyophilisers without demonstrating how the friable particles would be finally dispensed or 
aliquoted (Carson et al., 2005, Wende and Jesziorski, 2011, Middlebeek et al., 2009). The 
possibilities for dosing freeze dried powders disrupted after drying is as yet unclear. 
There are a wide range of pharmaceutical powder dispensing technologies available such as 
augers, dosators and vacuum dosators (Yang and Evans, 2007). These are used in other 
applications such as capsule fillers and dry powder inhaler filling. Due to the poor powder 
flow characteristics, volumetric dosing technologies may be unsuitable for dispensing freeze 
dried powders accurately.  
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5.2 Aim and Objectives 
It was the aim of this chapter to investigate volumetric and gravimetric lyophilised powder 
dispensing from bulk trays into final container closures using immunoglobulin G (IgG), Beta 
Galactosidase and Lactate dehydrogenase (LDH) formulations in crystalline and amorphous 
sugar systems.  
An objective was to identify any relationship between constituents or physical form of the 
loose freeze dried powdered states, known flow behaviour and accuracy of the dispensing 
system used. A further objective was to investigate if regulatory expectations could be met 
from the final content uniformity of dosed units. A final objective was to identify the most 
suitable dispensing approach and key considerations for the successful adaptation of freeze 
dried powders for powder transfer. 
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5.3 VOLUMETRIC AND GRAVIMETRIC DISPENSING USING ACCOFIL AND 
QUANTOS DOSING SYSTEM 
5.3.1 Materials and Methods 
5.3.1.1 Materials 
D-mannitol Ph. Eur. and Sucrose BP were supplied as fluid bed dried from Fagron, UK and 
Fischer, UK. Beta galactosidase was purchased from Sigma UK. Lactate dehydrogenase 
(LDH) and CombiCoulomat fritless Karl Fischer reagent were obtained from VWR, UK. 
Ovine sera containing fluorescein isothiocyante anti bodies (Anti-FIT C) was received as a 
gift from MicroPharm, UK and IgG was precipitated using caprylic acid and dialysed with 20 
mM citrate buffer pH 6.2 using a kvick 30 kDa Nominal molecular weight cut off filter Kvick 
Lab packet and holder (GE Healthcare, UK). A multi compartment bulk drying tray was 
designed and machine cut form polystyrene to produce a frame (Trylon UK) and a 
polyethylene 1 mm base added. 
 
5.3.1.2 X-ray powder diffraction studies 
The physical form of lyophilised powders were analysed using X-ray powder diffraction 
(Bruker D2 Phaser, UK) equipped with a 30 kV 10 mA 300 W X-ray source.  
 
5.3.1.3 Dosing Time 
Time required to dose a single formulation vial was recorded using an automatic inbuilt timer 
in the mass dispenser or manually kept using a standard laboratory stop watch for the 
volumetric dispenser. 
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5.3.1.4 Lyophilisation Process  
Samples were lyophilised in a bench top Virtis advantage freeze dryer in 100 mL volumes in 
a custom made compartment polyethylene tray system. Vial samples were dried in 5 mL 
volumes in a tubular type 1 freeze drying vial (Adelphi healthcare, UK). All samples were 
chilled at 2°C/min from 16°C to -55°C and held for 6 hours. Primary drying was on a -40°C 
shelf for 36 hours at -75°C condenser and 267 µbar (27 Pascal) vacuum. Secondary drying 
was at 20°C for 9 hours. Product temperature was monitored as the average reading from K 
type thermocouples positioned at the bottom edge and centre of each tray compartment (RS 
Components, UK). 
Bulk dried cakes were passed through a funnel into sealed 500 mL bottles for storage. Vials 
were stoppered in the freeze dryer and aluminium crimped on removal from the chamber. 
 
5.3.1.5 Visual inspection 
Dosed formulations were visually inspected for acceptability. 
 
5.3.1.6 Moisture Content Analysis 
Residual moisture content was determined with a coulometric C20 Karl Fischer titrator 
(Mettler Toledo, Switzerland) as previously described in materials and methods using a 12 
cm hypodermic needle and 10 mL syringe, 2 mL of dry Karl Fischer reagent was drawn from 
the titration cell into aluminium crimped sample vials.  
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5.3.1.7 Flowability Characterisation 
Carr's compressibility index was calculated from measurements from a tap density 
apparatus (Sotax FD2, USA) and bulk density as described in materials and methods 
chapter (Section 3.4.10.1.2) except for the use of a 10 mL volumetric cylinder.  
 
5.3.1.8 Porosity  
The closest to true sample volume measurements were determined using a helium gas 
multipycnometer (Quantachrome, USA). Porosity was then calculated for 3 sample 
replicates from resulting particle density and measured bulk density. 
 
5.3.1.9 Gravimetric and Volumetric dispensing  
Bulk freeze dried powder cakes were broken down into powder using a standard tablet 
friabilator (Sotax UK) using a fixed 1000 revolutions. Samples in vials were mechanically 
disrupted with an aluminium paddle of 10 x 2 cm until the powder had visible flow. Powders 
were then dispensed using either a Quantos (Mettler Toledo UK) mass dispenser or Accofil 
(Biopharma UK) volume dispensing system. LDH and IgG freeze dried in 15 %w/v mannitol 
solution was also ball milled (Fritsch Pulverisette 7, Germany) at 300 rpm for 5 minutes and 
volumetrically dosed. All dosing was conducted at room temperature and pressure. 
 
5.3.1.10 Morphology studies 
Powder morphology was investigated using a light microscope (Carl Zeiss, Scope.A1 
Germany) with a camera system at x100-400 magnifications and Axiovision version 4.8 
imaging software. 
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5.3.1.11 Particle sizing by mechanical sieving 
Cumulative over size powder distribution was obtained from measurements using a nest of 
brass wire woven sieves (Endecotts, UK) and a mechanical sieve shaker (Retsch, AS 200 
basic, Germany). A 1000-63 μm, 200 mm diameter sieve nest was used in bulk flow studies 
and a 16 set 38 mm diameter sieve nest with aperture sizes ranging from 1000-63 μm used 
in dispensing investigations. Test samples were shaken at an amplitude of 80 mm at 5 
minutes interval. The endpoint of the sieving process was determined as previously 
described in materials and methods. 
 
5.3.1.12 Content uniformity test of dosed units 
IgG activity was determined using fluorescence quenching assay previously described in 
Section 3.4.9 of materials and methods. An acceptance value was calculated form 
measured protein activity (British Pharmacopoeia Commission, 2013b). 
 
5.3.1.13 Definitions and pass criteria 
Definitions used in this text include ‘Target dose’ which refers to the desired final mass the 
powder dispenser has been programmed to dispense. 'Mean deviation from target dose' is 
the average mass of all dosed vials expressed as a percentage error from the target dose 
and is herein used mainly to compare powder behaviour and not as final assessment of 
compatibility for dosing. 'Over fill' and 'under fill' refers to the dosing device exceeding or 
failing to meet a target dose and are also represented by positive and negative masses 
respectively. 
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Conclusions of the powders compatibility for dispensing were drawn from assessment of 
final dosed units using the British Pharmacopoeia acceptance value criteria and relative 
standard deviation (RSD) of a specific dosed formulation batch. 
Formulations were passed if an acceptance value (AV) was below 15. None of the passed 
formulations should fall below 0.75 or 1.25 of the case reference value (M) which was 98.5% 
or 101.5% or the average of individual dispensed contents expressed as a percentage of the 
label claim (British Pharmacopoeia Commission, 2013b). 
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5.3.2 Results  
5.3.2.1 GRAVIMETRIC DISPENSING OF NON-ANNEALED FREEZE DRIED POWDERS 
(WITH QUANTOS) 
Residual moisture content (%w/w) from Karl Fischer analysis was between 1.30 ± 0.06 to 
4.93 ± 2.38 (Table 5.1 and Table 5.2).  
Table 5.1: Moisture content (n = 3) of formulations dosed using gravimetric (quantos) and 
volumetric (accofil) powder dispensing systems.  
Formulation Moisture content (mean ± SD) 
Fluid bed dried  
Mannitol 1.40 ± 0.43 
Sucrose 1.30 ± 0.06 
Bulk lyophilised*  
Man 1 %w/v 4.5 ± 1.43 
MAN 15 %w/v 4.72 ± 1.23 
SUC 1 %w/v 4.15 ± 0.86 
SUC 15 %w/v 4.93 ± 2.38 
Bulk lyophilised* (Accofil only) 
IgG MAN 1 %w/v 4.23 ± 1.68 
IgG MAN 5 %w/v 4.67 ± 2.01 
IgG Man 15 %w/v 5.16 ± 1.87 
LDH MAN 15 %w/v 4.28 ± 2.54 
LDH SUC 15 %w/v 4.84 ± 0.98 
*from solution (%w/v) 
Table 5.2: Moisture content (n = 3) of vial lyophilised formulations dosed using gravimetric 
(quantos) powder dispensing system. Lyophilised IgG with 18.22 %w/v mannitol (MAN IgG), 
IgG with 34.23 %w/v sucrose (SUC IgG) and beta galactosidase with 3.42 %w/v sucrose (SUC 
BGAL). IgG fraction was from 1.7 g/L IgG in 20 mM citrate buffer. 
Vial Lyophilised 
Formulation 
Moisture content (mean ± SD) 
Suc Bgal 2.3 ± 0.3 
Suc IgG 1.9 ± 0.2 
Man IgG 2.5 ± 0.6 
IgG only 1.8 ± 0.36 
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The observed relative standard deviation (RSD) for the dosed masses of mannitol, sucrose 
and protein containing formulations was 0.54-7.37% RSD (Figure 5.1). Overfilling of vials 
was observed for vials of sucrose containing Bgal and IgG.  
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Figure 5.1: Variation in powder mass transfer using Quantos gravimetric dispenser. Powders 
were disrupted from non-annealed freeze dried cakes. Box and whisker plot with 
corresponding RSD of Left: 50 mg target dosing (n = 12) of bulk lyophilised mannitol (MAN) 
and sucrose (SUC) from 1 %w/v and 15 %w/v solutions. Right: 5 mg target dosing (n = 9) of 
vial lyophilised IgG with 18.22 %w/v mannitol (MAN IgG), IgG with 34.23 %w/v sucrose (SUC 
IgG) and beta galactosidase with 3.42 %w/v sucrose (SUC BGAL). IgG fraction was from 1.7 
g/L IgG in 20 mM citrate buffer. BGAL fraction contained 2 units/mL. Fluid bed dried mannitol 
and sucrose are BP, Eur. ph. grade crystalline powders. 
 
A bulking agent will be required in many cases if a researcher is to consider dosing of a 
biologic. IgG dried with no bulking agent was not dispensable (Figure 5.2 Left #) neither was 
1 %w/v sucrose content. The latter showed very poor flowability resulting in arching or 
blockage in the dosing reservoir of the powder doser. Increasing solute content showed a 
trend of improved mean deviations from target in pure crystalline formulations. However, 
introduction of an amorphous component distorted the observed pattern as seen in 1-34 
%w/v sucrose containing formulations (Figure 5.2). 
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Figure 5.2: Left: Mean % deviation (n = 12) from the target dose as dispensed with the Quantos 
system. Formulation batches are non-annealed bulk lyophilised mannitol (MAN), sucrose 
(SUC), vial lyophilised (n = 9) mannitol with IgG (MAN IgG), sucrose with IgG (SUC IgG) and 
sucrose with beta galactosidase (SUC BGAL) freeze dried from different %w/v solutions. IgG 
fraction contained 1.7 g/L IgG and 20 mM citrate buffer. BGAL fraction contained 2 units/mL. 
Fluid bed dried mannitol and sucrose are BP, Eur. ph. grade crystalline powders. # Represents 
n = 3 as subsequent doses were not achieved. # # Represents n = 2 due to an insufficient 
sample flow into dosing head. Right: Activity (n = 4) ± SD of dosed freeze dried Mannitol IgG. 
Stock powder was freeze dried from solution containing 1.7 g/L of IgG, 20 mM citrate buffer 
and 1 M mannitol. Dosed samples were reconstituted with distilled water and quantification 
conducted with a fluorescence quenching assay. Target dose (dotted grey line) content was 
0.5 mg to contain 0.7g/dl IgG. Calculated acceptance value (AV) = 0.16. 
  
The compendia content uniformity (CU) test criteria were met by dosed mannitol IgG 
formulations using 1 M mannitol solutions. From IgG activity recovery (Figure 5.3) of mass 
dispensed mannitol from freeze dried 15 %w/w solution, the calculated acceptance value of 
0.16 and that none of the dosed units deviated below 0.75 of the reference case (M) or 
above 1.25M would mean this powder was processed and would be acceptable under the 
pharmacopeia parameters for content uniformity. 
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Figure 5.3: IgG activity recovered (n = 4) of dosed freeze dried Mannitol IgG lyophilised from 
15 %w/v solution. Stock powder was freeze dried from solution containing 1.7 g/L of IgG, 20 
mM citrate buffer and 1 M mannitol. Dosed samples were reconstituted with distilled water and 
quantification conducted with a fluorescence quenching assay. * represents significance at 
p<0.05 
 
The time taken to dose a formulation (Figure 5.4) was found to negatively correlate with the 
increase in solute content, increases in solute content increase flowability (chapter 4 ) and 
reduce the time taken to dispense. The time required to dose the masses (50 mg and 5 mg) 
into vials was below the target of one minute and could be deemed time efficient however a 
fully automated process may demand further optimisation. 
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Figure 5.4: Automated dosing time (n = 12) of bulk lyophilised mannitol (MAN), sucrose (SUC), 
vial lyophilised (n = 9) mannitol with IgG (MAN IgG), sucrose with IgG (SUC IgG) and sucrose 
with beta galactosidase (SUC BGAL) from different %w/v solutions. MANNITOL and SUCROSE 
are fluid bed dried BP grade crystalline powder mannitol and sucrose. IgG fraction contains 
1.7 g/L IgG and 20 mM citrate buffer. BGAL fraction contains 2 units/mL.  
 
5.3.2.2 Volumetric dispensing of non-annealed freeze dried powders (with Accofil) 
Volumetric dispensing was researched as it provides the main alternative to mass dosing.  
Residual moisture content (%w/w) from Karl Fischer analysis was between 1.30 ± 0.06 to 
5.16 ± 1.87 (Table 5.1). A comparison of means and standard deviation using one way 
Anova and Tukey’s multiple comparisons test showed no significant difference between the 
residual moistures observed (Table 5.1 and Table 5.2). 
Large variations in the mass transferred were noted for volumetric systems with %RSD 
values for non-milled freeze dried powders ranging from 1.6%-48.9% (Figure 5.5).  
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Figure 5.5: Variation in powder mass transfer using a volumetric dispenser (Accofil). Powders 
were disrupted from non-annealed freeze dried cakes. Box and whisker plot with 
corresponding RSD of dosed bulk lyophilised material Left: mannitol (MAN) and sucrose 
(SUC) from 1 %w/v, 5 %w/v and 15 %w/v solutions containing IgG and LDH (n = 6). Right: 
mannitol (MAN) and sucrose (SUC) from 1 %w/v and 15 %w/v solutions (n = 6). Fluid bed dried 
mannitol and sucrose are BP, Eur. ph. grade crystalline powders. 
 
Dosing was largely affected by bulk density and particle size distribution. More dense 
formulations resulting from higher solute content were expected to have better particle 
packing within the dosing die and did show improved reproducibility; a trend seen between 
IgG freeze dried in 5 %w/v mannitol (IgG MAN 5 %w/v) and in 15 %w/v mannitol (IgG MAN 
15 %w/v) as well as sucrose (SUC) freeze dried from solutions in the range of 1-15 %w/v.  
 
Particle size and complete homogeneity in formulations were important parameters that 
influenced volumetric dispensing. A 10 fold improvement in %RSD was realised in IgG 
lyophilised in 15 %w/v mannitol (IgG MAN 15 %w/v) when milled with a change from 16.9 to 
1.7%. This value was similar to that seen in fluid bed dried mannitol and sucrose which were 
significantly (p<0.001) bulkier and less porous (Figure 5.6). 
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Figure 5.6: Bulk density and porosity of dosed bulk lyophilised mannitol (MAN) and from 1 
%w/v and 15 %w/v solutions. Fluid bed dried mannitol and sucrose are BP, Eur. ph. grade 
crystalline powders. *** = p< 0.001 from all formulations. * = p< 0.05, ** = p< 0.01 (one way 
ANOVA). 
 
Compressibility index for dosed freeze dried mannitol from 15 %w/v solution and IgG dried in 
1-15 %w/v mannitol solution (IgG MAN) showed very poor powder flowability (Figure 5.7). 
 
 
Figure 5.7: Compressibility index (n = 3) of dosed formulations freeze dried from different 
concentrations (%w/v) of mannitol solution. Fluid bed dried mannitol and sucrose are BP, Eur. 
ph. grade crystalline powders. *** represents significance at P≤ 0.001 (n = 3) ANOVA from all. * 
represents significance from MANNITOL at p<0.05 (ANOVA). ϴ represents significance from all 
formulations at p< 0.001 and p<0.05 (ANOVA) from Man IgG 5 %w/v. 
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While the time taken to manually dispense individual formulations cannot necessarily be 
used to compare formulations because they are dictated by how skilled an operator is in the 
art, it gave a clear indication of how potentially time efficient the process could be if 
automated for scaled up powder dispensing (Figure 5.8).  
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Figure 5.8: Total manual operation time for dispensing batches (n = 10) of bulk lyophilised 
mannitol (MAN), sucrose (SUC), IgG and LDH formulations (n = 6).  
 
Lyophilised IgG in mannitol and sucrose were crystalline and amorphous respectively from 
XRPD (Figure 5.9). This would be expected to affect flowability and was discussed in 
chapter 4. 
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Figure 5.9: X-ray powder diffractograms for A: IgG freeze dried with mannitol (I) and sucrose 
(II) showing crystalline and amorphous diffraction patterns. B: fluid bed dried sucrose and C: 
fluid bed dried mannitol showing crystalline diffraction patterns.   
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5.3.2.3 Visual appearance of dosed formulations 
Powders dispensed volumetrically (Figure 5.10 A&C) showered signs of agglomeration after 
ejection from the dosing die but were easily broken with gentle agitation of the vial (Figure 
5.10 B&D). Powders dispensed using mass filling showed evidence of electrostatic charging 
and sticking to inner walls of dosing head (Figure 5.11) but with no concern for 
agglomeration.  
 
Figure 5.10: Appearance of dosed formulations (A) Lyophilised LDH in Mannitol from 15 %w/v 
solution**. (B) Dosed sample (A) after agitation. (C) Lyophilised IgG in Mannitol from 15 %w/v 
solution**. (D) Dosed sample (C) after agitation. (E)* From left: lyophilised Mannitol from 15 
%w/v solution, Lyophilised Mannitol from 1 %w/v solution, fluid bed dried mannitol and 
lyophilised Sucrose from 15 %w/v solution. ** = Dosed with volume dispenser. * = Dosed with 
quantos dosing head. Not all dosed using accofil showed agglomeration after dosing. 
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Fill
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Fill
A                  C
B                  D
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(Agitation)
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A B 
  
Figure 5.11: Gravimetric or mass filled lyophilised powder losses due to sticking to inner walls 
of dosing head (A) and brim of glass vial (B). 
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5.3.3 Discussion 
Two dosing systems employing different mechanisms for dispensing powders have been 
investigated. The accofil powder dispenser is a volumetric doser working using a pneumatic 
or pressure control system working in combination with a dosing die (aspirator) to dispense 
powders. The quantos system uses a dosing head in combination with a stirring and tapping 
dosing mechanism to powder dispense.  
The goal for any dispensing task is to discharge an accurate amount of formulation into 
individual vials with no or negligible over or under filling (deviations) from the target. The 
Quantos® system was observed to over fill for sucrose powders while producing improved 
performance with mannitol containing formulations. This was consistent with initial flowability 
assessments where mannitol was found to be better flowing (discussed in chapter 4). The 
role of bulking agents on flowability was emphasised by two trends. Dosed accuracy of 
similar formulations correlated with increased solute concentration of the bulking agent while 
the absence of a bulking agent resulted in IgG being non dispensable (Figure 5.2). 
Flowability of freeze dried powder were previously found to benefit from increases in solute 
content of solutions freeze dried and bulking agent was identified as a necessity for 
flowability (Studied in chapter 4). 
Larger deviations from final target dose were observed using the volumetric dosing system 
compared to the gravimetric (Figure 5.1 and Figure 5.5). This was to due the differences in 
the dosing mechanisms. A gravimetric system uses a computerised feedback loop to control 
the dispensed amounts for more accuracy by opening and closing the outlet of the dosing 
head. These systems allow operators to control settings to suit a material being dispensed. 
In this work, the best load cell sensitivity setting was used to acquire the most accurate 
outcome achievable. The volumetric method however relies solely on proper sample packing 
into the dosing die or aspirator for subsequent ejection into final containers, although the die 
volume can be adjusted this is not dynamic. 
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The quantos gravimetric dosing head was notably prone to blockage with freeze dried 
powders which belong to the 'very very poor' flow category investigated in this work. This 
was due to bridging or arching close to the neck of sample reservoir attached to the dosing 
head. The freeze dried powders experience different stresses within the reservoir which 
result in consolidation of the powder. A larger shear stress from the head will be required to 
overcome these consolidation stresses. The absence of a controlled humidity environment 
during quantos dispensing work may have been contributory to the larger dosing 
incompatibilities observed particularly in sucrose containing formulations (Figure 5.1 and 
Figure 5.2) due to the known hygroscopicity of sucrose. 
While a standard anti-static kit is available for the quantos system, this was unavailable 
during this study and freeze dried powders were found to acquire charge. The phenomenon 
referred to as triboelectrification is due to transfer of electrons between dissimilar materials 
and is influenced by stresses (in our case from mechanical stirring and tapping), moisture, 
temperature and adsorbed gas molecules on surfaces (Yang and Evans, 2007). Particle –
particle and particle-wall collusions have been previously mentioned as causes of powder 
charging (Amidon, 1995). We advise that charging of freeze dried powders need to be 
avoided or reduced to the minimum due to the observed sample losses and therefore 
concerns of its negative effect on freeze dried powder flow behaviour. This view is reinforced 
by Staniforth (1982) whose work revealed even powder flow behaviour of free flowing 
crystalline sugars and cohesive crystalline cellulose charged by friction using air cyclone 
showed poorer flow compared to the uncharged forms. The charged powders recorded 
higher angles of repose and 21-84% reduced rates from flow through an orifice 
characterisation.  
We have reported that volumetric powder dispensing is less precise than the gravimetric 
system for dispensing freeze dried powders. This observation is supported by similar 
comments on volumetric metering of powders attributing the poorer accuracy to its 
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dependence on size distribution, powder electrostatics, humidity and packing geometry 
(Lang et al., 2009). This supports the 10 fold increase in precision observed after milling IgG 
freeze dried in 15 %w/v mannitol (Figure 5.5). Use of this system is common in capsule 
filling and the food industry but we do not recommended for dispensing lyophilised 
biologicals due to the significant irreproducibility illustrated (Figure 5.5). 
 
5.3.4 Conclusion 
The study has demonstrated that lyophilised formulations can be dosed time efficiently while 
meeting the British Pharmacopeia regulatory expectations for content uniformity (Section 
5.3.2.1). Due to the large dosing variations revealed, a gravimetric powder dispensing 
system utilising a stirring and vibration mechanism was recommended over volumetric 
methods. The influence of powder flowability on final dosing accuracy was correlated with 
increases in solute concentration of up to 15 %w/v in gravimetric dosing systems. The 
bulking agent (mannitol) is indicated in concentrations not less than 5-15 %w/v together with 
assurances of powder homogeneity. A high amount of amorphous content though necessary 
for lyoprotection impedes the accurate adaptation of powder dispensing.  
Freeze dried powders easily acquired electrostatic charge (Triboelectrification) which could 
have been caused by stresses induced during handling to include stirring, tapping, mixing or 
electron transfer between powders and the processing surfaces. This was responsible for 
sample losses during the dosing process. It is concluded powder electrostatics and 
environmental humidity should be controlled.  
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5.4 GRAVIMETRIC DISPENSING OF BULK LYOPHILATES USING THE 
FILL2WEIGHT™ SYSTEM 
5.4.1 Background 
The preceding study investigated the use of both volumetric and gravimetric powder 
dispensing systems for use with bulk dried lyophilates. Conclusions were consistent with the 
initial postulate that flowability of freeze dried powders influenced all aspects of the dosing 
process. The gravimetric dosing system was found to be the most suitable for adaption. In 
this study the number of formulations studied was narrowed to those containing mannitol or 
a mannitol:sucrose combination while exploring the use of annealing during the freezing 
stage. This allowed the number of dosage forms dosed to be increased to 40 dosed units. 
Annealing was envisaged to enhance the mechanical strength of powders to facilitate 
accurate dosing while sucrose would serve as lyoprotectant. The new Fill2Weight 
gravimetric system with a larger throughput and potential for large scale production is 
investigated for compatibility. 
 
5.4.2 Materials and Methods 
5.4.2.1 Materials 
Fluid bed dried D-mannitol Ph. Eur. was purchased from Fagron, UK. Fluid bed dried 
sucrose BP, reduced nicotinamide adenine dinucleotide (NADH) and sodium pyruvate were 
from Fischer Scientific, UK.  
IgG was obtained from caprylic acid precipitation of ovine sera as previously described in 
materials and methods (Section 3.1) and was received as a gift from MicroPharm UK 
(Polyclonal, Wales, Sheep no. 1363 16/02/94). Lactate Dehydrogenase (LDH) and 
CombiCoulomat fritless Karl Fischer reagent were both purchased from VWR, UK. 100 mM 
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Sodium phosphate buffer (pH 7.4) was prepared from sodium phosphate monobasic 
monohydrate from Fischer, UK and sodium phosphate dibasic from Sigma UK. 
 
5.4.2.2 Collapse point and eutectic measurements 
Formulation collapse temperatures were measured using a freeze drying microscopy 
(Lyostat3, Biopharma UK) as previously described (Section 3.2.1 on page 52). 
 
5.4.2.3 Lyophilisation Process  
Samples were lyophilised in a laboratory scale Virtis advantage freeze dryer. 1.6 mg/mL 
Immunoglobulin G (IgG) and 0.06 mg/mL lactate dehydrogenase (LDH) formulations were 
bulk lyophilised in a 3 compartment polyethylene tray system from 100 mL volumes. The 
freeze dried solution also contained either 1 M or 0.5 M mannitol or sucrose concentrations. 
Molar ratios of 1:1, 5:2 and 5:1 mannitol-sucrose combinations were formulated to contain 
0.09 mg/mL of LDH where mannitol remained fixed at 0.5 M. Samples were equilibrated on 
a 25°C shelf for 30 minutes, chilled to -55°C (0.5°C/min) and held frozen for 6 hours. 
Formulations were annealed during the freezing stage to an additional temperature hold at -
25°C for 2hours. Primary drying used a -40°C shelf temperature except for mannitol: 
sucrose systems which were dried at -25°C and were annealed at -20°C during the freezing 
stage. A constant -75°C condenser and vacuum of 200 µbar (20 Pa) was used. Shelf was 
subsequently elevated to 20°C for secondary drying over 9 hours. K type thermocouples 
were placed at the bottom centre and edge of trays to monitor product temperature during 
the entire freeze drying cycle. Tray containing bulk dried cakes where transferred into 
polyethylene bags and into a nitrogen purged isolator (Soloflex, UK). Cakes were passed 
through a funnel into 500 mL sealed bottles for storage. 
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5.4.2.4 Moisture Content Analysis 
Residual moisture content determinations were performed using a coulometric C20 Karl 
Fischer titrator (Mettler Toledo, Switzerland) as previously described in material and 
methods. Three sample replicates were extracted and sealed into vials. Using a 23G needle, 
these were reconstituted with 2 mL dry Karl Fischer reagent and 1 mL aliquots were injected 
into the titration cell. 
 
5.4.2.5 Flowability Characterisation 
Compressibility index was determined using a tap density apparatus (Sotax FD2, USA) as 
previously described in materials and methods. Bulk density measurement was adapted 
using a 50 mL cylinder. Samples were passed through a sieve with 1 mm aperture to 
remove agglomerates formed on storage. The endpoint of the tapped sample was reached 
when there was no more than a 2 mL change in sample volume. Tapped density was 
calculated as a ratio of sample weight to tapped volume. Compressibility index was 
calculated as a percentage of the ratio of the difference between tapped and bulk density to 
its tapped density. 
 
5.4.2.6 Porosity  
Particle density measurements were made using a helium gas multipycnometer 
(Quantachrome, MUP- 6DCE, USA). Porosity was then calculated from resulting particle 
density and measured bulk density as previously described in materials and methods. 
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5.4.2.7 Gravimetric dispensing of annealed freeze dried powders 
Prior to dispensing, disruption of freeze dried cakes were conducted through mechanical 
sieving at a vibration amplitude of 80 mm through a 200 mm diameter sieve of 1 mm 
aperture size where particles greater than 1 mm were removed. Immediately prior to dosing 
samples were passed through a second 1 mm aperture sieve to break up any agglomerates 
that may have formed on storage before dispensing using a commercial Fill2Weight (F2W) 
powder dispensing system (3P Innovation, UK). Powders were conditioned by dry aeration 
before dosing. Dosing to 10 mg and 150 mg targets were performed in a fixed relative 
humidity (12.8%-14.5%) controlled with dry compressed air at a 20°C temperature. 
 
5.4.2.8 Particle Morphology studies 
Morphology studies were conducted with a light microscope (Carl Zeiss, Scope.A1 
Germany) equipped with a polariser, camera system (Axiocam MRM) and imaging software 
(Axiovision version 4.8). Magnifications of x10 eyepiece with x10 or x40 objectives were 
used. 
 
5.4.2.9 Particle sizing 
The size distribution of powders were measured as previously described in materials and 
methods using a mechanical sieve shaker (Retsch, AS 200 basic, Germany) with a 16 set 
38 mm diameter sieve stack (Endecotts, UK) with aperture sizes ranging from 1000-63 μm. 
Test samples were shaken at an amplitude of 80 mm at 5 minutes intervals. The endpoint of 
the sieving process was reached when the mass of any of the test sieves was unchanged by 
more than 5% or 0.1 g of its previous mass (British Pharmacopoeia Commission, 2013a). 
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5.4.2.10 Protein recovery and activity 
Total protein content was determined using a bicinchoninic acid (BCA) assay kit (Thermo 
scientific, UK) based on the colorimetric detection of cuprous cations at 526 nm using BCA  
LDH activity was determined using a kinetic UV spectroscopy assay conducted at 340 nm 
on the Multiskan spectrum plate reader (Thermo scientific, UK). These assays were 
previously described in the materials and methods. 
 
5.4.2.11 Content uniformity test of dosed units 
An acceptance value was calculated form total protein content assays for an enzyme were 
applicable (British Pharmacopoeia Commission, 2013b). 
 
5.4.2.12 Pass criteria 
Formulations with an acceptance value (AV) below 15 were passed. None of the passed 
formulations should fall below 0.75 or 1.25 of the case reference value (M) which was 98.5% 
or 101.5% or the average of individual dispensed contents expressed as a percentage of the 
label claim (British Pharmacopoeia Commission, 2013b). 
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5.4.3 Results  
5.4.3.1 Gravimetric dispensing of freeze dried powders  
A lead formulation had been optimised for both protein and flow before being dosed with the 
high throughput gravimetric F2W powder doser. F2W uses a powder dosing valve which is 
opened and closed in response to weight feedback. The accuracy is a function of the time 
taken to dispense the target dose and the consistency of the powder flow properties: 
Consistent powder flow characteristics are necessary for accurate dosing. Dosing was 
conducted to meet BP requirements with assessed masses of 40 individual units for 7 
batches of freeze dried powder. 
 
Pre-formulation characterisation for collapse point and eutectic using freeze dried 
microscopy (FDM) showed a collapse temperature of -31.7°C ± 0.6 for 0.5 M sucrose 
containing 6-9 mg/100 mL LDH (See Figure 5.12 for typical thermogram). Results for 
samples containing 0.5 M mannitol and 0.5 M sucrose showed a eutectic melt at between -
1.7°C and -1.4°C. There was evidence of micro structure collapse between -17.7°C and -
21.1°C. These values were in agreement with the reported eutectic temperature of -1.4°C for 
mannitol (Kim et al., 1998) and -32°C collapse temperature of sucrose (Pikal, 2007). These 
critical temperatures were useful in avoiding complete or macro collapse and eutectic melt in 
formulations by ensuring product temperature was always below these critical temperatures.  
 
Powder dosed for the 10 mg target showed a (-1% to 0.3%) mean deviation from the target 
while those dosed for 150 mg were dispensed within -2.7% to 1.2% deviations (Figure 5.13). 
Higher 150 mg target doses showed greater mass variation for the formulations initially dried 
from a 0.5 M mannitol concentration (Figure 5.13). Fluid bed dried mannitol and mannitol 
with IgG freeze dried combination (IgG 1 M MAN) showed 2.2% and 1.3% relative standard 
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deviations at 10 mg mass target dose. The same when dosed at higher 150 mg targets 
showed 0.8% and 0.79% (Figure 5.14 & Figure 5.15 Left).  
 
 
 
 
 
Figure 5.12: Typical images and temperature profile from freeze drying microscopy analysis of 
LDH in 0.5 M sucrose solution. Left: Sample aliquot (1.5 µL) containing 1.7 mg/ml frozen from 
room temperature at -20 °C/min to -40°C and held isothermal (A). A sublimation front (B) 
developed on pulling a 0.064 mbar vacuum. Onset of collapse was initially identified at -31.9°C 
during product temperature elevation period (C) using a 1 °C/min temperature ramp with 
further viscous flow observed over time (C). Decreasing sublimation temperature to -35°C (D) 
caused a regain in dried structure. Repeated heat cool heat cycles (E-F and G on graph) at a 
slower ramp rate of 0.5 °C/min revealed a total collapse temperature of -31°C and -32.2°C. 
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Figure 5.13: Mean deviations from target doses (n = 40) of lyophilised IgG from 0.5 M,1 M 
mannitol (MAN) and varied molar ratios of mannitol and sucrose solutions containing lactate 
dehydrogenase (LDH MAN:SUC).  
 
Figure 5.14: Left: Variation in mass of powder transfer (n = 40). Box and whisker plot with 
corresponding RSD of dosed bulk lyophilised mannitol (MAN) and sucrose (SUC) from 0.5 M, 1 
M solutions containing 1.6 mg/mL IgG and 6-9 mg/100 mL LDH. Fluid bed dried mannitol and 
sucrose are BP, Eur. ph. grade crystalline powders. Target dose = 10 mg **p<0.05 Right: 
Compressibility index of the same bulk lyophilised formulations (n = 3) of mannitol (MAN) from 
1 M solutions containing IgG and LDH. 
 
Solute content above 0.5 M did not significantly make any difference to the accuracy of 
dosed IgG despite the significant differences in bulk density (p<0.0001) and porosity 
(p<0.001) of the powders (Figure 5.16).  
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Figure 5.15: Variation in mass of powder transfer (n = 40) using Fill2weight gravimetric 
dispenser. Average dosing time = 7.7 sec per dose. Powders were disrupted from annealed 
freeze dried cakes. Box and whisker plot with corresponding RSD of dosed bulk lyophilised 
mannitol (MAN) and sucrose (SUC) from  
Left top: fluid bed dried mannitol and sucrose (BP, Eur. ph. grade crystalline powders).  
Left bottom: 0.5 M, 1 M solutions containing 1.6 mg/mL IgG and 6-9 mg/100 mL LDH.  
Right: varied molar ratios of mannitol (MAN) and sucrose (SUC) solutions containing 9.12 
mg/100 mL lactate dehydrogenase (LDH). *** P< 0.001 (one way ANOVA).  
 
 
Figure 5.16: Porosity (n = 3) and bulk density (n = 3) of dosed bulk lyophilised IgG and LDH 
from 0.5 M,1 M mannitol (MAN) and varied molar ratios of mannitol (MAN) and sucrose (SUC) 
solutions containing 1.6 mg/mL IgG and 6-9 mg/100mL LDH lactate dehydrogenase (LDH). 
Fluid bed dried mannitol and sucrose are BP, Eur. ph. grade crystalline powders. 
 
Powders defined as good flowing using BP criteria are expected to be dosed most 
accurately. Fluid bed dried sucrose had excellent flow properties (Figure 5.14 Right) but 
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exhibited 1.4%-1.5% RSD across 10 mg and 150 mg target doses suggestive that the 
individual particle size would be critical to dosed masses (Figure 5.14 & Figure 5.15). The 
cohesive nature of fluid bed dried mannitol contributed to the largest variation of 2.2% RSD 
at 10 mg target. We conclude mannitol was most accurately dosed gravimetrically while in 
its freeze dried form with IgG than from the unprocessed crystalline form. 
IgG and LDH dried with 1 M mannitol are significantly different in dosing accuracy depicted 
by 0.79% and 1.3% RSD values respectively (p<0.001). This is also true when comparing 
powders of the lower solute (0.5 M) contents of both proteins (p<0.001). 
The F2W system displayed a level of high precision for metering a wide spread of powders 
to include LDH freeze dried in mannitol-sucrose (LDH MAN:SUC) combinations. The latter 
displayed the best dosing accuracy with a relative standard deviation range of 0.32-0.4% 
(Figure 5.15 Right). At worst it was less than 1.61 mg over filled and 1.38 mg under filled 
corresponding to % mean deviations from target mass ranges of -0.18% to 1.1% (Figure 
5.13).  
Particle distribution through sieving provided no statistical evidence for a difference between 
amorphous systems expected to freeze dry with freeze drying induced phase collapse and 
those formulations without freeze dry collapsed solutes. However a 1:1 molar ratio of 
mannitol to sucrose was significantly bigger in size distribution than those of the 5:1 or 5:2 
ratios (Figure 5.17). The median particle size of the freeze dried powders were 100-200 µm 
(p>0.05) except for a single formulation (LDH MAN:SUC 1:1) which was distinct in its larger 
450 µm median size. This same formulation showed no significance (p>0.05) in size 
distribution from fluid bed dried sucrose. Fluid bed dried mannitol was not any different in 
size distribution when freeze dried with either IgG or LDH.  
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Figure 5.17: Particle size distribution of formulations (n = 1) freeze dried from 1 M mannitol 
(MAN) and varied molar ratios of mannitol and sucrose (LDH MAN:SUC). Stock solutions 
contained 1.6 mg/mL IgG and 6-9 mg/100 mL LDH lactate dehydrogenase (LDH). Fluid bed 
dried mannitol and sucrose are BP, Eur. ph. grade crystalline powders.  
 
Polarised light microscopy revealed distinct differences in the morphology of fluid bed dried 
mannitol as well as IgG and LDH freeze dried in mannitol (Figure 5.18). These distinct 
differences in particulate morphologies indirectly affect individual powder flow behaviour. 
Birefringence was observed in all freeze dried samples (Figure 5.18-5.20). 
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Figure 5.18: Polarised light microscopy images of F2W gravimetric dispensed powders at x100 
magnification A) IgG 0.5 M MAN B) IgG 1 M MAN C) LDH MAN:SUC 1:1 D) Fluid bed dried 
mannitol. Bold scale bar = 50 microns. 
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Figure 5.19: Polarised light microscopy images of F2W gravimetric dispensed powders at x100 
magnification E) LDH 0.5 M MAN F) LDH 1 M MAN G) LDH MAN:SUC (5:1) H) LDH MAN:SUC 5:2 
Bold scale bar = 50 microns. 
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Figure 5.20: Polarised light microscopy images of F2W gravimetric dispensed powders at x400 
magnification A) IgG 1 M MAN B) LDH 0.5 M MAN C) LDH MAN:SUC 5:2 D) LDH MAN:SUC 1:1. 
Bold scale bars = 10 microns. 
 
5.4.3.2 Uniformity of Content Assays  
Increasing the amount of bulking agent correlated with an increase in variation of content 
uniformity observed through the total protein content assay. Content uniformity deteriorated 
when IgG was substituted with LDH using the same formulation conditions (Figure 5.21). 
This would indicate that a change of protein type could significantly affect the protein 
recovery within a specific dosage target. The same trend was seen in 5:1 (13.85% RSD) and 
1:1 (15.54% RSD) mass ratios of mannitol:sucrose systems (Figure 5.23).  
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Figure 5.21: Total protein content (n = 3) with % relative standard deviation (RSD) of Top: 
dosed Mannitol-IgG Freeze dried. Bulk dry powder was freeze dried from 0.5 M and 0.1 M 
solutions containing total protein content of 1.6 mg/mL. Bottom: Dosed Mannitol-LDH Freeze 
dried. Bulk dry powder was freeze dried from 0.5 M and 0.1 M solutions containing total 
protein content of 6-9 mg/100mL. Samples were reconstituted with 1 mL distilled water and 
quantified using bicinchoninic acid (BCA) assay. Target dose = 150 mg. 
 
Increasing the sucrose content in LDH freeze dried in mannitol:sucrose was hypothesised to 
improve activity recovery but negatively affect flow behaviour and dosing accuracy. This 
increase did not have any significance on flowability of formulations (Figure 5.22 Left). There 
was a difference between total protein content and actual activity recovery of LDH in 
mannitol:sucrose formulations (Figure 5.23). This trend was consistent with the increasing 
amorphous sucrose content of these formulations protecting the activity. Optimising the 
1 2 3 4 5 6 7 8 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 1 9 2 0 2 1 2 2 2 3 2 4 2 5 2 6 2 7 2 8 2 9 3 0
0
2 5
5 0
7 5
1 0 0
1 2 5
V ia l  n u m b e r  o f  d o s e d  f r e e z e  d r ie d  Ig G - M a n n it o l
T
o
ta
l 
P
r
o
te
in
 R
e
c
o
v
e
r
y
 (
%
)
Ig G  0 .5 M  M A N  (2 .0 2 %  R S D )
Ig G  1 M  M A N     (5 .1 9 %  R S D )
V ia l  n u m b e r  o f  d o s e d  f r e e z e  d r ie d  L d h -M a n n it o l
T
o
ta
l 
P
r
o
te
in
 R
e
c
o
v
e
r
y
 (
%
)
1 2 3 4 5 6 7 8 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 1 9 2 0 2 1 2 2 2 3 2 4 2 5 2 6 2 7 2 8 2 9 3 0
0
5 0
1 0 0
1 5 0
L D H  0 .5 M  M A N  (5 .6 4 %  R S D )
L D H  1 M  M A N     (9 .4 2 %  R S D )
160 
 
recovery of LDH was not within the scope of this work but has been covered in literature 
(Anchordoquy and Carpenter, 1996, Anchordoquy et al., 2001, Kawai and Suzuki, 2007). 
The first 30 LDH Mannitol:sucrose dosed units assayed for both activity and total protein 
content had a mean dosed mass between 149.7-150.3 mg (0.08-0.2% mean target 
deviation).  
 
 
Figure 5.22: Left: Compressibility index of bulk lyophilised formulation prior to mass 
dispensing (n = 3). Bulk lyophilised formulations consist of varied molar ratios of mannitol 
(MAN) and sucrose (SUC) solutions containing lactate dehydrogenase (LDH). Right: Moisture 
content (n = 3) of bulk freeze dried formulations and fluid bed dried mannitol and sucrose. 
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Figure 5.23: Total protein and activity recovery in mass dosed LDH formulations (n = 3). LDH 
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was bulk lyophilised in molar ratios of mannitol (MAN) to sucrose (SUC) of Top: 1:1 Middle: 5:2 
and Bottom: 5:1  
 
Through knowledge of the freeze drying cycle due to a high shelf temperature, there is an 
expectation the sample would contain micro collapse phases. Thermocouple product 
recordings confirm samples exceeded the collapse temperatures for the sucrose phase. 
However, crystalline mannitol would be expected to maintain the macro structure of the bulk 
cake. The presence of collapse may explain the poor content uniformity (Table 5.3) for 
mixed sucrose mannitol systems which had poor acceptance values consistent with 
increasing sucrose collapse. The use of such mannitol and sugar mixtures have been 
studied and are also present in commercial products (Johnson et al., 2002).  
 
Table 5.3: Content uniformity and calculated acceptance values (AV) of dosed formulations  
Formulation 
Label claim 
(µg/mL) % Recovery SD 
Acceptance 
Value Comment 
LDH 0.5 MAN 35 100.1 2.0 4.0 Pass 
LDH 1 M MAN 20 99.4 1.9 3.7 Pass 
LDH MAN:SUC 1:1 85 101.7 13.4 27.1 failed 
LDH MAN:SUC 5:2 90 100.2 12.0 23.9 failed 
LDH MAN:SUC 5:1 70 100.0 9.7 19.4 failed 
      
Formulation 
Label claim 
(mg/mL) % Recovery SD 
Acceptance 
Value Comment 
0.5 M MAN IgG 1.9 100.2 0.04 0.1 Pass 
1 M MAN IgG 1 101.0 0.05 0.1 Pass 
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5.4.4 Discussion 
Powder flow behaviour influences the compatibility of powders for dispensing in this 
application. Consistently flowing powders are easier to dose. It is also important for powder 
transfer from intermediate storage or hoppers to dosing heads for dispensing. Powder 
arching and rat holing are typical flow problems to avoid. In gravimetric systems, powder 
feed from a hopper on reaching the dosing head is dispensed by controlling the duration of 
opening and size of a dosing orifice in response to the dispensed weight and flow rate. It is 
also common practice to condition the powders before and during the dosing process to 
encourage flow by aerating them.  
Flowability was measured by compressibility index which is an indirect measure of physical 
properties including size, surface area, shape and moisture (British Pharmacopoeia 
Commission, 2013c). Cohesive or poor flowing powders tend to be more compressible and 
display higher compressibility indices (Carr, 1965, Howard, 2007). Freeze dried formulations 
were cohesive and more compressible (Figure 5.14 Right) and had a general median 
particle size of 100-200 µm (Figure 5.17). Particles above 250 microns are free flowing while 
below 100 microns flow problems are eminent due to increased cohesiveness (Staniforth 
and Aulton, 2007). Observed compressibility indices were in agreement with previous work 
on freeze dried powders which were classified as having very poor flow behaviour (Chapter 
4). 
 
It was observed that excellent flowability did not always guarantee accurate dosing in 
granular materials. Fluid bed dried sucrose, despite its better flowability (Figure 5.14), 
showed relatively higher dosed %RSD when compared to freeze dried batches. It is 
hypothesised that this is due to the larger particle size distributions (median size of 625 µm 
(Figure 5.17) and significant bulk density (Figure 5.16): this leads to a greater propensity to 
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overfill during the dosing system’s controlled opening and closing of the dosing orifice. A few 
irregular particulates towards the end of the dosing cycle have the ability to skew the final 
masses over the target weight. This effect is less apparent for the smaller sized, porous and 
less dense freeze dried particles. 
There was a positive correlation between solute content and final porosity (Figure 5.16). 
Freeze dried formulations were all very significantly (p<0.0001) porous with lower bulk 
densities. Bulk densities affect packing of powder within feed hopper and hopper capacity of 
dosing heads. Hopper replenishing needs to be carefully controlled during repetitive dosing. 
The height of the powder in the hopper generates a pressure head which alters flow rates 
and can adversely impact dosing repeatability. It is important therefore to consider the 
hopper design to include appropriate hopper feed angles and opening dimensions. The F2W 
system includes in-built stirring and vibration mechanisms which avoid problems such as 
powder arching and rat holing: these are evident in other systems without these features. 
There is a superior compatibility of IgG over LDH when freeze dried in 1 M mannitol for 
powder dispensing. A difference in particle morphology from light microscopy explains this 
observation. These distinct differences in particulate morphologies were observed as needle 
like particulates in IgG (Figure 5.18 A&B, Figure 5.20 A) and more flaky irregular surfaces in 
LDH (Figure 5.18 C). Rough surfaces cause particles to interlock with each other leading to 
poorer flow from hopper to dosing pins. No significant differences existed in particle size 
(Figure 5.17); moisture (Figure 5.22 Right), porosity (Figure 5.16) and flowability of both 
formulations (Figure 5.14 Right). The very porous nature of freeze dried powders in general 
means that their flowability is not affected by minute differences in moisture. Moisture in 
porous and cohesive materials penetrate the core of the particles and no liquid bridges 
which affect flow are formed (Howard, 2007). This explains why IgG and LDH in 1 M 
Mannitol (MAN) formulations were not significantly different in flowability despite a 1% non-
significant difference in moisture. 
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Birefringence observed in all freeze dried samples (Figure 5.18) was indicative of crystallinity 
after freeze drying in mannitol. Generally a more amorphous character was suggestive in the 
presence of LDH. Such a conclusion would require confirmation using X-ray powder 
diffraction analysis.  
 
Dosed accuracy also correlated with the amount of solute content present and powder 
flowability. While this study revealed solute contents above 0.5 M ( 9 %w/v) did not 
significantly enhance the accuracy of 150 mg target dosing of IgG and LDH formulated in 
mannitol, previous flowability studies (discussed in chapter 4) of mannitol as a carrier agent 
revealed that above 5 %w/v of pure lyophilised mannitol there was no significant decrease 
(P>0.05) in compressibility and improvement in flow.  
Tendencies to under fill or over fill were evident across both target doses investigated. 
These are errors attributable mainly to flow behaviour of the powder samples and or 
systemic errors of the dosing machinery. Systemic errors cannot be detected by replicates of 
measurements and may be caused by equipment or localised changes in physical properties 
of the powder affecting flow. In many cases it is responsible for very low or very high values 
even in replicate determinations (Miller and Miller, 2005). 
 
Though over and under filled container closures were included in these studies, availability 
of online process analytical technology mean these outliers can be rejected in practice and 
fed back into bulk feeds to be metered again. This process may require validation and it is 
envisaged will be easily implemented in gravimetric systems as an integral feedback loop 
mechanism is already present. 
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Gehrmann et al. (2010) used a gravimetric system composed of a screw conveyor with a 
vibrating chute to dose 69-199 units of freeze dried pellets and achieved a mean maximum 
deviation of ± 2 mg. We have shown smaller maximum deviations at 150 mg target using 
LDH freeze dried in mannitol and sucrose mixtures (+0.86 mg, -1.39 mg; +0.5 mg, -1.4 mg; 
+1.61 mg, -0.99 mg). These are in good agreement and indicate similar performance using a 
non-pelleted formulation. Freeze dried pellets of significantly larger size range of 500 µm 
fines, 1000-2000 µm as coarse and a mix of both were used by Gehrmann et al. Results 
obtained in our work from non-segregated freeze dried powder mix below 1000 µm and 
median size of 100-200 µm suggest pelleting may not be a necessity for accurate powder 
dispensing and optimising ordinary powders could suffice.  
Masses dosed accurately do not guarantee content uniformity. Acceptance value 
calculations determine if batches are to pass or fail (Table 5.3). Excluding mannitol sucrose 
mixtures, all batches assessed for uniformity passed. 
 
The distribution of protein content within powder particles is believed to be as a result of 
crystal growth during the annealing process. However, annealing encourages crystal growth 
and improves the dosing accuracy from preliminary work. The use of an annealing step 
further encouraged mannitol crystallisation (Hawe and Friess, 2006a) which is 
recommended for long term stability if continued crystallisation and further release of 
moisture on storage are to be avoided. Mannitol however provides minimal lyoprotection 
compared to other non-reducing sugars such as sucrose and trehalose. Mannitol has found 
use in lyophilisation mainly as a bulking agent to provide an elegant cake appearance. It 
also provides essential macro structural support in the micro collapse of mannitol:sucrose 
mixtures where the use of aggressive cycles provide cost savings. It is however important to 
not unduly add bulk to formulations as this will add to the cost. Bulking agents are important 
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for flowability of the freeze dried formulations but their addition reduces API density in the 
final powder and increase target weights. Bulk dried formulations with the same API content 
and varying amounts of bulking agent would require different dosed masses for same 
therapeutic effects. Manufacturers must therefore approach dilution of a freeze dried API 
with care as there is an increase in economic cost associated with the increase excipient 
mass to be dried. 
 
5.4.5 Conclusion 
Manufacturers of reconstitution injectable formulations who are considering dosing freeze 
dried powders from bulk need to optimise a number of factors: these include the cake 
disruption process, the physical form, flowability, process humidity control and also the 
choice of dosing system. This study has shown this to be practical. 
Annealed mannitol bulk content aids dosing accuracy with the gravimetric powder dispenser 
used (F2W). The type of protein to be dispensed affects morphology of final powders and 
dosing accuracy due to differences in powder flow behaviour. Bulk mannitol content above 9 
%w/v or 0.5 M provide no addition benefits to dosing accuracy or uniformity of content of 
dosed units. A mannitol solute content of no more than 0.5 M or 9 %w/v in initial freeze dried 
solution feed is recommended for compatibility with gravimetric powder dispensing. Excess 
bulk will dilute the API and unduly add to cost of drying. 
Further work is required to formulate proteins in a mix of amorphous and crystalline phases 
which will balance the need for good flow behaviour, dosing accuracy and long term stability. 
This work shows annealing treatment is required and micro collapse need to be avoided if 
both crystalline and amorphous bulk phases co-exist to guarantee content uniformity of 
dosed vials.  
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The use of a gravimetric dosing system with a process analytical tool to exclude outliers is 
recommended for freeze dried powder dispensing. 
We have demonstrated it is possible to meet current regulatory approval in the illustrated 
cases using a simple, low cost and reproducible cake disruption process in conjunction with 
a commercially available powder dosing system. 
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6 X-RAY MICRO COMPUTER TOMOGRAPHY STUDIES OF LYOPHILISED 
POWDER FOR DETERMINATION OF FLOW CHARACTERISTICS AND 
DOSE UNIFORMITY OF ACTIVE PHARMAEUTICAL INGREDIENTS. 
 
6.1 Introduction 
Lyophilisation or freeze drying demands adequate characterisation during formulation and 
cycle development to guarantee the final dried forms are desirable. Attributes desired after 
freeze drying include but not limited to stability, final physical form, appearance, moisture 
content, dissolution and morphology. These attributes are quality factors which we defined 
elsewhere as “ the term given to the individual priorities developers place on distinct aspects 
of a formulation to define its final acceptance” (Ekenlebie and Ingham, 2011). Various 
aspects of the product development process need attention to ensure final product 
acceptance such as freezing, primary drying, thermal treatment (annealing) and final surface 
area. Many characterisation techniques are therefore available and have been reviewed 
(Liu, 2006, Devi and Williams, 2013). Selection of a suitable technique is also influenced by 
duration of analysis, convenience, versatility, cost or simply its availability at the time of 
research and development.  
The final morphology of a freeze dried cake is commonly studied using microscopy. 
Scanning electron microscopy (SEM) is the most widely used microscopic tool by freeze 
drying scientists to qualitatively study microstructure. Applications of the various forms of 
microscopy including SEM, transmission electron microscopy (TEM), environmental 
scanning microscopy (ESEM) and light microscopy in freeze drying have been reviewed 
extensively (Overcashier, 2003, Liu, 2006). 
It is common practice in microscopy to cut or break glass vials open to access dried cakes. 
Cakes are subsequently sectioned using razor blades and gold coated if SEM was the 
choice (Schersch et al., 2010, Liu et al., 2005, Overcashier, 2003). The series of sample 
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preparation steps involved can be hazardous to the unskilled; tedious if simultaneous control 
of humidity is required and quite arguable if the true micro structure is indeed revealed due 
to changes induced by coating and cutting. An interesting approach by Patapoff and 
Overcashier (2002) involved the use of paraffin wax and a fluorescent dye to enhance 
imaging of cake cross sections. 
 
Advances in pharmaceutical technology have seen the development of newer quantitative 
imaging techniques for characterisation of aqueous and dry powder in their various forms. 
Fu et al. (2012) used a computer aided microscopic particle image characterisation device to 
characterise size and shape of lactose. The device allows dry powder samples between 0.5 
microns to 10 mm to be dispersed onto glass slide and images are captured for high through 
put software analysis of individual particles (Malvern Instruments, 2014). Optical coherence 
tomography-based freeze drying microscopy has been reported superior to traditional freeze 
drying microscopy to predict collapse temperatures and also produce three dimension 
images (Mujat et al., 2012). Davis et al. (2013) employed micro flow imaging to study the 
effect of sub visible particles on stability of lyophilised IgG (Immunoglobulin G). The inner 
workings of the imaging technique has been described (Protein Simple, 2013). 
The use of X-ray radiation has also found newer applications in industry. Its use in freeze 
drying which was previously limited to characterisation of the final physical form (amorphous 
or crystalline) via X-ray powder diffraction or freeze drying X-ray powder diffraction (Cavatur 
and Suryanarayanan, 1998) has recently been demonstrated commercially useful in visual 
inspection of defects and foreign particles in the range of 40-200 microns in freeze dried 
cakes within intact glass vials (Prinz, 2012).  
X-ray microcomputer tomography (MCT) has aroused interest in pharmaceutics as a non-
destructive technique which requires little or no sample preparation to quantitatively inform 
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structural attributes of materials. A detailed description of the background and inner 
workings of MCT together with the subject of tomography was previously described (Section 
3.4.12 page 74 & 1.8 page 47). Parker et al. (2010) used MCT to quantify pore size 
distribution, porosity and connectivity in vial lyophilised BSA cakes subjected to a 
conventional and high temperature aggressive cycles. Authors found a correlation with SEM 
in observed connectivity. 
 
6.2 Aims and Objectives 
Here X-ray microcomputer tomography (MCT) was explored as a versatile quantitative 
approach to characterising freeze dried cakes and powders. It was the aim of this chapter to 
identify correlations that exist between traditional techniques and MCT. Objectives were to 
correlate porosity measurements with gas pycnometry and predict powder flowability from 
minute sample sizes. Results were compared using regression analysis. New morphometric 
parameters to freeze drying from three dimensional image analyses as well as creation of 
three dimensional fly through cross sectional images of powders were investigated. It was a 
further objective to quantify the distribution of pharmaceutical active ingredients when freeze 
dried with different cooling rates using a platinum dispersion model. 
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6.3 STUDY OF POROSITY, PACKING AND MORPHOMETRIC PARAMETERS 
IN BULK LYOPHILISED POWDERS 
6.3.1 Background 
It is hypothesised that MCT would allow the use of small sample sizes of freeze dried 
formulations to be well characterised to inform powder packing and morphology which 
include porosity, size and shape. Packing and powder morphology are useful indicators of 
powder flow behaviour. Knowledge of the porosity of the final dried cake or powder 
influences reconstitution time and duration of primary drying. The porosity of freeze dried 
cakes can be qualitatively assessed using microscopy. A quantitative approach involves the 
determination of a material’s true density using gas or mercury pycnometry. MCT is capable 
of quantitatively analysing pore size distribution and porosity of materials. In this section of 
the thesis MCT technique was compared with the traditional gas pycnometry to investigate 
any correlations that exist. The use of two different inert gases, nitrogen and helium were 
initially studied in pycnometric analysis of lyophilised mannitol.  
 
6.3.2 Materials and Methods 
6.3.2.1 Materials 
Fluid bed dried D-mannitol Ph. Eur. was purchased from Fagron, UK. Packing straws were 
obtained from Sainsbury's, UK. Sealing film (Parafilm™) and CombiCoulomat fritless Karl 
Fischer reagent obtained from VWR, UK. Dental beading wax was from Kemdent, UK. 
6.3.2.2 Lyophilisation 
6.3.2.2.1 Bulk dried mannitol powders 1 
Freeze drying of mannitol (100 mL, 5-22.5 %w/v) solutions was in a Virtis Advantage bench 
freeze dryer using a custom made stainless steel tray as bulk container systems (Material 
and Methods Figure 3.3 page 57). Samples were chilled at -55°C from room temperature 
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and held for 6 hours. Primary drying was at a low -40°C despite the known eutectic 
temperature of mannitol of -1.5°C (Kim et al., 1998) for comparative studies not disclosed in 
this chapter. Secondary drying was at 20°C for 4 hours with a constant -75°C condenser and 
pressure at 200 µbar. K type thermocouples (RS Components, UK) were used to monitor 
product temperature during the drying process. Trays containing bulk dried cakes were 
transferred through a funnel into sealed bottles for storage in desiccators over moisture 
indicating dried silica gel. Cakes were later broken down into powder with the British 
pharmacopeia tablet friabilator (Sotax USP F2, Switzerland) using a fixed 1000 revolutions 
in simulation of typical handling. 
 
6.3.2.2.2 Bulk dried mannitol powders 2 
Mannitol solutions (100 mL, 0.056 M-1 M) were freeze dried in a Virtis advantage freeze 
dryer using a custom made three compartment tray as previously described (Material and 
Methods, Figure 3.3 on page 57). 
Different cooling rates of 0.2 °C/min, 1 °C/min and 5 °C/min were used. Samples cooled at 
0.2 °C/min and 1 °C/min were equilibrated on a 25°C shelf for 30 minutes, shelf temperature 
was ramped to -55°C and held frozen for 6 hours. Annealed samples were equilibrated on a 
25°C shelf for 30 minutes and cooled to -55°C (0.2 °C/min) with an additional temperature 
hold at -20°C for 2 hours. Samples cooled at 5 °C/min were loaded directly onto a -70°C 
precooled shelf. Primary drying was at -10°C shelf temperature. A constant -80°C condenser 
and vacuum of 200 µbar was used. Shelf was elevated to 20°C for secondary drying over 6 
hours. K type thermocouples were placed at the centre and edge of trays to monitor product 
temperature during the entire freeze drying cycle. Tray containing bulk dried cakes where 
transferred into polyethylene bags and into nitrogen purged isolator (Soloflex, UK). Cakes 
were passed through a funnel into sealed bottles for storage in desiccators over moisture 
indication dried silica gel. 
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Samples were disrupted or broken down into loose powders using a nest of sieves as 
previously described (4.4.2.2). 
 
6.3.2.3 X-ray scans and image processing 
6.3.2.3.1 Bulk dried mannitol powders 1 
Samples were scanned as previously described in materials and methods (section 3.4.12.2 
page 75) using a 40 kV X-ray source voltage and 169 µA current at a scanning resolution of 
3 µm. Stage was rotated stepwise at 0.7° with frame averaging and random movement 
options set to 3 and 4. Images were reconstructed using the Nrecon reconstruction software 
(version 1.6.4) and quantitatively processed using CT-analyser software. 
6.3.2.3.2 Bulk dried mannitol powders 2 
Sample scanning and image preconstruction were performed as previously described in 
materials and methods. An X-ray voltage source of 36 kV and 200 µA current at a scanning 
resolution of 3 µm was used. Stage was rotated stepwise at 0.7° with frame averaging and 
random movement options set to 3 and 4.  
6.3.2.4 Descriptives  
Results and discussion within this chapter make references to common terms used in MCT. 
These are used through the following sections and definitions are next highlighted from 
Skyscan (2011). The term 'Pixel' is a square element of an image with a characteristic grey 
level of the brightness at its particular location. A pixel with a known x, y and z dimensions is 
three dimensional and referred to as a 'voxel'. A region of interest (ROI) is a selected area 
within a single two dimensional image slice within an object and the addition of a set of 
adjacent ROIs forms the volume of interest (VOI) within the selected volume.  
  
175 
 
6.3.3 Results 
 
 
A B 
 
 
C D 
Figure 6.1: Typical results from MCT scans and 2D morphometric analysis for packed fluid bed 
dried sucrose A) Reconstructed image from projected X- ray shadow images after stepwise 
beam scanning. Red vertical line through packed sample corresponds to a 2D image slice at 
the location shown as B) the two dimensional binarised image slice. Red circular region within 
image is the region of interest selected for morphometric analysis. The selected region of 
interest corresponds to C) grey scale indexes which are segmented into pores (black) and 
sample (grey) D) Processed 2D coloured size distribution. A collection of image slices from 
top to bottom make up a volume of interest (VOI) and were analysed to produce 3D 
morphometric parameters. Black vertical scale bar = 1,000 µm. Total slices = 1099. 
 
All projected X-ray shadow images from scanned samples were successfully processed 
qualitatively and quantitatively. Qualitative results were obtained from volume rendering 
Thresholding 
F
re
q
u
e
n
c
y
 (
%
) 
Grey scale Indexes 
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using CTvox software. Typical software processing route for fluid bed dried sucrose 
illustrates the intermediate results from the methodology involved (Figure 6.1). 
 
6.3.3.1 Porosity correlation study 1 (Bulk dried mannitol powders 1) 
 
Figure 6.2: Porosity and particle density of lyophilised mannitol using helium (He) and 
nitrogen (N2) as pycnometric gases (n = 3). 
 
The use of either helium or nitrogen as inert gas for pycnometric analysis showed no 
significant differences in measured porosity and calculated particle density (Figure 6.2). 
Initial correlation studies comparing helium pycnometry and MCT did not demonstrate any 
statistically significant correlation (Figure 6.4). MCT measurements were significantly 
different and lower in value in comparison with pycnometric data (Figure 6.4). While 
pycnometry measurements showed no significant changes in porosity with increasing 
mannitol concentration in freeze dried powders from 7.5%-22.5 %w/v; an unexpected 
increase was observed from MCT measurements from 7.5%-17.5 %w/v suggesting 
disagreement between the two techniques. 
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B u lk  ly o p h ilis e d  m a n n ito l fro m  s o lu tio n  (%  w /v )
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Figure 6.3: Porosity of bulk lyophilised mannitol from solution using X-ray MCT (n = 3, sample 
volume in volume of interest = 2.5-2.59x103 µm
3
 and Helium pycnometry (n = 3, sample volume 
= 3.9-4.2 cm
3
). Samples were tapped gently 3-5 times before measurements.  
 
Figure 6.4: Porosity correlation study 1. Correlative plot of helium pycnometry and X-ray 
microcomputer tomography (MCT) porosity measurements for powders from bulk lyophilised 
mannitol (n = 3). Mannitol samples were lyophilised from 7.5-22.5 %w/v mannitol solutions. R
2
 
of linear trend line = 0.0918.  
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6.3.3.2 Powder packing study 1 
 
 
 
Figure 6.5: Three dimensional cross-sectional X-ray MCT into packed powders. Mannitol bulk 
lyophilised from Top left: 1 %w/v solution and Top right: 15 %w/v solution. Bottom: Fluid bed 
dried mannitol powder. Scale bar: 1.25 mm.  
 
Preliminary studies from MCT provided a qualitative assessment of powder packing 
arrangement. The differences in packing were distinct between the low and high solute 
content formulations (Figure 6.5). Mannitol bulk lyophilised from an initial 1 %w/v solution 
was the least densely packed with more air pockets (more aerated) or inter particular 
packing porosity. Fluid bed dried mannitol showed the most dense packing with the least 
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inter particulate porosity. These observed trends correlate with pycnometric measurements 
(See Table 6.1). Volumetric bulk density measurements increased with initial mannitol solute 
content and inversely with calculated pycnometric true density measurements (See Table 
6.1). The true density of fluid bed dried mannitol was therefore expectedly the highest; an 
expectation for bulk solids with high bulk densities. 
Table 6.1: Bulk and true density measurements of bulk lyophilised mannitol by helium 
pycnometry in powder packing study 1 (n = 3). 
Bulk freeze dried mannitol 
Fluid bed dried 
Batch (%w/v)* 1% 5% 15% 
Bulk density (g/cm³) 0.030 0.030 0.087 0.455 
Standard Deviation (n = 3) 0.00 0.00 0.01 0.02 
True density (g/cm³) 9.235 4.524 2.275 1.732 
Standard Deviation (n = 3) 0.11 1.18 0.09 0.02 
* Expressed batch concentration refers to initial mannitol solute concentration in solution 
before bulk freeze drying. 
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6.3.3.3 Powder packing study 2 
 
 
A B 
  
C D 
Figure 6.6: Three dimension cross-sectional X-ray MCT images of mannitol lyophilised from 
solutions of A) 0.056 M B) 0.25 M C) 0.5 M D) 1 M. Samples were cooled at 0.2 °C/min and 
annealed at -25°C. Scale bar is 2.5 mm. Powder volume was less than 1 mL. 
 
Qualitative three dimensional models of a powered formulation reconstructed using 
projected X-ray shadow images can inform differences in packing as earlier observed in 
(Powder packing study 1). Relevance of this parameter to powder handling and hence 
flowability is discussed later in this chapter. Differences in packing and bulk density were 
observed to correlate with increasing solute concentration of mannitol within minute powder 
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volumes of less than 1 cm3. Increasing concentrations from 0.056 M-1 M showed increasing 
bulk densities which were observed as more solid prominent structures with minimum 
aeration or air pockets. Fu et al. (2006) found particle packing studied using discrete 
element method (DEM) simulation and MCT to be in agreement but work was restricted to 
the use of glass beads and micro crystalline cellulose spheres. 
 
6.3.3.4 Porosity correlation study 2 
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Figure 6.7: Helium pycnometry and X-ray MCT computer tomography porosity measurements 
for powders from bulk lyophilised mannitol (mean ± SD, n = 3). Mannitol was lyophilised from 
0.056-1 M mannitol solutions at different cooling rates with or without thermal treatment 
(annealing) during freezing. Slow: cooled at 0.2 °C/min Annealed: cooled at 0.2 °C/min and 
held at -25°C (2hrs). Mid: cooled at 1 °C/min. Fast: cooled at 5 °C/min. Samples were tapped 
100 times on the laboratory bench prior to measurements.  
 
182 
 
MCT and pycnometry was repeated in this second study with changes in sample 
methodology. Here samples were tapped on the bench 100 times from a height of about 2 
cm for powder packing repeatability across all samples. An expected trend of decreasing 
porosity with increasing solute content was observed within all formulations using either 
helium pycnometry or MCT techniques (Figure 6.7). From reviewing data from MCT across 
all formulations, it was evident that relatively larger standard deviations were derived 
compared to helium pycnometry. These resulted in a range of small to large linear patterns 
of associations informed by regression analysis from calculated correlation squared values. 
Squared regression constants were 0.4275, 0.7715, 0.8153 and 0.9307 for the various 
powders analysed (Figure 6.8). The observed correlation is however convincingly strong to 
demonstrate correlation between the results from both gas pycnometric and MCT 
techniques. 
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Figure 6.8: Porosity correlation study 2. Correlative plot of helium pycnometry and X-ray MCT 
porosity measurements for powders from bulk lyophilised mannitol (mean ± SD, n = 3). 
Numbers adjacent data points represent concentration of mannitol (M) in solution. Mannitol 
was lyophilised from 0.056-1 M mannitol solutions at different cooling rates with or without 
thermal treatment (annealing) during freezing. Slow = 0.2 °C/min. Annealed = 0.2 °C/min and 
annealed at -25°C. Mid = 1 °C/min. Fast = 5 °C/min. Samples were tapped 100 times on the 
laboratory bench prior to measurements.  
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6.3.3.5 Morphology parameters 
6.3.3.5.1 Size correlation study 
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Figure 6.9: Cumulative undersize distribution using structure thickness parameter from MCT 
(n = 3). Mannitol was lyophilised from 0.056-1 M mannitol solutions at different cooling rates 
with or without thermal treatment (annealing) during freezing. Slow = 0.2 °C/min. Annealed = 
0.2 °C/min and annealed at -25°C. Mid = 1 °C/min. Fast = 5 °C/min. Samples were tapped 100 
times on the laboratory bench prior to measurements.  
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Table 6.2: Median over size distribution of powder measured from analytical sieving and MCT. 
Samples differ in cooling rate during freeze drying. Slow = 0.2 °C/min. Annealed = 0.2 °C/min 
and annealed at -25°C. Mid = 1 °C/min. Fast = 5 °C/min. Samples were tapped 100 times on the 
laboratory bench prior to measurements. 
 
Batch (Concentration*) 
Median Size 
Sieve (Mesh size) MCT (Structural thickness) 
Annealed batch 
0.056 M 190 20 
0.25 M 90 32 
0.5 M 100 34 
1 M 180 36.7 
Slow batch 
0.056 M 120 25 
0.25 M 100 30 
0.5 M 140 30 
1 M 210 40 
 
Mid batch 
0.056 M 240 - 
0.25 M 150 30 
0.5 M 150 32.25 
1 M 100 35 
Fast batch 
0.056 M - 25 
0.25 M 100 30 
0.5 M 80 30 
1 M 60 30 
* Mannitol was lyophilised from 0.056-1 M mannitol solutions at different cooling rates with or 
without thermal treatment (annealing) during freezing. 
 
 
Median particle structural thickness ranged from 20-40 µm for powders analysed (Figure 6.9 
and Table 6.2). Particular trends observed were an apparent increase in median volume 
thickness with increasing concentration of mannitol in initial freeze dried formulation.  
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6.3.3.5.2 Structural model index 
0
.0
5
6
 M
A
N
 S
lo
w
0
.2
5
 M
A
N
 S
lo
w
0
.5
 M
A
N
 S
lo
w
1
 M
A
N
 S
lo
w
0
.0
5
6
 M
A
N
 S
lo
w
 a
n
n
e
a
le
d
0
.2
5
 M
A
N
 S
lo
w
 a
n
n
e
a
le
d
0
.5
 M
A
N
 S
lo
w
 a
n
n
e
a
le
d
1
 M
A
N
 S
lo
w
 a
n
n
e
a
le
d
0
.0
5
6
 M
A
N
 M
id
0
.2
5
 M
A
N
  
M
id
0
.5
 M
A
N
 M
id
1
 M
A
N
  
M
id
0
.0
5
6
 M
A
N
 F
a
s
t
0
.2
5
 M
A
N
 F
a
s
t
0
.5
 M
A
N
 F
a
s
t
1
 M
A
N
 F
a
s
t
M
a
n
n
it
o
l
S
u
c
ro
s
e
S
p
h
e
r i
c
a
l 
g
la
s
s
 b
e
a
d
R
o
d
 s
h
a
p
e
d
 c
o
p
p
e
r
- 1
0
1
2
3
4
5
L y o p h ilis e d  m a n n ito l fro m  s o lu tio n  (M )             C o n tro l
S
tr
u
c
tu
r
e
 m
o
d
e
l 
in
d
e
x
P la te s
R o d s
S p h e re s
* *
*
**
***
#
 
Figure 6.10: Structural model index (SMI) investigations into effect of cooling rate and 
annealing on the morphology of lyophilised mannitol (MAN) powder. Samples were cooled at 
different rates. Slow = cooling rate of 0.2 °C/min Mid = cooling rate of 1 °C/min. Fast = cooling 
rate of 5 °C/min. CCD camera resolution of 6 microns was used. Schematic shapes to the right 
of main figure correspond to expected values for an ideal sphere, rod and plate. # represents 
significance from 0.5 MAN Fast (p<0.05, one way ANOVA n = 3). Significance from rod shaped 
copper (one way ANOVA n = 3) are depicted by * p<0.05, ** p<0.001 and *** p<0.0001. Tukey's 
multiple test used to compare means. 
 
  
A B 
Figure 6.11: Picture of standard shapes used in structural model index morphometric 
parameter in MCT studies A) spherical glass beads B) rod shaped copper wires. Volume of 
interest analysed was limited to the protruding rods only. Scale bars = 5 mm. 
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Structure model index parameter from MCT technique was useful in determining the 
closeness of individual particulate shapes within formulation powders to known spherical, 
rod and plate like morphologies. Ideal spheres, rods and plates have SMI values of 4, 3 or 0 
respectively dependent on the most dominant shape (Hildebrand and Rüegsegger, 1997b). 
These reference values were in agreement with control samples used in the study. Copper 
rods and spherical glass beads were used as standard control morphologies for sphere and 
rods (Figure 6.11 and Figure 6.12 B&C). 
 
 
 
A B 
 
 
C  
Figure 6.12: Three dimension X-ray tomography models of A) fluid bed dried sucrose B) 
spherical glass spheres C) Rod shaped copper wires. Volume of interest analysed was limited 
to the protruding rods only. Scale bars = 2.5 mm. 
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Figure 6.13: Light microscope images at x100 magnification for powders freeze dried from 
mannitol solutions of Top Left: 0.5 M (cooled at 0.2 °C/min, Slow). Top Right: 0.5 M (cooled at 1 
°C/min, mid). Bottom Left: 0.5 M (cooled at 0.2 °C/min, Annealed) and Bottom Right: 0.5 M 
(cooled at 5 °C/min, fast). Scale bar = 20 µm 
 
Light microscopy images showed flaky (plate like) and elongated needle like morphologies 
present in all powders (Figure 6.13). 
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6.3.3.5.3 Fragmentation Index 
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Figure 6.14: Fragmentation index investigation (n = 3) into effect of cooling rate and annealing 
on fragmentation index of lyophilised mannitol (MAN) powder. Slow = cooling rate of 0.2 
°C/min Mid = cooling rate of 1 °C/min. Fast = cooling rate of 5 °C/min. CCD camera resolution 
of 6 microns. 
 
Fragmentation index is a relative measure of connectivity within compared materials (Hahn 
et al., 1992) and lower values are representative of better connectivity. Negative values are 
indicative of the presence of many enclosed cavities and concave surfaces. The trend 
observed is similar to that seen in SMI due to the similarities in parameter mathematical 
derivations. Generally, an increased connectedness was observed to correlate positively 
with increasing mannitol concentration in initial freeze dried formulations. 
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6.3.3.5.4 Fractal dimension 
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Figure 6.15: X-ray microcomputer tomographic investigation into effect of freezing rate and 
annealing on fractal dimension of lyophilised mannitol (MAN) powder (n = 3). Slow = cooling 
rate of 0.2 °C/min. Mid = cooling rate of 1°C/min. Fast = cooling rate of 5°C/min. CCD camera 
resolution of 6 microns. 
 
Fractal dimension quantifies how an object’s surface fills a given space and indicates how 
complex its surface is (Chappard et al., 2001, Skyscan, 2011). The results show an increase 
in fractal dimension of freeze dried mannitol in the volume of interest with increasing solute 
content.  
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6.3.4 Discussion 
Powder particles can be in the form of ideal or irregular shapes. Defining the dimensions of 
irregular particle can be challenging compared to that for those with closeness to ideal rod or 
spherical shapes. The influence of particle shape on its size distribution determination has 
therefore seen the definition of various equivalent diameters which require fitting or relating a 
particle to an equivalent diameter, volume or surface area of a sphere (Randall, 1995, 
Washington, 1992). For example, a particle with a fixed volume can be described by either a 
representative sphere of the same volume or one with the same surface area (Washington, 
1992).  
The various measurement techniques will generally adapt a size characterisation approach 
and here we discuss the parameter 'structure thickness' of particles derived from 3D images. 
Structure thickness estimation from 3D image analysis is a volume based approach which 
unlike surface based approaches will not overestimate the thickness of particles of irregular 
or non-ideal structures (Hildebrand and Rüegsegger, 1997a). The model is based on the 
fitting of maximal spheres to particles where they are within the boundaries of the solid 
surface without assumptions of the type or shape of the structure in question (Skyscan, 
2011, Hildebrand and Rüegsegger, 1997a).  
 
The SMI parameter is reflective of the ratio of any one of the recognisable shapes within a 
3D image based on the volume ratios present in the structure or VOI analysed. Meaning an 
equal volume of rods and plates will yield a value of 1.5 which is 50% between 3 (100% 
rods) and 0 (100% plates) (Hildebrand and Rüegsegger, 1997b). The results (Figure 6.10) 
showed a trend of more rod-like morphology for lyophilised particles at low mannitol 
concentrations and a trend which declined as concentration increased to show greater plate 
morphologies. This trend without statistical significance appeared more prominent with 
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increasing cooling rate from slow (0.2 °C/min) to fast (5 °C/min). This was confirmed by the 
significant difference from rod-like morphology observed at p<0.05 and p<0.0001 for 
powders from fast cooled solutions of 0.25 M-1 M mannitol (Figure 6.10). Fluid bed dried 
sucrose showed a wide standard deviation across plate, rod and sphere morphologies 
suggesting there were a variety of shapes present. Negative SMI values inform the presence 
of more enclosed and concave surfaces (Skyscan, 2011). Optical microscope images 
showed irregular particle shapes showing plate like (Flaky), elongated, needle like or rod like 
shapes which was in agreement with SMI parameters (Figure 6.10 and Figure 6.13). 
Values calculated for SMI are independent of dimension and Hildebrand and Rüegsegger 
(1997b) found the presence of both plates and rods of equal thickness within a 3D structure 
to have SMI values between 0 and 3.  
 
Particle morphology is known to influence powder flow behaviour. Irregular particle shapes 
will cause mechanical interlocking which will impede powder flow. 
Calculated SMI parameter allows particulates with sphere, rod and plates shapes to be 
distinguished (Figure 6.10). There was a good correlation in the observed particle 
morphology from microscopy and calculated SMI values obtained from 3D image analysis 
(Figure 6.6). The presence of elongated or rod like morphologies within a given test sample 
was found not to be statistically different from rod shaped copper wires used as a 
morphology standard. Hildebrand and Rüegsegger (1997b) found minute differences 
between SMI values to be consistent with 3D images and were adequate at differentiating 
between either rod like or plate like morphology. For example SMI values of 2.06, 1.65 and 
1.05 were found to be consistent with decreasing presence of rods in iliac crest bone 
biopsies. 
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Similar mannitol morphologies observed in our study have been reported (Kaialy and 
Nokhodchi, 2013, Armstrong, 2009a). Kaialy and Nokhodchi (2013) using optical microscopy 
in combination with a calculated aspect ratio. They found freeze dried mannitol from 5 %w/v 
solution had the most irregular and elongated shapes compared to commercial and spray 
dried forms. This was confirmed using SEM and it was emphasised elongated morphology 
made freeze dried mannitol good carriers for pulmonary delivery. In their study, aspect ratio 
was obtained from a ratio of particle length to breadth. When crystallised from alcohol, 
mannitol has been reported to have a morphology described as orthorhombic needles 
(Armstrong, 2009a). 
 
Hildebrand and Rüegsegger (1997b) used SMI to study the presence of rods and plates in 
osteoporosis where the presence of more rods was a measure of deteriorating disease. This 
was calculated from the equation: 
      (
    
  
)  (6.1) 
Equation 6.1: Where SMI is calculated from the surface area (S) of a binarised 
image with a known volume (V) and a resulting change in surface area (S') after 
addition of one voxel thickness in a process known as voxel dilation. The surface 
area and volume were obtained by calculating the total area of triangles that fitted 
on object surfaces; a process known as surface triangulation. 
 
Fragmentation index was calculated within the CT analyser software as a ratio of the change 
in solid surface (     ) to change in volume (     ) before and after image dilation (Hahn 
et al., 1992) : 
                     (
     
     
) (6.2) 
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For powders the parameter was evaluated after compaction by a fixed 100 taps from a 
height of about 2-5 cm on a laboratory bench. Bulk solids or powders with a low bulk density 
would be more aerated (have more entrapped air) and particles would show less 
connectivity. Increased bulk density within a powder bed previously seen in freeze dried 
powders, result in more connected packing. One would expect powders that show more 
connectivity to be less compressible as lesser amounts of voids are available for 
rearrangement in the powder bed. This parameter can therefore be used as an indirect 
measure of powder's susceptibility to be compacted which in turn can be related to its flow 
behaviour. Materials which remain relatively less connected after consolidation (fixed 
number of taps) would be expected to have poorer flowing behaviour. This analogy is similar 
to that achieved with standard powder tap density experiments except here, the powder’s 
endpoint is not necessarily realised making this approach useful for relative comparisons 
only. The endpoint in tapped density is said to have been reached when no change in 
volume is observed with further powder tapping. In standard pharmacopeia volumetric 
methods this is a change of no more than 2 cm3 as previously discussed (British 
Pharmacopoeia Commission, 2013a). While the relative values serve the purpose of 
comparing scanned objects, its absolute values have little meaning (Skyscan, 2011). 
Nonetheless powders scanned using the same acquisition modes and sample preparation 
can be evaluated. 
The results from fragmentation index parameter (Figure 6.14) reinforced corresponding 
porosity data of the same samples (Figure 6.7). The more porous powders were found to be 
less connected as expected. Parker et al. (2010) found connectivity deduced from 
fragmentation index to agree with SEM. Vial lyophilised BSA cakes which showed 45% 
porosity and -0.07 fragmentation index had more connected SEM images compared to 
cakes with 70% porosity and a fragmentation index of 0.01. We here use this parameter with 
the analogy that similar powders should pack to the same extent. 
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An alternative approach involving the use of porosity to predict flow was reported by Guerin 
et al. (1999) using an indirect pycnometric approach. The study used the inflections 
recorded in porograms obtained from mercury extrusion porosity characterisation technique. 
Guerin and co-workers found flowability to correlate to tap density and some shear cell 
measurements using 250 mg samples of lactose grades, analgesic and beta blocker 
powders. Here we show the use of sample sizes of less than 1 mL to predict flow, unlike 
mercury porosimetry MCT is neither destructive nor involves the use of toxic mercury. 
The results for fractal dimension (Figure 6.15) suggested a relationship between the surface 
complexities of freeze dried powder volumes and increasing concentration of solute. Fractal 
dimension was found to increase with increasing mannitol concentration. The trend was 
therefore consistent with the concentration dependence of freeze dried powder flow. An 
object is fractal if its size when determined using a measured scale displays more detail than 
when it is measured at higher magnifications (Washington, 1992). Meaning the higher 
resolution offered by MCT allowed the characterisation of freeze dried powders to reveal an 
increased surface area. Washington (1992) suggested particles with rough surfaces occupy 
large volumes and have fractal dimensions of between 2 and 3. A correlation between 
increased surface area and surface complexity of freeze dried powders was present. CT-
analyser software calculated the fractal dimension using a box counting method also known 
as the Kolmogorov method (Skyscan, 2011). It involved a set of cubes of similar dimensions 
being over laid on the volume of interest and the number of cubes encapsulating parts of the 
powder surface was counted. The fractal dimension was given by the slope of the 
logarithmic plot of cube number versus cube length.  
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6.3.5 Conclusion 
X-ray microcomputer tomography has been demonstrated as a useful non-destructive tool 
for characterising bulk freeze dried powders. 
Comparison of the porosity results with traditional gas pycnometry showed a strong 
correlation (Section 6.3.3.4). The use of a fixed number of powder taps about 2-5cm off the 
bench (100) for uniformity across samples was recommended.  
Differences in powder packing of freeze dried powders can be ascertained with sample 
volumes of less than 1 mL (Section 6.3.3.3). Powder sample used must be representative of 
the powder stock or batch due to the minute volumes required. Packing and powder porosity 
have been illustrated as indirect measures for powder flowability (Section 6.3.4). 
Morphometric parameters such as size, structural model index, fragmentation index and 
fractal dimension were useful tools for the relative prediction of flow for freeze dried powders 
(Section 6.3.3.5). The SMI index provided knowledge of freeze dried particulate shapes but 
results were restricted to comparison with plate, rod or spherical shapes.  
The differences in sample size and methodology did not allow direct extrapolation of sieving 
data to MCT structural thickness. However, MCT was demonstrated capable of 
distinguishing between various freeze dried powders which were distinctly different in size to 
those of equivalent fluid bed dried powders. 
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6.4 INVESTIGATIONS INTO LOCALISATION OF ACTIVE PHARMACEUTICALS 
IN LYOPHILISED FORMULATIONS 
6.4.1 Background 
Content uniformity was earlier studied in chapter 5 for machine dosed formulations from bulk 
into vials. It was important to have target doses within pharmacopeia acceptance limits to 
satisfy regulatory approval requirements. The dosing from bulk approach was demonstrated 
feasible and practical as a result of good content uniformity demonstrated in cases.  
An active pharmaceutical ingredient (API) is distributed throughout a formulation during 
drying and localisation in particular parts of the dried cake may occur depending on the 
freezing condition used. Localisation of API should therefore be important to scientists 
looking to adopt bulk drying from fill to finish into container closures. This would typically not 
be of concern where dried formulations were vial dried and required only reconstitution just 
before administration. 
The use of different freezing rates is known to affect API location in segments of formulation 
due to induced freeze concentration and phase separation that may have occurred 
dependent on constituents. This had in the past been demonstrated using destructive 
techniques which were often chemical assays.  
How ice nucleates in a formulation during freezing is important for many reasons. It is 
responsible for batch to batch variation as it directly affects the size and number of ice 
crystals formed. Ice crystals grow to different extents after sublimation and leave behind 
pores. Qualitative analyses of these pores have reported different resulting morphologies in 
literature. These studies were however not holistic as they used either qualitative two 
dimensional images limited to small sections of an entire formulation or parts of the dried 
cake were sectioned using razors and assayed after reconstitution.  
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Here a mannitol-platinum dispersion model was used as a model to study API localisation. 
The relationship between API localisation and cooling rate were within complete or whole 
formulations from top to bottom using three dimensional image analyses. 
 
6.4.2 Materials and Methods 
6.4.2.1 Materials 
Fluid bed dried D-mannitol Ph. Eur. was purchased from Fagron, UK. Fluid bed dried 
sucrose BP, platinum powder, analytical grade Glycerol was from Fischer Scientific, UK.  
Sealing film (Parafilm™), aluminium foil and CombiCoulomat fritless Karl Fischer reagent 
obtained from VWR, UK. Dental beading wax was from Kemdent, UK. Drying straws were 
obtained from Macdonalds,UK. Transparent dual cartridges epoxy adhesive and extra 
flexible single core copper wire RS356-173 were obtained from RS components, UK. 
 
6.4.2.2 Optimisation of platinum model 
Platinum powder of 17.7 mg and 56.15 mg were weighed and vortexed for 10 minutes in 25 
mL of 10 %w/w mannitol (0.71 mg/mL, Dispersion A) and 31.72 %v/v glycerol (2.25 mg/mL, 
Dispersion B). Another weighed 7.12 mg and was bath sonicated for 24 hours in 25 mL of 1 
M Mannitol (0.29 mg/mL, Dispersion C). Platinum (7.12 mg) was dispersed in 25 mL of 1 M 
mannitol (0.29 mg/mL, Dispersion D) and 42.44 mg in 50 mL of 1 M mannitol (0.85 mg/mL, 
Dispersion E). These were probe sonicated at 5 KHz for 60 minutes at 10 minute intervals. 
Aliquots (3 mL) of dispersions A, B and C were transferred into cuvettes and absorbance 
measured at 500 nm over 30-120 minutes. Dispersion D and E were left on the bench for 60 
minutes and supernatant collected for UV analysis. Supernatant and sediments from 
dispersion E were mixed and vortexed for a minute. The supernatant was collected after an 
hour of being undisturbed on the bench. An aliquot (3 mL) was transferred in a cuvette and 
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analysed. The dispersion or supernatant showing a steady rate of change in absorbance 
over at least 30 minutes was deemed satisfactory and used for lyophilisation experiment. 
 
6.4.2.2.1 Lyophilisation in straws and preparation of epoxy control 
  
A B 
Figure 6.16: Experimental set up for lyophilisation of optimised 1 M mannitol platinum 
dispersions filled into straws and supported in A: tube rack placed on a B: Virtis advantage 
shelf to dry. Product temperature was monitored using K type thermocouples temperature in 
representative samples. 
 
Straw samples were chilled to -55°C (0.2 °C/min and 1.5 °C/min) and held for 6 hours. 
Samples requiring fast cooling were covered in aluminium foil and quench cooled in liquid 
nitrogen. Foil jackets were removed and samples were transferred onto precooled -55°C 
shelf. Primary drying was at -10°C for 22 hours. Secondary drying was at 20°C for 4 hours 
with a constant -80°C condenser and pressure at 200 µbar. K type thermocouples were 
used to monitor product temperature during the drying process.  
Freeze drying straws were sealed at the base with Sealing film (Parafilm™) and checked for 
any leakage. Freeze drying of mannitol (700 µL, 1 M) at a fill height of 1.97 cm was filled into 
bottom sealed straws and freeze dried in a Virtis Advantage bench freeze dryer (Figure 
6.16). 
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6.4.2.2.2 Sample preparation of platinum in epoxy  
700 µL of the optimised 1 M mannitol platinum dispersion in a freeze drying straw was 
sealed and left to settle over 24hours. The supernatant was discarded and filled to its initial 
volume with transparent epoxy adhesive. This was stirred with a micro spatula and allowed 
to set for X-ray scanning. 
 
6.4.2.2.3 X-ray scanning and image processing 
Sample scanning and image reconstruction were performed as previously described in 
materials and methods (Section 3.4.12.2). 59 kV X-ray source voltage and 122 µA current at 
a scanning resolution of 3.94 µm were used. Stage was rotated stepwise at 0.7° with 4 
frame image averaging in combination with a 0.5 mm aluminium filter was used. Images 
were reconstructed using Nrecon software and reconstructed images were analysed for 
morphometric parameters using CT-analyser software. 
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6.4.3 Results 
6.4.3.1 Optimisation of platinum model 
 
Figure 6.17: Optimisation of platinum dispersion stability for freezing studies with X-ray 
microcomputer tomography. Initial stock dispersions or supernatants were assayed. Stock 
dispersions contained A: 0.71 mg/mL in 10 %w/w mannitol; B: 2.25 mg/mL in 31.72 %v/v 
glycerol; and C: 0.29 mg/mL in 1 M Mannitol. Supernatant dispersions contained D: 0.29 
mg/mL in 1 M Mannitol; E: 0.85 mg/mL in 1 M mannitol. * represents supernatant and the 
duration allowed before collecting supernatants from sediments are in brackets. Platinum 
particle size in E: X90= 2.43 ± 0.0 µm, X99=4.28 ± 0.0 µm (from laser light diffraction). 
 
The proposed mannitol-platinum dispersion for use as a model was initially optimised. The 
focus of optimisation process was to ensure particles did not unduly settle under gravity 
before adequate freeze concentration and complete solidification during the formulation 
freezing process. The optimal formulation had to contain the maximum amounts of platinum 
and viscous enough to control sedimentation rate.  
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A supernatant collected from 0.85 mg/mL of platinum in 1 M mannitol initially probe 
sonicated to disperse any aggregates was identified as ideal from A500 sedimentation study 
over 30 minutes. Success demanded evidence of freeze concentration or complete freezing 
before 30 minutes. This was confirmed using a slow shelf ramp of 0.2 °C/min (slow, control) 
and 1.5 °C/min cooling rate steps. Product temperature monitored during the freeze drying 
cycle is available in Appendix VII on page 264. These are discussed later in detail in relation 
to the various cooing rates used and the onset of ice nucleation. Nucleation and onset of 
freezing was confirmed to have occurred before 30 minutes during the freezing stage in the 
desired formulation (Appendix VII Figure A 16). 
 
6.4.3.2 Localisation of platinum in lyophilised dispersions  
Freeze dryer shelf and freeze dried samples were visually inspected. There was no sign of 
sample spillage due to leaking container content within the freeze dryer. Samples dried after 
slow shelf ramp of 0.2 °C/min (Slow) showed a substantial amount of visible black particles 
at the bottom when viewed from the parafilm covered base. Samples dried after 1.5 °C/min 
shelf cooling ramp (Mid) showed no visible black deposits when viewed through the parafilm 
covered base. Both sample cakes were intact with 2 tinny protruding dried bumps or masses 
on the surface.  
Quench cooled samples were intact after drying with a single tinny pointed protruding dry 
mass on its surface. The base of the sample which was first immersed into liquid nitrogen 
showed signs of mannitol expansion but no evidence to suggest the ingress of liquid 
nitrogen into sample which would have been observed as a hollow cavity within the dried 
cake. Reconstructed images showed no form of ring artefacts which commonly present as 
concentric rings.  
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Figure 6.18 : X-ray microcomputer tomographic investigation into effect of cooling rate on 
number of platinum particulate model localisation in lyophilised mannitol (MAN) cake. 
Formulations of 1 M Mannitol contain 0.85 mg/mL of platinum. CCD camera resolution was 
3.94 microns. Mid = 1.5 °C/min. Slow = 0.2 °C/min. Fast = Quench cooled in liquid nitrogen. 
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Figure 6.19: X-ray microcomputer tomographic investigation into effect of freezing rate on 
volume of platinum particulate model localisation in lyophilised mannitol (MAN) cake. 
Formulations of 1 M Mannitol contain 0.85 mg/mL of platinum. CCD camera resolution was 
3.94 microns. Mid = 1.5 °C/min. Slow = 0.2 °C/min. Fast = Quench cooled in liquid nitrogen. 
 
Three dimensional binarised image of VOI within top, middle and bottom segments of 
formulations revealed differences in the volume and number distribution of platinum particles 
(Figure 6.18 and Figure 6.19). Presence of a large volume of platinum did not necessarily 
represent or show a large number of platinum particles and vice versa. Platinum particles 
present were therefore present in different surface areas. A large surface area of many 
particles or fewer particles with a smaller surface area could equate to the same volume 
results obtained from analyses. 
Platinum mannitol dispersion was shown to be optimised and a valid model. Using a slower 
cooling rate (Experimental control) that did not guarantee solidification of all phases within 
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30 minutes caused particulate sedimentation to a very high extent. The use of a slow shelf 
cooling ramp rate of 0.2 °C/min showed an expectedly high 98% of its particulate volume 
settled at the bottom of the dried formulation (Figure 5.18) as it took about 3.5 hours for the 
onset of ice nucleation as per thermocouple reading (Appendix VII Figure A 15). This was in 
accordance with the initial visual inspecting which revealed many black deposits of platinum 
at the sample container base.  
The use of a relatively faster shelf cooling rate of 1.5 °C/min (Pt Man Mid) was ideal and 
showed a nucleation event at a nucleation temperature of -4.7°C after 28 minutes of cooling 
(Table 6.3). Nucleation was completed at -0.65°C with the subsequent onset of solidification 
(Appendix VII Figure A 16). This was evidence that the dispersion was held below the 
equilibrium freezing temperature of water or super cooled before the initiation of ice 
nucleation (Table 6.3). 
Table 6.3: Observed nucleation events and calculated rates for mannitol only and mannitol-
platinum dispersions from product freeze drying cycle plots. 
Sample batch Set shelf cooling 
rate* (°C/min) 
Pre nucleation 
cooling rate** 
(°C/min) 
Post nucleation 
freezing rate** 
(°C/min) 
Nucleation 
temperature 
(°C) 
Mannitol-platinum 
dispersion 
0.2 0.10 0.18 -5.4 
Mannitol only 0.2 0.15 0.26 -8.13 
Mannitol only  1.5 ---- ---- -3.29*** 
Mannitol-platinum 
dispersion 
1.5 1.42 1.79 -4.7 
*Specified in freeze drying cycle protocol. **Calculated from product temperature cycle plot 
measured using K type thermocouple in a separate representative sample. *** A typical 
prominent nucleation event not observed on thermogram but a distinct inflection in baseline 
suggested a nucleation temperature around -3.29°C. 
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Complete solidification was observed at 44 minutes where the product temperature was at -
41.5°C and close to the assigned inlet shelf temperature of -55°C. The use of double folded 
parafilm as container base may explain the temperature lag due to a poorer thermal transfer 
than could be expected for other materials such as glass or stainless steel.  
Platinum localisation results from epoxy resin samples were expected to be similar to 
quench cooled samples but not found true in all cases. Within minutes of manual mixing of 
the 2 component epoxy (resin and hardener) with platinum, the resulting viscous mix 
hardened. Results for platinum distribution in epoxy resin did not show similar patterns of 
volume distribution as quench cooled samples (Figure 6.18). Interestingly, similar amounts 
were found from the calculated percentage number of platinum present in their mid-regions 
which were 57% and 56% for epoxy resin and quench cooled samples (Figure 6.19). The 
least volume of platinum particles was present at the top of both epoxy (5.95%) and quench 
cooled (18.9%) samples (Figure 6.18 and Figure 6.19). The expansion observed at the base 
of quench cooled sample correlated with the 10.67% difference in volume distribution when 
the bottom VOIs for quench cooled and epoxy resin samples were compared (Figure 6.19). 
While the volume of formulations cooled at 1.5 °C/min (Pt Man Mid) showed increasing 
volume of platinum from bottom VOI through to the top VOI, the reverse was true for quench 
cooled formulations (Figure 6.189, Fast). The trend supports the fact that upward particulate 
migration along the freezing front or ice crystal growth within both sample sets occurred. The 
number of particulate distribution in the quench cooled sample which was found to be 
highest in the middle VOI suggested there was particulate migration from the bottom VOI but 
the fast freezing process did not allow this to proceed much longer and further compared to 
samples cooled relatively slowly at 1.5 °C/min. 
The afore mentioned results involved the use of large VOI corresponding to top, middle and 
bottom VOI which were analysed for patterns in volume and number of platinum distribution 
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within samples (Figure 6.18 and Figure 6.19). This was overly generalised and a more 
detailed approach using many well distributed VOI was investigated. This was aimed at 
obtaining a more detailed understanding of particulate distribution. The individual large 
sectioned top, middle and bottom VOI were investigated to ascertain where particulates 
were distributed along the path from the central core of a cake towards the walls of its 
container vessel. These sections were shown as centre (CR), ring 1 and ring 2 (See 
schematic on Figure 6.20 and Figure 6.21). Ring 2 was hence the closest to the container 
wall and both ring 1 and ring 2 consisted of 8 individual volumes of interest labelled 1-5 
along the axes A-D (See schematic on Figure 6.20 and Figure 6.21). 
Since the formulation components had mannitol, water and platinum phases present, a 
platinum-ice-eutectic or partly amorphous mix will form on solidification. Pure ice would 
sublime to leave behind pores which may be varied in structure dependent on the ice crystal 
morphology.  
 
A correlation between the concentration or amounts of platinum within the sectioned VOI 
and nucleation as well as the direction of the freezing front was apparent. This correlation 
was caused by the method of cooling.  
The results for sample shelf cooled at a ramp rate of 1.5 °C/min showed a heterogeneous 
distribution of particulate volume within the volumes of interest. Observing the volume 
distribution along the axes A, B, C and D within the volumes of interest showed patterns in 
volume distribution (Figure 6.21). From the volume distribution within the bottom volume of 
interest, an irregular pattern of platinum volume was observed from left through the centre to 
the right container wall along each axis labelled A to D (Figure 6.21 Bottom Left). The 
observed pattern however for the middle and top volumes of interest generally showed 
either an increase in volume distribution along any axis A-D or a volume distribution that 
208 
 
increased from outwards (container wall) towards the central core of the dried cake. The 
amount of platinum present within the central core was highest within the entire cake from 
top to bottom (Figure 6.21, Right, top to bottom).  
The volume distribution pattern observed when sample was quench cooled was found to be 
generally more orderly within the top to bottom volumes of interest studied. All sections 
generally followed either an increase in volume distribution along any axis A-D or an 
increase from the container walls towards the central core. Unlike the shelf cooled sample, 
the bottom core had the least platinum volume (Figure 6.210). 
The impact of this heterogeneous freezing pattern within a shelf cooled sample and the 
directional freezing in quench cooled samples was demonstrated for visual clarity using a 
platinum volume distribution map (Figure 6.22).  
 
A coloured scale represented the relative amounts of platinum in any one volume of interest 
(Figure 6.22). Earlier it was deduced that the freezing front, ice nucleation sites and amount 
of platinum in any section of a dried cake freeze dried from previously homogenous platinum 
mannitol dispersion could be made. This postulate was found to be true and clarified by the 
volume distribution maps. 
The observed pattern for shelf cooled formulation suggested heterogeneous nucleation sites 
with the ice crystal growth or freezing front migrating towards the central core of the 
formulation. Based on our suggested deduction, the number of nucleation sites was at a 
minimum where volume distribution was highest within the dried cake.  
Applying the same thought process to quench cooled sample showed nucleation was not 
heterogeneous but localised to any one section of the volume of interest closest to the 
container wall. This is consistent with the quench cooling process where the entire 
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formulation was immersed into liquid nitrogen. The freezing front is consistent with the 
expectation that nucleation will be from the closet point of contact with the cooling medium 
which were the container walls. For example from Figure 6.22 (Left), the bottom volume of 
interest of quench cooled sample had the least platinum volume distribution which increased 
along the A, B and C axes towards the central core of the cake.  
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Figure 6.20: X-ray microcomputer tomographic investigation into effect of quench cooling and 
fast cooling rate on platinum in lyophilised mannitol (MAN) cakes. Formulations of 1 M 
mannitol contain 0.85 mg/mL of platinum was optimised for particulate sedimentation rate. 
CCD camera resolution was 3.94 microns. Samples were sectioned into Left: Top, middle and 
bottom volumes of interests. Each volume of interest was further sectioned into horizontal 
slices. Each horizontal slice was further sectioned into regions of interests along the axis A-D. 
The volume and number of platinum within each region of interest was quantified. Right: sum 
of platinum volume and number within each horizontal slice.  
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Figure 6.21 : X-ray microcomputer tomographic investigation into effect of medium cooling 
rate of 1.5°C (Mid) on platinum in lyophilised mannitol (MAN) cake. Formulations of 1 M 
mannitol contain 0.85 mg/mL of platinum. CCD camera resolution was 3.94 microns. Left: 
Volume of interest. Each volume of interest was further sectioned into horizontal slices. Each 
horizontal slice was further sectioned into regions of interests along the axis A-D. The volume 
and number of platinum within each region of interest was quantified. Right: sum of platinum 
volume and number within each horizontal slice. 
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Figure 6.22: Relative volume colour scale distribution of platinum within freeze dried mannitol 
along each axis labelled A-D. Left: shelf ramp cooled at 1.5 °C/min. Right: quench cooled 
samples in liquid nitrogen. Colour scale is relative across each axis. Similar colour scales on 
different axes do not represent equal volume. Arrows represent suggested path of freezing 
front.  
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6.4.4 Discussion 
It was possible to generally predict the likely proximity or the location of nucleation sites or 
direction of ice crystal growth within the volumes of interest analysed based on platinum 
distribution within dried cakes. The binarised image thresholding performed allowed the 
separation of images to include only platinum objects for analysis. X-ray photons are 
attenuated based on atomic number and density (Baruchel et al., 2000). Unlike 
monochromatic gamma ray source or synchrotron tomography, the polychromatic X-ray 
source used in this study can have problems with beam hardening resulting from varied 
attenuations within samples to produce attenuations from even low energy photons 
(Baruchel et al., 2000). The concept of X-ray attenuation and background of micro-computer 
tomography was previously discussed in the thesis (Sections 1.8 and 3.4.12.1). 
Because low energy photons experience more attenuation compared to high energy 
photons, a beam is said to have hardened when the X-ray spectrum shifts towards higher 
energy in relation to increasing attenuation through a given sample (Zou et al., 2011). A 
beam hardening correction of 20-30% was ideal and in combination with the 0.5 mm 
aluminium filter used in this chapter, the noise to signal ratio was minimised. Artefacts 
introduced by beam hardening are commonly observed as streaks in reconstructed images. 
These introduce errors when present and quantitative analysis will be erroneous due to the 
introduction of corrupt pixels.  
A limitation with the technique is the rather subjective nature of the thresholding process 
especially where grey scale indices signals for different material components overlap on the 
grey scale histogram distribution. This was resolved in our work using the linear binarised 
scale in combination with deduction of a blank value. A similar study by Koroteev et al. 
(2011) studied the use of MCT to threshold quartz, halite, and calcite mineral powder mix. 
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The analysed binarised images for the corresponding top, middle and bottom volumes of 
interest showed differences in volume and number distribution of platinum within the 
samples analysed (Figure 6.18 and Figure 6.19). The absence of platinum in any one region 
meant the presence of either a pore and or mannitol in this region. Freeze dried cakes are 
by nature very porous with pores varied in size and tortuosity (Dawson and Hockley, 1992). 
It could be inferred that the presence of a pore meant the presence of an ice nucleation site 
at or within the proximity of the pore in question. The volume distribution within the volumes 
of interest could therefore be used to a large extent as an indicator of ice nucleation sites 
and ice crystal growth within a formulation.  
The direction of the freezing front and ice crystal growth was also expected to influence 
platinum volume distributions within the final dried cakes. Since the freezing front and 
nucleation sites are initially in close proximity, a correlation between these and the amount 
of platinum distributed within a cake could therefore be made. This was under the assurance 
that sample solutions prior to freeze drying had a uniform distribution of platinum which was 
ensured through formulation optimisation studies (Section 6.4.3.1 on page 201). 
The observed varied platinum redistribution (Figure 6.19) within the various volumes of 
interest studied was supported by the rationale that formulation components migrate from 
the coldest section within a formulation towards the surface when chilled on a freeze drying 
shelf (Franks, 1990, Dawson and Hockley, 1992). Our results showed a detailed quantitative 
observation of this trend but migration was to a lesser extent in quench cooled samples 
(Figure 6.19). The assessment of the dried cake in this study demonstrated the 
aforementioned phenomenon and showed the trail of resulting concentration gradient 
created along four planes within formulations (Figure 6.22). The wider implications of this 
phenomenon would require formulators especially those intending to powder dispense bulk 
dried formulations to consider the choice of cooling rate. Relating the current results to 
conclusions from previous powder dispensing studies in chapter 5 (Section 5.3.4 on page 
215 
 
144), the need for powder homogeneity cannot be over emphasised. A homogenous final 
powder from a reproducible powder breaking step would be required for success. 
These observed differences in API homogeneity due to cooling rate suggested homogeneity 
was influenced by the direction of the freezing front. Here, bottom to top freezing was 
observed to correlate with API migration from bottom to top. Not all types of freezing follow 
this pattern and it would be expected that top to bottom freezing which occur in ice fog 
(Rambhatla et al., 2004) and vacuum induced freezing techniques (Liu et al., 2005) would 
have API migration follow same. 
Thermocouples were placed at the bottom of container vessel of representative formulations 
but not into the formulations scanned to eliminate thermocouple induced ice nucleation at 
higher nucleation temperature (Roy and Pikal, 1989). The presence of platinum particulates 
also in itself could be viewed as nucleating agents. Nucleating agents are useful for 
modifying the ice nucleation temperature during sample cooling and examples studied in 
literature include silver iodide and Pseudomonas syringae (Searles et al., 2001b, Liu et al., 
2005). Searles and co-workers who studied formulations seeded with Pseudomonas 
syringae and silver iodide saw a reduction in nucleation temperature by -11.6°C (87%) 
and -7.3°C (55%). 
Evidence of ice nucleation temperature alteration was present to a lesser extent in the 
freeze dried mannitol platinum dispersions (Table 6.3). From comparing similar formulations 
containing 1 M mannitol only to that containing platinum showed a -2.73°C (34%) change in 
ice nucleation temperature. Searles and Randolph (2000) found 1 mg/2 mL silver iodide 
particles used in controlled nucleation studies floated at the meniscus before freezing and 
induced nucleation was detected by external temperature probes. There were no floating 
particulates visually present on the meniscus of samples in our study and this was because 
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platinum was denser (21.45 g/cm3) compared to silver iodide (5.675 g/cm3) (Fischer 
Scientific, 2012, Acros Organics, 2009).  
The observed platinum volume distribution trends (Figure 6.19) resonate with known 
differences in nucleation events described in literature. For shelf ramped cooling of 
solutions, the observed results were consistent with Dawson and Hockley (1992) who found 
the formation of proteinaceous skin layer at the surface of 1 %w/v trehalose containing 5 
mg/mL protein when shelf freeze dried at 1 °C/min. Authors found this to be absent when 
samples were fast frozen and was attributed to migration of formulation components to the 
surface. The plug or cake had a protein rich surface with most protein within the top fifth 
(Dawson, unpublished). Franks (1990) observed buffer salt migration towards formulation 
surface as surface protrusions and was linked to 90% enzymatic denaturation due to pH 
shifts. Nakagawa et al. (2013) however found the activity of bovine serum albumin to be 
higher at the bottom of a vial which was slow shelf cooled and attributed the observed to the 
freezing process. 
 
Platinum and mannitol solute migration toward the surface of formulations occurred during 
the freezing process. Ice crystals growth forming the freezing front can cause the migration 
of platinum within the formulation. This migration could be confirmed from reviewing the 
localisation patterns within fast or quench cooled and mid freezing rate frozen samples. Fast 
frozen formulation where solidified instantaneously from bottom to top as they were dipped 
into liquid nitrogen. Solute and liquid phases present held the platinum within the ice-eutectic 
mix. It was also assumed that all formulations contained the same amounts of platinum and 
were dispersed uniformly within the optimised formulations. From a simple density-mass 
relationship, the presence of a large volume could be interpreted as the presence of a high 
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platinum mass. A high platinum volume could also be either made up of a high surface area 
of many small platinum particulates and vice versa. 
 
6.4.5 Conclusion 
We have demonstrated for the first time a detailed non-destructive application of MCT for 
quantification of a complete freeze dried formulation to inform API localisation (Section 
6.4.3.2). 
Using optimised platinum in mannitol dispersions as a model, findings were in agreement 
with literature and provided the most detailed quantitative report to date of the differences in 
API localisation in relation to the cooling rate. 
Volume and number distribution of platinum was determined by API migration from bottom to 
top in shelf cooled formulations. While samples cooled at 1.5 °C/min showed a trend of 
increasing volume of platinum from bottom VOI to top VOI, the opposite was found true for 
quench cooled samples. This was due to differences in the rate and direction of the freezing 
front. Freezing front velocity and freezing rate were faster in quench cooling.  
The freezing front was responsible for redistribution of API through a formulation. The 
creation of concentration gradients dependent on this within a formulation was demonstrated 
along four different planes within three volumes of interest. This was dependent on 
nucleation events and method of freezing. Quantitative mapping scale for platinum volume 
distribution demonstrated heterogeneous freezing and solidification fronts in samples dried 
at 1.5 °C/min. Uniform pockets of API localisation due to directional solidification were 
revealed in quench cooled formulations due to inward directional solidification of the freezing 
front from container walls in contact with the cooling medium.  
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7 FINAL CONCLUSIONS AND IMPLICATIONS  
This thesis has made important steps in broadening the knowledge that exists for bulk 
freeze drying and demonstrated this approach to be cost effective, meets regulatory 
approval and practical. It offers manufacturers and researchers the building blocks for further 
work and also directs on critical considerations for optimal powder handling and 
performance. 
In the conclusions of chapter 4, it was noted that 23%-34.4% of freeze dryer shelf volume 
was wasted when compared to the typical vial arrangement in freeze drying. Mannitol and 
sucrose bulk lyophilised formulations in typical concentration ranges of 1 %w/v to 15 %w/v 
could be disrupted uniformly to provide free flowing powders with flow classified over the 
range of ‘poor’ to ‘very very poor’. Techniques were defined that allowed disruption and 
testing of these highly hygroscopic powders. Cake disruption technique (I) involved the use 
of a fixed number of rotations by adopting a standard friability tester (Section 4.3.1.2). While 
the alternate technique (II) involved the use of a nest of standard stainless steel sieves (710 
µm-75 µm) shaken mechanically at an amplitude over time till the powder endpoint was 
reached (Section 4.4.2.2).  
Our initial hypothesis that crystalline bulk content would benefit freeze dried powder flow 
compared to an amorphous powder was substantiated (Section 4.3.2.2). Crystalline mannitol 
was found to display superior flow behaviour over amorphous sucrose after freeze drying 
and disruption to powder. However both agents were still categorised using Carr's 
classification as ‘very very poor'. This meant they were very cohesive and presented with 
potential handling problems. The concentration-flowability relationship was quantified and 
related to bulk density and porosity. The main mechanism for improving flowability was to 
increase the density of the powder which had significant considerations for impedance 
during the freeze drying process.  
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Implications of this chapter to our overall objectives were that the identification of poor flow 
behaviour of bulk freeze dried powders would be a barrier to the successful adoption of 
powders to a dispensing process. Angle of repose experiments showed occurrence of 
bridging or arching and powders would require agitation to initiate flow through orifices such 
as those of commercial hoppers. While the typical residual moisture levels in freeze dried 
powders were too low to influence its flow, there was a significant need to control humidity 
during powder disruption and handling.  
Formulators hoping to manipulate freeze dried powders would need to avoid mannitol 
content of less than 5 %w/v. The low concentrations provided no benefit for flow. Although 
concentrations of up to 15 %w/v showed a relative increase in flow behaviour, further 
increase in solute content did not benefit flowability. This was limited by solubility in cases 
and further addition would only add to cost of drying. 
 
In conclusions for investigations into the effect of cooling rate on freeze dried powder 
flowability (Section 4.4.5), it was revealed that cooling rates of between 0.2 °C/min to 1 
°C/min were beneficial in combination with mannitol solute contents of 0.5 M-1 M. It was 
found that powders treated by annealing benefited from an increased mechanical strength. 
The previously described cake disruption technique (II) (Section 4.4.2.2) was found as most 
suitable for powder disruption as a low cost and industrially reproducible approach.  
Formulators must avoid cooling rates of 5 °C/min because they produced the most cohesive 
powders as revealed from compressibility indices and flow function curves (Section 4.4.3.3 
and 4.4.3.8).  
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In the conclusions of chapter 5, larger variations from dosing targets were found to be 
associated when using volumetric powder dispensing method compared to a gravimetric 
method due to the differences in their dosing mechanisms. A gravimetric powder dispenser 
was recommended for dispensing freeze dried powders together with assurances of powder 
homogeneity.  
Freeze dried powders were found to easily develop electrostatic charge during handling 
(Triboelectrification) and was responsible for sample losses during dispensing. 
Manufacturers must therefore control triboelectrification.  
 
Powder dispensing of disrupted freeze dried powders in a moisture free and static controlled 
environment was demonstrated to be practical, time efficient and able to meet regulatory 
approval in cases. Pharmacopeia acceptance values criteria for dosage uniformity of dosed 
formulations into container closures determined if samples passed or failed. The presence of 
micro collapsed amorphous phase in formulations would cause dosed units to fail and must 
be avoided. The type of protein formulation would influence dosing accuracy because it 
influences the morphology of the final powders. Annealed formulations with a mannitol 
solute content of 0.5 M or 9 %w/v was recommended as optimal for use in combination with 
a gravimetric powder dispenser. The gravimetric dispenser must be equipped with powder 
stirring and vibration mechanisms. 
The use of online process analytical tools to exclude outliers was advised for use with 
gravimetric dispensers to allow the setting of acceptable weight deviation limits.  
It was appreciated that the use of an amorphous and crystalline blend could potentially 
benefit the requirements for good flow, dosing accuracy and long term stability. 
Manufacturers considering dosing freeze dried powders from bulk need to optimise the cake 
disruption process, the physical form, flowability, process humidity control, powder 
electrostatics and also the choice of dosing system.  
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In conclusions for chapter 6, it was demonstrated for the first time the use of X-ray 
microcomputer tomography (MCT) in informing the flow characteristics of freeze dried 
powders and finally its API dose uniformity. Sample requirements were less than 1 mL in all 
cases and was therefore recognised to be potentially useful during early lyophilised product 
development.  
Porosity measurements revealed a strong correlation with traditional helium pycnometric 
measurements (R2 = 0.93). The combination of porosity, size, structural model index, 
fragmentation index and fractal dimension analyses as determined by MCT were 
complimentary attributes which enabled dried powders to be indirectly characterised for flow 
behaviour. Due to the very small sample volumes used, homogeneous sampling from stock 
powders was advised. 
Scientists intending to inform flow characteristics using MCT need to use a fixed number of 
bench tapping for uniformity across samples to be analysed. A 100 taps within 2-5cm from 
the bench was recommended.  
 
It has also been demonstrated a detailed quantitative account of freezing events that occur 
during freeze drying of an API. Volume and number distributions showed the largest amount 
of API was localised in the top VOI when cooled at 1.5 °C/min. The evidence showed this 
was due to API migration during freezing. The freezing front was found to create an API 
concentration gradient within a formulation dependent on the freezing rate. Heterogeneous 
freezing and solidification front was revealed in samples cooled at 1.5 °C/min compared to a 
directional freezing front observed when samples were quench cooled. 
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Appendix I: Standard operating procedure for optimised method for 
IgG purification using caprylic acid fractionation. 
 
PRINCIPLE: 
Ovine sera                                        IgG Precipitate                                               Pure IgG 
 
Figure A 1: Principle of IgG purification using caprylic acid fractionation. 
METHOD: Caprylic acid precipitation and filtration based on the principle in (Figure A 1). 
REAGENTS: 
A. Caprylic Acid (n- Octanoic acid); Sigma Product No. C5038. 
B. Citric Acid, 99.6%, Anhydrous; ACROS Organics Product No. 423565000. 
C. Citric Acid trisodium salt, 99%, Dihydrate; ACROS Organics Product No. 227135000. 
D. 20 mM Citrate buffer solution pH 6.2. 
 (Prepare 10 L in deionised water using Reagent B and Reagent C; Mix 3868.63 mL of 7.74. 
mM solution of reagent C and 6131.37 mL of 12.26 mM Reagent B). 
E. 0.9 %w/v Saline solution. 
(Prepare 2 L in deionised water using Sodium Chloride; Sigma Product No. S7653; weigh 
18g and make up to volume). 
F. 0.1 M NaOH solution. 
(Prepare 2L in deionised water using Sodium hydroxide pellets; Sigma Product No.S5881; 
weigh 8g and make up to volume). 
MATERIALS: 
1. Ovine Sera supplied in 1L bottles; MicroPharm UK. 
Caprylic acid 
Cross 
Filtration 
Citrate Buffer  
Diafiltration Saline 
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2. Glass microfibre filter, Whatman, GF/B 1.0 µm retention, 90 mm; VWR Product No. 
513-5219. 
3. Membrane filter, cellulose acetate, 0.45 µm, 47 mm, Fischer Product No. FDM-309-
110N. 
4. 30 kDa NMWCO (Nominal molecular weight cut off) filter, Kvick Lab packet, GE 
Healthcare Product No. 56-4112-08. 
APPARATUS: 
1. Kvick Packet holder, GE Healthcare Product No. 11-0006-70. 
2. Peristaltic pump, Watson-Marlow. 
3. 50 mL Centrifuge tubes, Polypropylene, Corning Incorporated Product No. 430829. 
4. Centrifuge, Baird & Tatlock Mark IV. 
5. Spectrometer, Jenway 6405UV/VIS . 
6. Vortex-2, Genie, model G560E, Scientific Industries, USA. 
PROCEDURE: 
A. SERUM FILTRATION AND CAPRYLIC ACID PRECIPITATION 
1. Thaw about 1 litre of sheep sera raised against Fluorescein Isothiocyanate (Anti-FITC) 
noting the date, sheep number and volume. 
2. Using a suction pump, pre-filter each bottle through a GF/B glass microfibre filter and 
then filter through a 0.45 µm cellulose acetate membrane filter into glass flask. 
3. Weigh filtrate and record the following: 
a. Weight of glass flask (g) 
b. Weight of filtered serum + glass flask (g) 
c. Total weight of filtered serum (g) 
4. Take 5 mL aliquot of filtrate for storage in freezer. 
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5. Dilute the total weight of filtered serum from step 3c by 50% with 0.9 %w/v Saline 
solution by flashing through filter to recover serum proteins.  
6. Record amount of saline added for dilution = 50% x total serum volume from step 3c. 
7. Weigh and record the following : 
a. Final weight of glass flask (g) 
b. Serum + glass flask (g) 
8. Calculate actual weight of saline added (7a-7b). 
9. Weigh and add caprylic acid (Reagent A) at 6 %w/w of total weight of serum volume 
(step 3c). For example add 62.22g of caprylic acid for a 1037g of total weight of serum 
volume.  
10. Note actual weight of caprylic acid added. 
11. Vortex continuously for 30 minutes. 
12. Record total weight: 
a. Total weight = Total weight of filtered serum (step 3c) + actual weight of caprylic 
acid added (step 10) + actual weight of saline (Step 8) 
13. Add a further amount of saline. This should be the same amount of saline previously 
added at step 8 after 30 minutes. 
14. Note the following: 
a. Weight of the expected final volume = Total volume (step 12) + Further amount of 
saline added (step 13) 
b. Weight of actual volume added 
15. Leave to stand for 1 hour. 
16. Split into four or more equal weights into centrifuge tubes. 
17. Centrifuge using an appropriate sized holder depending on volume of each split part 
(step 16) in a Baird & Tatlock Mark IV centrifuge for 60 minutes at 4000 rpm. No 
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refrigeration is required. Balance tubes in holders with a minimum of two and a 
maximum of six tubes. 
18. Decant supernatant, pool and store at 2-80C overnight in 1 litre plastic bottle. 
19. Hold pellets at 2-8oC until completion of quantifying assay. 
 
B. IgG FILTRATION AND FORMULATION IN CITRATE BUFFER 
1. Filter refrigerated supernatant of IgG (from procedure A) through a 0.45 µm filter. 
2. A cross filtration set up as shown figure (Figure A 2) will be used. Use a 30 kDa 
NMWCO membrane filter in membrane cassette holder and perform a pre-treatment : 
a. Washing and sanitising with 2L of 0.1 M NaOH for 30 minutes. 
b. Flashing with 2L of 0.45 µm filtered purified water.  
c. Flash with 2L of 20 mM citrate buffer solution. pH of retentate and permeate 
must be equal to 5.8-6.2.  
3. Operate for 5minutes at 1 bar pressure and no retentate pressure. 
4. Reduce flow and concentrate by applying retentate pressure. Keeping inlet pressure at 
1bar. 
5. Concentrate to 500 mL and diafilter IgG filt against ten 500 mL exchanges of 20 mM 
citrate buffer solution (Reagent C).  
6. Measure pH of permeate after 10 volume exchanges which should read about 6.2 
7. Flush with a further 500 mL of 20mM citrate buffer solution and record final weight. 
8. Perform a 1:50 dilution by pipetting a 60 µL sample of the concentrated and diafiltered 
IgG solution and add 2940 µL of citrate buffer. 
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Figure A 2: Set up for a Kvick cross filtration kit. Image was taken from instrument manual (GE 
Healthcare, 2011). 
 
9.  Filter the 1:50 dilution using a 0.45 µm filter and measure optical density (A280) at 280 
nm with a Jenway spectrometer to estimate protein concentration. The use of a quartz 
cuvette is recommended.  
10. With reference to step 9, dilution factor (D) = 50 Use Beer Lambert Law A = εcl 
Extinction coefficient = 1.5 L/mol/cm 
 
Table A 1: Measured absorbance and concentration 
Sample A280 Concentration (g/L) Concentration x D (g/L) 
1    
2    
3    
Average  
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11.  Using the concentration obtained from optical density reading, dilute concentrate to a 
lower known concentration and note new volume (For example from 28 g/L to 15g/l) and 
repeat step 9. This is to test for accuracy of optical density readings. 
12. Store concentrated and diafiltered IgG over night at 2-8oC. 
13. Filter product through a 0.45 µm filter into a sterile bottle and store at 2-8oC. 
14. Disconnect Membrane filter and store in appropriate storage solution to prevent damage.  
 
REFERENCES: 
GE HEALTHCARE. (2011). Membrane Separations Quick Reference Guide 11-0003-81 AD 
[Online]. Available from http:// www.gelifescience.com [Accessed on 21/01/11]. 
CHERRY, C. (2010). Laboratory book extract. MicroPharm Limited. Wales. UK. 
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Appendix II: Standard operating procedure for porosity 
investigation using helium pycnometry. 
 
PRINCIPLE: 
True density of a sample can be measured by measuring the pressure difference as a result 
of allowing a known quantity of helium to flow from a precisely known reference volume (VR) 
into a sample cell. Based on the Archimedes principle of fluid displacement, gas pycnometry 
measures the particle density (the closest possible to measuring true density) of a sample. 
The choice of helium as the displacement gas is due to its small atomic dimension which 
allows open pores approaching one Angstrom to be investigated. 
APPARATUS: 
Multipycnometer, Quantachrome instruments, Model number MUP- 6DCE. 
PROCEDURE: 
A. Particle density  
 
Figure A 3: Photograph of the front panel of multipycnometer (Quantachrome instruments, 
Model number MUP- 6DCE). Labels A-K corresponds to operation procedure outlined below 
and is in brackets next to applicable procedure. 
A
B
C
D
E
F
G
H
K
J
I
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NOTE:  
Before using the multi pycnometer (Figure A 3) ensure it has been calibrated. To calibrate 
pycnometer, use the supplied standard calibration spheres. Decontaminate the sample with 
10 cycles of helium gas if necessary. 
1.  Ensure pycnometer is plugged in at the mains and connected to a helium gas cylinder 
feed.  
2. Open the helium gas feed to about 1 bar pressure by turning the regulator knob on the 
gas cylinder anticlockwise.  
3. Turn on the power switch (A) on the pycnometer and allow 15minutes for the pressure 
transducer to warm up and stabilize. 
4. Turn selector valve anticlockwise to “Cell”. Using the front panel guide (H) select the 
desired reference cell volume by closing or opening the toggle valves I and II (I). For 
example to select the micro reference cell, close both toggle valves I and II.  
5. Weigh by difference the sample powder to be analysed into a corresponding sample cell 
as chosen in step 4. Make sure it is filled to the brim but allow about 1 cm from the brim 
to allow for easy transfer using forceps in pycnometer kit.  
6. Open cover of sample cell holder and insert sample cell into sample cell holder. Use the 
two white guide marks (C) on cell cover and brim of cell holder to align and properly 
close cell holder. 
7. Raise the “GAS OUT” toggle valve (K) and turn “GAS OUT RATE” valve (J) 
anticlockwise to open. Wait for a stable zero reading on the display.  
8. Adjust reading to zero after stabilising if necessary by turning the zero knob (G).  
9. Turn the selector valve (D) to “REF”. 
10. Raise the “GAS IN” toggle valve (F) and turn “GAS IN RATE” valve (E) anticlockwise to 
open gas feed. Pressurise to approximately 17 PSIG and close toggle valve to stop flow.  
11. Record the pressure displayed as “ P1” 
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12.  Turn the selector valve to “CELL”. 
13. Allow reading to stabilize and record as “P2” 
14. Vent the pressure slowly to avoid blowing powder out of cell by raising the “GAS OUT” 
toggle valve (K) and turning “GAS OUT RATE” valve (J) anticlockwise to open. 
15. Repeat steps 5-14 twice.  
16. Remove sample cell holder and replace cover as specified in step 6. 
17. Turn off pycnometer using the front panel button (A), turn off gas supply at the cylinder 
valve and turn off pycnometer at the mains.  
CALCULATIONS  
Perform calculations manually using the operation equation below and reference values in 
Table A 3 or using the excel spread sheet file “Helium Pycnometry Template” (See Table A 
2) located on electronic file C:\Users\ekenleep\Documents\Aston PhD\Lab work\Pycnometry. 
Table A 2: Helium Pycnometry sample spread sheet 
Date: Sample ID: Reference Cell: Sample cell:  Lab book page:  
Weight (g) P1 P2 
Vp 
(cm³) 
Particle density 
(g/cm³) 
          
          
          
   
Mean   
   
S.D.   
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Table A 3: Reference volumes of multipycnometer: Micro cell volume, small cell volume and 
large reference volumes are reference compartments inside the pycnometer. 
Parameter Volume (cm
3
) 
Micro cell volume 12.030 
Micro reference volume 6.397 
Small sample cell volume 29.439 
Small reference volume 11.578 
Large sample cell volume 148.946 
Large reference volume 88.685 
 
 
Operating equation:          ((
  
  
)   )  A.1 
Where: 
P1= Pressure reading after pressurising the reference volume (psig) 
P2 = Pressure reading after including Vc (psig)     
Vp = Volume of powder (cm
3
)   
Vc = Volume of sample cell (cm
3
)   
Vr = Reference Volume (cm
3
) 
Example 
If the small sample cell is used, Volume of powder = 29.439-(      ((
  
  
)   )) 
REFERENCES 
QUANTACHROME INSTRUMENTS. (2009). Multipycnometer MVP-D160-E Operating 
Manual P/N 05034 Rev C.  
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Appendix III: Standard operating procedure for lactate 
dehydrogenase (LDH) enzymatic assay. 
 
PRINCIPLE: 
Time and cost savings associated with the UV method of quantifying proteins or enzymes 
makes it a widely used in literature alongside its high specificity, simple sample preparation, 
ease of measurement, high sensitivity and precision (Henniger, 2003).  
In the presence of NADH (Reduced Nicotinamide Adenine Dinucleotide) and LDH, Pyruvate 
is converted to lactic acid (Figure A 4). From measuring absorbance at 340 nm, the amount 
of NADH consumed can be used to quantify amount of LDH present (Krieg et al., 1967, 
Grant, 2010).  
 
     Pyruvate + NADH                                             Lactic acid + NAD  
Figure A 4: Principle of LDH enzymatic assay 
 
One unit will reduce 1.0 μmole of pyruvate to L-Lactate per minute (Sigma-Aldrich, 2012). 
CONDITIONS: T = 37oC, pH = 7.4 Wave length = 340 nm, light path length = 1 cm. 
METHOD: UV absorbance kinetic run determination. 
REAGENTS: 
A. Sodium Phosphate monobasic monohydrate Acros Product No. 207802500. 
(Prepare 0.1 M 200 mL in deionised water using Sodium monobasic monohydrate (mw = 
137.99 g/mol); Acros Product No. 207802500; weigh 2.7598 g and make up to volume). 
B. Sodium Phosphate Dibasic Sigma product No. S9763. 
LDH 
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(Prepare 0.1 M 200 mL in deionised water using Sodium phosphate dibasic (mw = 141.96 
g/mol); Sigma product No. S7907; weigh 2.8392g and make up to volume). 
C. 100mM Sodium phosphate buffer (SPB) solution pH 7.4. 
(Prepare 100mL in deionised water using 19 mL of 0.1 M sodium Phosphate monobasic 
monohydrate (Reagent A) and 81 mL of 0.1 M Sodium phosphate dibasic (Reagent B 
solutions). 
D. Lactate Dehydrogenase 29.9U, VWR Product No. A7979001. 
(Weigh 0.001g and make up to 25 mL Volume. Expected activity is 1.196 U/mL.) 
E. NADH Fischer Product No. BPE9747500. 
(Only freshly prepared solution should be used for assay. Prepare 0.5 mg/mL weighing 
0.005 g and make to 10 mL volume). 
F. Sodium pyruvate Fischer Product No. BP356-100. 
(Prepare 10 mg/mL in 100mM sodium phosphate buffer solution (Reagent C) by weighing 
0.25g and making to 25 mL volume). 
APPARATUS: 
1. UV plate reader, Multiskan Spectrum, Thermo scientific. 
2.  96 clear round bottom well plates, Fischer product FB56412. 
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PROCEDURE: 
 
Figure A 5: Flat bottom 96 well clear plate (400 μL volume) set up for determination of 28 
unknowns.       Contains 180 μL of prepared NADH (reagent). +/- controls are contained in 
 
1.  Reconstitute unknown lyophilised sample to original or desired volume with distilled 
water. Dilute 50% of the resulting solution with equal amount of 100mM SPB (Reagent 
C). Thus making a 1:2 dilution. 
2. Pipette the following amounts of Reagents into specified wells (Figure A 5). 
Reagent Volume (μL) Well 
F (NADH) 180 
A1-G12 
H10-H12 
C (SPB) 200 H7-H9 
E (LDH) 20 H1-H3 
3. Pipette 20 μL of unknown sample into Wells A1-G12. 
4. Leave to incubate for 20 minutes to allow LDH to uniformly mix with NADH.  
+/- 
Control 
 
180μL of NADH in 100mM SPB 
20 μL of unknown 
20 mins Incubation 
100 μL Pyruvate 
 Buffer  Blank NADH  Known 
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5. Pipette 100 μL of sodium pyruvate (Reagent A) into all unknown and known sample 
wells to initiate reaction. 
6. Measure absorbance at intervals of 30 seconds over 20 minutes. 
CALCULATION 
 
 
               ( )   (
                                        
                        
)       
 
(A.2) 
Dilution factor = 2 
Extinction coefficient of NADH = 6.2 mM-1cm-1 (Relyea et al., 2005). This is best determined 
from a calibration curve. Calculate the amount in total volume of assay (0.003 mL). 
REFERENCES 
GRANT, Y. (2010). Engineering the rational design and optimisation of lyophilization 
processes for biological materials. Doctor of Engineering, University College London. 
HENNIGER, G. (2003). Enzymatic Techniques for Authenticating Food Components. In: 
LEES, M. (ed.) Food Authenticity and Traceability. Cambridge: Woodhead Publishing 
Limited. 
KRIEG, A. F., ROSENBLUM, L. J. & HENRY, J. B. (1967). Lactate dehydrogenase 
isoenzymes a comparison of pyruvate-to-lactate and lactate-to-pyruvate assays. Clinical 
chemistry, 13, 196-203. 
RELYEA, H. A., VRTIS, J. M., WOODYER, R., RIMKUS, S. A. & VAN DER DONK, W. A. 
(2005). Inhibition and pH dependence of phosphite dehydrogenase. Biochemistry, 44, 6640-
9. 
SIGMA-ALDRICH. (2012). Enzymatic Assay of L-Lactic Dehydrogenase (EC 1.1.1.27) 
[Online]. Sigma-Aldrich. Available: http://www.sigmaaldrich.com/technical-
documents/protocols/biology/enzymatic-assay-of-lactic-dehydrogenase.html [Accessed 
28/05/12 2012].  
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Appendix IV: Standard operation procedure for optimisation of 
excitation and emission wave lengths for Anti-FITC IgG 
fluorescence quenching assay 
 
PRINCIPLE: 
A very small Stokes shift if present requires that excitation and emission wave lengths in a 
fluorescence assay need to be optimised. 
 
Figure A 6: Optimised excitation and emission reading wavelengths. Image drawn from 
Molecular Devices Spectramax Gemini XS Operators Manual. 
 
In an assay, best results are obtained when the reading wave lengths are not the same 
wave lengths as that of the fluorophore. Separating the reading excitation and emission 
 
 
 
 
Stokes shift 
Fluorophore’s 
excitation 
maximum 
Excitation 
reading 
wavelength 
500            550         600              650 
Emission reading 
wavelength 
1.0 
0.5 
R
e
la
ti
v
e
 F
lu
o
ro
s
c
e
n
c
e
 
Wavelength (nm) 
Fluorophore’s 
emission 
maximum 
253 
 
wave lengths allow a smaller amount of excitation light to pass through the emission 
monochromator onto the photomultiplier tube. 
METHOD:  
Spectral scanning to optimise excitation and emission wavelengths. 
REAGENTS: 
A. 10mM sodium borate pH 9.2 
(Prepare 1L in deionised water using sodium borate, Decahydrate; Sigma Product No. 
S9640; weigh 3.8137g and make up to volume)  
B. Bovine gamma globulins, Sigma Product No. G7516-10G 
C. Sodium Azide, Sigma Product No. S7653 
ABC. Assay diluent buffer solution 
 (Prepare 10L in deionised water using Reagent A, B and C; weigh 10 mg each of B and C, 
dissolve in A) 
D. Fluorescein sodium, Fluka analytical Product No. 46960 
E. 0.01 M NaOH solution 
(Prepare 50mL in deionised water using sodium hydroxide, Sigma Product No. S5881) 
DE. 1 mM Fluorescein stock solution 
 (Prepare 20mL in Reagent E; Weigh 7.6 mg of Fluorescein (Reagent D) and make up to 
20mL volume using 0.01 M NaOH solution (Reagent E).) 
 
APPARATUS: 
1. Fluorescence plate reader, Molecular Devices Gemni, USA. 
2. Black 96 well plate, Greiner Product No. 655076 
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PROCEDURE:  
1. Pipette 10 μL of sample and 190 μL of 0.8mM fluorescein into well A1 of the 96 black 
well plate. 
2. Pipette 200 μL of assay diluent buffer into well B1. 
3. Set up the following parameters on the fluorescence plate reader using the 
SOFTmax PRO software: Spectrum mode, Emission fixed/Ex scan, no cut-off filter 
and medium PMT (Photo multiplier tube) sensitivity.  
4. Set emission wave length of fluorescence to 520 nm. 
5. Set excitation wave scan to start and stop from 470 nm to 570 nm in step wise 
increments of 1 nm. 
6. Perform the scan. 
7. Note the excitation wave length at the emission peak and the maximum RFU 
(Relative fluorescence unit) value from the results obtained in step 6. 
8. Select the optimum excitation wave length with minimum interference from the assay 
diluent buffer spectra. If the difference between excitation peak maximum and the 
emission wave length is less than 80 nm, use the shortest wave length 
corresponding to 90% of maximal emission. 
9. Set up the following parameters on the fluorescence plate reader using the 
SOFTmax PRO software: Spectrum mode, Ex fixed/Em scan, no cut-off filter and 
medium PMT (Photo multiplier tube) sensitivity.  
10. Set Excitation wave length to the optimum excitation wave length determined in step 
8.  
11. Set emission wave length scan to start and stop from 520 nm to 570 nm in a 
stepwise increments of 1 nm. 
12. Perform scan and from results choose the wave length giving the maximum 
emission. 
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13. Repeat steps 9-12 using an emission cut off filter of 515 nm to block as much 
residual excitation light as possible without reducing the fluorescence signal. 
14. Compare the spectra of the sample containing fluorescein to the spectra of the assay 
diluent buffer for an estimate of the signal to noise ratio. Repeat step 11 to choose 
another cut-off filter wave length of significant background noise still persists. 
15. The optimum excitation and emission wave lengths are those chosen in step 8 and 
step 12. 
GLOSSARY 
Cut-off: blockage of unwanted residual excitation light using filters to minimise background 
interference. 
Emission fixed/Ex scan: Scan with desired emission wavelength kept constant while the 
excitation wave length is scanned in increments of specified wavelength. 
Ex fixed/Em scan: Scan with desired excitation wavelength kept constant while the emission 
wave length is scanned in increments of specified wavelength. 
PMT (Photo multiplier tube): vacuum tube that detects light. Its sensitivity can be set to low, 
medium and automatic. 
REFERENCE 
MOLECULAR DEVICES CORPORATION. (2000). Spectramax® Gemini XS Operators 
Manual. Using Spectral scanning to optimise Excitation and emission wavelengths for 
fluorescence assays. Page 5-8. 
  
256 
 
Appendix V: Standard operating procedure for fluorescence 
quenching assay for Anti FITC IgG. 
 
PRINCIPLE: 
A fluorescence quenching assay offers a simple analytical method for quantifying proteins. 
When attached to a protein, fluorescein will fluoresce when exposed to an excitation wave 
length of 491 nm and subsequently emit at 520 nm. If present, Immunoglobulin G raised 
against fluorescein isothiocynate (Anti-FITC IgG) will bind to fluorescein in solution and thus 
quench the fluorescence intensity of fluorescein present (Figure A 7).  
 
            Fluorescein                              X                   Fluorescence  
Figure A 7: Principle of Fluorescence quenching assay 
CONDITIONS: T = 25oC, Excitation wave length = 485 nm, Emission wave length= 520 nm 
METHOD: Fluorescence kinetic run determination 
REAGENTS: 
A. 10 mM sodium borate pH 9.2 
(Prepare 1L in deionised water using sodium borate, Decahydrate; Sigma Product No. 
S9640; weigh 3.8137g and make up to volume)  
B. Bovine gamma globulins, Sigma Product No. G7516-10G 
C. Sodium Azide, Sigma Product No. S7653 
ABC. Assay diluent buffer solution 
 (Prepare 1L in deionised water using Reagent A, B and C; weigh 1g each of B and C, 
dissolve in A) 
Anti-FITC 
IgG 
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D. Fluorescein sodium, Fluka analytical Product No. 46960 
E. 0.01 M NaOH solution 
(Prepare 200mL in deionised water using sodium hydroxide, Sigma Product No. S5881) 
DE. 1 mM Fluorescein stock solution 
 (Prepare 20mL in Reagent E; Weigh 7.6 mg of Fluorescein (Reagent D) and make up to 
20mL volume using 0.01 M NaOH solution (Reagent E). 
APPARATUS: 
1. Spectrometer, Jenway 6405UV/VIS  
2. Fluorescence plate reader, Molecular Devices Gemni  
3. Black 96 well plate, Greiner Product No. 655076 
PROCEDURE: 
1. Estimation of the concentration of fluorescein stock solution 
1. Take a sample of 100 µL of 1 mM fluorescein stock solution (Reagent DE) and dilute by 
a 100folds with 9900 µL of 0.01 M NaOH (Reagent E). 
2. Test absorbance using spectrophotometer at a wave length of 491 nm and calculate the 
concentration of fluorescein using published extinction co-efficient, ɛ = 8.72x 104 L/mol/cm.  
From Beer Lamberts law, Concentration = (Al/ɛ) x dilution factor Where dilution factor = 100 
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2. Determination of concentration of Anti-FITC IgG  
 
Figure A 8: Black flat bottom 96 well plate (400 μL volume) set up for assay.          contains 200 
μL of reagent ABC, ¤ contains 380 μL of reagent ABC, ψ contains 240 μL of reagent ABC, * 
contains 1 μM reagent fluorescein, and # contains 30 nM reagent fluorescein. 
  
1. Pipette the following amounts of assay diluent buffer (Reagent ABC) into the following 
wells: 
Volume (μL) Well 
380 E9, F9, G9, H9 
200 
E10, F10, G10, H10, A5-
A8, B1-B8 to H1-H2 
240 A1-A4 
2. Pipette 20 µL of test sample into well E9, F9, G9 and H9. 
3. Add 20 μL of unknown sample to E9, F9, G9, H9 to make 20 in 400 i.e. 1: 100 dilution.  
  
Empty 
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ψ ψ ψ ψ 
¤ 
¤ 
¤ 
¤ 
# # * 
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4. Pipette 200 μL from E9 in to the adjacent well E10 (10 μL of unknown sample in 400 μL 
reagent ABC) and repeat for F9, G9 and H9. 
5. Pipette 160 μL from E10, F10, G10 and H10 into wells A1, A2, A3 and A4 respectively (4 
μL of unknown sample in 400 μL of reagent ABC i.e. making 1:100 dilution) 
6. Pipette 200 μL from wells A1 to perform a 200 μL serial dilution down to well H1. Repeat 
this step for wells A2-A8. 
7. Dilute 0.8mM fluorescein (Reagent DE ; Concentration obtained from absorbance 
measurement) to 1 µM (800times dilution) by taking 10 µL and adding 7990 µL assay 
diluents buffer (Reagent ABC). 
8. Dilute the 1 µM fluorescein solution to 30 nM by making up to volume in a 100mL 
volumetric flask with assay diluents buffer (Reagent ABC).  
9. Add 100 µL of the 30 nM fluorescein to all wells with serial dilutions of unknown sample.  
10.  Test for fluorescence at 5 minutes intervals for 2 hours using excitation 481 nm and 
emission 520 nm with 515 nm filter cut off. 
11. Plot relative fluorescence intensity versus antibody sample dilutions and determine 50% 
fluorescence quenching (Figure A 9).  
CALCULATION: 
12. Find the final antibody sample dilution that corresponds to 50% quenching of the 
fluorescein. At this dilution, 5 nM fluorescein is bound to the antibody. Assuming 
antibody binding sits are saturated with fluorescein, the concentration of bivalent IgG 
antibody is 2.5 nM. 
Molecular weight of Sheep IgG = 160 kDa 
Estimated content of specific antibody = 2.5 nM x160 kDa x dilution factor g/L 
E.g. if at 50% quenching D = 1:5000 Then specific antibody = 2 g/L 
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Figure A 9: Typical fluorescence quenching curve showing specific antibody recovery after 
120 minutes quenching.  
 
REFERENCES: 
WALKER, D. (1987). A fluorescence technique for measurement of concentration in mixing 
liquids. Journal of Physics E: Scientific Instruments, 20, page 217. 
CHERRY, C. (2010). Laboratory book extracts. MicroPharm Wales, UK. 
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Appendix VI: Typical freeze drying cycle plot for samples studied 
 
 
Figure A 10: Typical thermogram from bulk freeze drying of 1 %w/v mannitol solution. 300mL 
sample volume was lyophilised in stainless steel tray. Product temperature was measured as 
an average reading from two k type thermocouples placed at the bottom centre and bottom 
edge.  
 
Figure A 11: Typical example of freeze drying process cycle of mannitol bulk lyophilised from 
0.5 M mannitol solution. Formulation was cooled at 0.2 °C/min. Product temperature was 
measured as an average reading from two k type thermocouples placed at the bottom centre 
and bottom edge.  
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Figure A 12: Typical example of freeze drying process cycle of mannitol bulk lyophilised from 
0.5 M mannitol solution. Formulation was cooled at 1 °C/min. Product temperature was 
measured as an average reading from two k type thermocouples placed at the bottom centre 
and bottom edge.  
 
 
Figure A 13: Typical example of freeze drying process cycle of mannitol bulk lyophilised from 
0.5 M mannitol solution. Formulation was cooled at 0.2 °C/min and annealed at -20°C (2 hours). 
Product temperature was measured as an average reading from two k type thermocouples 
placed at the bottom centre and bottom edge.  
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Figure A 14: Typical example of freeze drying process cycle of mannitol bulk lyophilised from 
0.056 M mannitol solution loaded onto pre-cooled shelf. 
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Appendix VII: Freeze drying cycle plot for samples studied with x-
ray microcomputer tomography. 
 
 
 
 
Figure A 15: Thermograph of freeze dried 1 M mannitol-platinum dispersion 1. Insert: 
Magnification of observed nucleation event. 700 µL sample volume was freeze dried in straws 
for microcomputer tomography investigation. Product temperature was measured using a k 
type thermocouple.  
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Figure A 16: Thermograph of freeze dried 1 M mannitol-platinum dispersion 2. Insert: 
Magnification of observed nucleation event. 700 µL sample volume was freeze dried in straws 
for microcomputer tomography investigation. Product temperature was measured using a k 
type thermocouple. 
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Appendix VIII: Typical MDSC thermographs form pre-formulation 
characterisation. 
 
   
 
Figure A 17: Typical MDSC thermographs. Top: 15 %w/v mannitol showing a eutectic melt (Teu) 
at -1.45 C. Bottom: 15% w/v sucrose showing a glass transition (Tg’) at -31.31°C. 
Method Log: 
1: Data storage: Off 
2: Equilibrate at -45.00°C 
3: Modulate +/- 1.00°C every 60 seconds 
4: Isothermal for 5.00 min 
5: Data storage: On 
6: Ramp 5.00°C/min to 10.00°C 
7: End of method 
 
Method Log: 
1: Data storage: Off 
2: Equilibrate at -40.00°C 
3: Modulate +/- 0.50°C every 100 
seconds 
4: Isothermal for 5.00 min 
5: Data storage: On 
6: Ramp 1.00°C/min to 20.00°C 
7: End of method 
 
